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Informing the development of a self-management care programme for 
older persons with type 2 diabetes in Community Health Centers in 
Cape Town, South Africa 
                                                     
                                                   Abstract 
Diabetes is a growing problem globally, with the major impact being experienced in low 
and middle-income countries. In 2017, there were an estimated 122.8 million people over the age 
of 65 years living with diabetes globally,  with a prevalence of 18.8% and 3.2 million deaths at this 
age. If the trends continue, the number of people living with diabetes over the age of 65 years will 
be 253.4 million in 2045.This is being driven by demographic changes including the ageing of the 
population. In South Africa, diabetes is a major cause of morbidity and mortality and a burden to 
the overstretched health services, community, family and people with the disease. Self- care 
management is a cornerstone of diabetes care. The purpose of this thesis is to inform the 
development of a self-care management programme for older people attending public sector 
primary health care services in Cape Town, South Africa by using the PRECEDE planning model. 
This model provides an eight-phase framework for health care professionals to determine, 
develop, implement and assess health promotion programmes, as well as the application of health 
promotion theories systematically within such programmes. 
The thesis incorporates five interlinked studies, presented as five publications, two published and 
three in review: The first was a systematic review of studies that assessed the prevalence of type 
2 diabetes mellitus among older people in African countries conducted between 2000 and 2015 
with the objective of providing data for the monitoring of future trends. This demonstrates that type 
2 diabetes is not rare in individuals aged 55 years and older across Africa – the overall prevalence 
of diabetes was 13.7% (95% CI 11·3–16·3) and was twofold higher in studies based on the oral 
glucose tolerance test than in those using fasting plasma blood glucose. The second is a 
secondary analysis of the Study on global AGEing and adult health (SAGE) South Africa Wave 1 
data that examined the prevalence of self-reported diabetes and the association between 
diabetes and each of health-related quality of life and disability amongst South Africa’s older 
adults. The results were that diabetes was associated with lower quality of life and greater 
 xii 
 
disability: it represented not only a risk factor for disability but was associated with a range of 
impairments and co-morbidities predisposing to loss of autonomy.  
The third, a cross-sectional survey, examines the knowledge of older people with diabetes 
attending primary care clinics in Cape Town, South Africa, about living with and managing their 
diabetes; and aims to determine the relationship of social support, especially that of family and 
friends with their self-management. Its major finding is that there was a lack of knowledge about 
the complications of diabetes, suggesting that the available diabetes educational opportunities 
have not been effective. Importantly, however, social support was positively associated with both 
knowledge and a number of self-care aspects. The fourth is a qualitative study consisting of 
documentary review and individual interviews with key informants to investigate the current 
policies, programmes and any other interventions as they relate to older people with diabetes. 
This found that generally older persons face numerous barriers in managing their condition. 
Further, there are multiple efforts to re-orientate the healthcare system to focus more effectively 
on non-communicable diseases for the population which would benefit older patients with 
diabetes. Finally, the study includes a systematic review of peer and non-professional health 
worker-led diabetes self-management programmes (COMP-DSMP) in low and middle-income 
country primary health care settings, and also examines the implementation strategies and 
associated diabetes-related health outcomes This found equivocal evidence supporting the use 
of COMP-DSMP for people with diabetes in these countries and suggested that the models of a 
peer/CHW-led programme need to be further explored, especially given the inevitability of a 
professional healthcare workforce shortage in LMICs.   
In conclusion, this research study has described the extent of the need for developing and 
evaluating education programmes that focus on older people with diabetes and emphasises the 
role of family and friends. Whilst there have been some significant policy interventions pertaining 
to the protection of the health and welfare of older persons in SA, the needs of this vulnerable 
group remain relatively low on the list of priorities in terms of focus and resource allocation. In this 
context, older people, as a distinct group, are also not a strong focus in current health policy 
relating to the provision of NCD care. This thesis alerts policymakers and clinicians to some of 
the specific issues considered to be pertinent and important in the care and management of older 
persons with diabetes. Many of these would also be applicable to older individuals with other 
chronic conditions. 
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Chapter 1    
Introduction 
 
1.1 Study background  
Population ageing is a global phenomenon However the definition of old age varies across countries 
and regions, influenced to an extent by demographic trends, such as high or low life expectancy, 
and social, cultural and political factors (1). The World Health Organization (WHO) posits the 
chronological age of 65 years as an acceptable definition of older persons in developed countries. 
This like many westernized concepts, may not be appropriate or directly translatable to all of Africa., 
but as a result of the changing in legislation via the Social Assistance Amendment Act, 6 of 2008, 
South Africa aligned itself with the WHO’s definition of the ‘older persons’ as all persons over the 
age of 65 years (2-3).  
At present, there are approximately 600 million people over the age of 60 globally. This number is 
projected to increase to approximately 2 billion by 2050 (1). There were in Africa an estimated 50.5 
million people of the same age group in 2007 and 64.5 million in 2015; this number is projected to 
exceed 103 million in 2030 and 205 million in 2050; with the annual growth rate exceeding that of 
the general population (2). South Africa (SA) is also experiencing the ageing of its population, driven 
by declining fertility and mortality. There the population aged 60 years and older numbered over 4.5 
million in 2016, thereby accounting for just over 8% of the South African population (3-4). 
 The number of people with diabetes globally is also increasing. According to the updated figures 
of the International Diabetes Federation (IDF) Atlas 8th edition, it has been projected that there 
would be a rise from 451 million people with diabetes in 2017 to 693 million by 2045 (5). In 2017, 
there were an estimated 122.8 million people over the age of 65 years living with diabetes, with a 
prevalence of 18.8% and 3.2 million deaths at this age which counts for more than 60% of all deaths 
attributable to diabetes in people over the age of 17 years. If the trends continue, the number of 
people living with diabetes over the age of 65 years will be 253.4 million in 2045 (5). 
The 8th edition of the IDF Atlas (2017) estimated 15.9 million people aged 20–79 have diabetes in 
the sub-Saharan Africa (SSA) region, representing a prevalence of 2.1–6.7%. SSA has the highest 
percentage of undiagnosed cases of diabetes; over two-thirds (66.7%) of individuals with diabetes 
are unaware of their status (6). The majority of individuals with diabetes (58.8%) live in towns, 
although the population in the region (61.3%) is mainly rural. It is concerning that studies suggest 
that Africa has the highest age-specific mortality rate in the world (6–7).  
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In South Africa, non-communicable diseases (NCDs), including diabetes, continue their increase in 
the rankings of top 10 leading causes of death, with DM moving from the third position in 2014 to 
the second position in 2015 (8). NCDs accounted for 63% of the top 10 leading causes of death 
among women aged 65 and above, whereas among men in the same age group these constituted 
48.0% (8). The rising number of people with DM together with other NCDs added to the other 
ongoing burdens of HIV/AIDS, and Tuberculosis (TB) is causing a major impact on the country’s 
healthcare system, in particular, the primary healthcare facilities (9) – originally equipped to deal 
with patients with acute conditions – are now struggling to provide adequate care for those with 
NCDs. Therefore, levels of control of diabetes are poor, leading to high rates of complications (9–
11).  
Older persons with diabetes are at a higher risk of microvascular and macrovascular disease such 
as ischaemic heart disease, peripheral artery disease, stroke, heart failure, and chronic kidney 
disease (12–15). Additionally, their  demands for hospital care are increased two to three times 
compared with an aged-matched non-diabetes population,(18) with more frequent clinic visits and 
a five-fold higher admission rate. Acute hospital admissions account for 60% of total expenditure in 
this group (18).  
Given that patients visit healthcare professionals only periodically, health promotion activities 
focused on self-management is vital to the maintenance of long-term health for older persons. (19) 
Self-management is a process whereby persons and their families maintain health through health-
promoting practices and managing disease. Individuals use self-management as they respond to 
signs and symptoms when they occur (20). Self-management in diabetes focuses on a balance of 
dietary intake, exercise, medication management and the self-monitoring of blood glucose (SMBG) 
which constitutes its four main cornerstones (21). Individuals who engage in self-care maintenance 
adhere to those behaviours needed to maintain physical and emotional stability. 
Self-management is an essential element of the Chronic Care Model (CCM), it develops the role of 
healthcare professionals from delivering information and traditional patient education to include 
helping patients build confidence and make choices that lead to improved self-management and 
better outcomes (22–26). The literature on diabetes encompasses evidence that specific self-
management interventions, including the introduction of blood glucose-lowering medications or new 
insulin delivery systems, and educational and counselling interventions designed to facilitate the 
development of diabetes-specific coping skills, can improve both glycaemic control and quality of 
life in people with diabetes (27–34). Thus, to preserve the best possible quality of life, the person 
diagnosed with diabetes must be supported in overcoming any barriers associated with older age 
and his or her diabetes care. It has been recommended that age does not influence a person's 
ability to learn new diabetes management skills (35–40). However, self-management is challenging 
for all those with the condition but is likely to create a higher demand for those who may have 
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existing co-morbidities associated with age and long-standing chronic illnesses such as diabetes. 
(37).  
1.2. Problem statement  
Because of concerns about cognitive problems and co-morbidities, individuals older than 65 years 
are often excluded from clinical research trials. As a result, there is little evidence globally, let alone 
in LMICs, on how best to support older persons’ self-management efforts (37). Although there are 
numerous guidelines for the management of diabetes, only a few are specifically designed for older 
persons with diabetes (38-40). Furthermore, the current support programmes, particularly those 
that are disease-specific, such as those for diabetes, may not be relevant to the specific self-
management support needs of older persons with multiple co-morbidities or chronic disability (41–
43). Additionally, many frail older individuals do not only suffer from multiple diseases:  cognitive 
impairments and poor mental health often also coexist (44). Hence, research is needed to find out 
which approach in management best meets the needs of the older people with diabetes (45). In 
South Africa, little is known about older people’s knowledge about living with and managing their 
diabetes and the complications and challenges they face as regards an adherence to lifestyle 
changes. Self-management approaches are needed to limit the consequences of this chronic illness 
for older persons and society(46-48). This is recognised as a gap in the research literature.  
1.3. Purpose of the study  
This study sets out to fill the current gaps in knowledge of diabetes in the older person in South 
Africa, with a view of developing a diabetes self-care management programme targeted at this 
group and therefore limiting the impact of the disease and improving their health-related quality of 
life. Furthermore, the study findings may provide the healthcare professional and health 
policymaker with a better understanding of self-management practice of older persons with diabetes 
attending primary care settings in Cape Town, South Africa where little research has been done.  
1.4. Theoretical framework    
The critical question of health promotion programme planning is to understand what the community 
wants, what is needed, and, what can be done. The three areas overlapped represent what can be 
achieved, but, resources, time and other boundaries do not allow everything to be addressed and 
so areas must be prioritised (49). This study is framed within the PRECEDE-PROCEED theoretical 
model (50–51) and uses a mixed-methods approach with the following objectives:  
1.5. Study objectives 
Objective 1:   To examine the association between self-report diabetes and each of health-related 
quality of life and disability amongst South Africa’s older adults.  
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Objective 2: To conduct a systematic review of studies assessing the prevalence of type 2 diabetes 
mellitus among older people in African countries. 
Objective 3: To investigate the status of knowledge, self-management practice, and social support 
for South African older persons with type 2 diabetes and determine the relationship of social 
support, especially that of family and friends with their self-management. 
Objective 4: To identify and explore emerging policies and practices in diabetes self-management 
care for older persons in South Africa.  
Objective 5: To conduct a systematic review assess peer and non-professional health worker-led 
diabetes self-management programmes in the low and middle-income country (LMIC) primary 
healthcare settings, examine the implementation strategies, and associated diabetes-related health 
outcomes. 
1.6. Outline of thesis  
The thesis is structured as follows. Chapter 2 provides a comprehensive literature review of the 
major concepts in the study. Chapter 3 briefly describes the methodological approaches that were 
undertaken for each of the objectives by applying the PRECEDE planning phase (Phase 1 to Phase 
4). The 5 papers relating to the various objectives are to be found in Chapters 4 to 8. The paper in 
Chapter 4 presents the systematic review of studies assessing the prevalence of type 2 diabetes 
mellitus among older people in African countries conducted between 2000 and 2015 with the 
objective of providing data for the monitoring of future trends. The paper in Chapter 5 examines the 
prevalence of self-report diabetes and the association between diabetes and each of health-related 
quality of life and disability factors amongst South Africa’s older adults as assessed using SAGE 
Wave 1 data. The paper in Chapter 6 examines the knowledge of older people with diabetes 
attending primary care clinics in Cape Town, South Africa about living with and managing their 
diabetes; and to determine the relationship of social support, especially that of family and friends 
with their self-management. The paper in Chapter 7 reviewed current policies, programmes and 
any other interventions as they relate to older people with diabetes. The paper in Chapter 8 presents 
the systematic review to assess peer and non-professional health worker-led diabetes self-
management programmes in the low and middle-income country (LMIC) primary healthcare 
settings, examines the implementation strategies, and associated diabetes-related health 
outcomes. Chapter 9 provides a summary of the major findings in the context of public health, 
practice, policy impact, recommendations regarding the self-management care programme 
development and other appropriate strategies and future research. 
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1.8. Chapter summary 
In this chapter an overview of the study context, aims, objectives and theoretical framework has 
been presented and the research work done for this PhD thesis briefly described, so as to inform 
the development of a self-care management programme for older persons with type 2 diabetes who 
live in Cape Town, South Africa.  
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Chapter 2 
Literature review 
 
2.1. Chapter outline 
This literature review provides an overview of literature dealing with population ageing in Africa and 
South Africa; diabetes mellitus in the ageing population; the challenges of managing diabetes in 
African settings; diabetes self-care management/education; the challenges faced by older people 
in primary healthcare settings; and concludes with a description of the health promotion theoretical 
framework that underpins the body of this work. Library database searches were undertaken in 
medical and healthcare fields for relevant papers and reports in the last fifteen years (2000–2015) 
since significant developments in diabetes management have been published in that time. 
2.2. Part 1:  Population ageing in Africa 
According to the United Nations Department of Economic and Social Affairs (UNDESA) 2017 
Revision, the world’s population numbered nearly 7.6 billion as of mid-2017(1). Africa is often 
referred to as the youngest continent regarding age structure (2). However, this is changing 
dramatically, and the continent is projected to experience the fastest rate of growth of numbers of 
older persons than any other continent by 2050 (3). The number of persons aged 60 and over in 
Africa is expected to increase from 50.5 million in 2007, to 64.5 million in 2015, and  to reach 205 
million by 2050 (3). This represents a rate of increase of double the yearly population growth, with 
the figure of older individuals in the population increasing at an annual rate of 3.1% between 2001 
and 2015  and of 3.3% between 2015 and 2050,  as shown in Figure 2.1 (3).   
   Figure 2–1 Population aged 60–79 years and 80 years or over in sub-Saharan Africa, 1990–2050 (3) 
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As seen in Figure 2–2, in 2000 South Africa, had the greatest proportion of older people in its 
population (7%), in Africa, followed by Cameroon with 5.2% and Ghana with 5.1% (4). The  World 
Health Organisation (WHO) estimates suggest that the ageing population of South Africa will 
increase to 11.5% in 2030, followed by Ghana with 9.5% and Kenya with 6.7% (Figure 2–.2) (4). 
The latest WHO predictions are  that South Africa's older population is projected to more than 
double,  from 7.2% to 15% of the country’s total population by 2050 (5) and from about 4.2 million 
to 10.6 million. 
   Figure 2–2 The percentage of the population 60 years and over in African countries, 2000 
and 2030 (4).  
 
2.2.1. Demographic profiles of older persons in South Africa 
There have been a few reports about the rise in the ageing population in SA over the past few 
years. The percentage population growth of older persons by  province in South Africa  is shown in 
Table 2–1. (6) The provincial variations show that the population size of older persons was 6.2% to 
9.2% in 2001  and 6.8% to  9.5% in 2016. (6) In 2016, the highest population growth of older people 
was documented in the Northern Cape, where the older persons represented almost 10 % of the 
provincial population, followed by the Western Cape with a 9.5% growth rate. These variations can 
be attributed mainly to the outmigration of young people in search of opportunities, in the case of 
the Northern Cape, and because of an inflow of the older persons, in the case of Western Cape, as 
the province is generally observed as a good retirement destination.(6) 
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     Table 2–1 Percentage growth in the population of older persons, 2001–2016 by Province  
in South Africa  (6) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2–.2 shows the population distribution of older persons by age and sex. Between 2011 and 
2016, the age group 60–64 contained the largest proportion of older persons, followed by age group 
65–69, whilst the age group 85+ comprised only 5% of older people in 2016. (8)  There was a higher 
proportion of men than women amongst the age groups 60–64 and 65–69, but this changed after 
the age of 70 years. (6) This demonstrates the ageing phenomenon in which women tend to live 
longer than men and hence constitute the majority of the older people. In 2016, there was an 
increase in the proportions of older persons among both sexes in the age groups 60–64, 65–69 and 
70–74. After age 75, there is a steady decline in the percentage of older persons for both sexes, 
with a sharper decline for men than for women. (6) 
 
Province 
 
2001 
 
2007 
 
2011 
 
2016 
Western Cape 7.8 8.6 8.9 9.5 
Eastern Cape 9.2 9.6 9.7 8.1 
Northern Cape 8.2 9.0 8.6 9.6 
Free State 7.3 8.0 8.3 8.7 
KwaZulu-Natal 6.9 7.0 7.6 7.3 
North West 7.3 7.6 8.3 8.0 
Gauteng 6.2 6.9 6.9 8.7 
Mpumalanga 6.3 6.5 7.0 6.8 
Limpopo 7.7 8.5 8.6 7.6 
South Africa (Overall) 7.3 7.8 8.0 8.1 
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Table 2–2 Distribution of persons aged 60 years and older by age and sex, 2011 and 2016 in South 
Africa (6). 
           Source: Report: Vulnerable Group Series II 2011–2016 (6)  
  
2.2.2 The social and economic situation of older people in South Africa  
  
The social and economic situation of older persons in SA is deteriorating, migration and 
urbanisation poor education, unemployment, lack of access to basic services and poverty and the 
huge burden of HIV and NCDs had been identified as contributing factors to the destabilisation the 
older persons in a closely-knit age-integrated African society (6). These factors have combined to 
impact not only older people’s financial security but also traditional levels of respect and valuing (6).  
2.2.2.1. Living arrangements: 
The living arrangements of older persons are made up of many factors, including cultural values 
regarding co-residence and intergenerational ties and family support. Between 2011 and 2015, the 
proportions of older persons living alone increased by 1.4 percentage points from 8.8% to 10.2%. 
(7). In South Africa and elsewhere, living alone poses certain risks for older people, especially if 
they have limited resources to sustain themselves. Living arrangements are reported to influence 
an older person’s ability to access services, including healthcare and social support to ensure their 
needs are met as they age. (7) 
2.2.1.2. Old-age grant 
Over time, South Africa has experienced a decline in the proportion of economically active people 
employed by the formal sector, because of the shrinking of the national economy. This has led to 
the retrenchment of workers and/or compulsory early retirement, although there has been 
expansion of the informal sector (7). Concerningly, the high levels of unemployment and poverty in 
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the country is making it difficult to save for old-age. This means that a growing proportion of the 
population is likely to be poor and in need of state support for their health and welfare needs (7). 
 
An old-age grant is a monthly income that is managed by the South African Social Security Agency 
(SASSA), a government agency. (8) In SA, over 3.1 million of persons aged 60 years and older 
received an old-age grant in 2015 compared to 2.6 million in 2011. The grant is paid out only to 
people whose financial income is below a certain level. It is the main source of income for most of 
the older persons in South Africa but, in many cases, older persons use their grants to support the 
entire family, which is mostly multigenerational. (8) In addition, people receiving old-age grants are 
open to financial abuse by other family members and may not fully benefit from this income. (8) 
Vulnerability to poverty is compounded by cumulative inequalities over the life course and health, 
function and survival are unequally distributed across the population. Poverty and poor living 
conditions significantly exacerbate the degenerative effects of ageing, increasing the likelihood of 
ill-health, disability and cognitive decline. (8) 
For those older people whose physical health enables them to pursue income generation activities 
there is often the obstacle of lack of opportunity. It is in the interest of the SA government to consider 
what potential exists to create employment opportunities or to support sustainable livelihoods for 
older persons (7). 
2.2.1.3. Educational attainment 
Low levels of educational attainment in South Africa often translate into poor living circumstances, 
as they have a bearing on the type of employment and income levels during a person's economically 
productive years as well as their ability to be financially independent after retirement. (9) Poor 
literacy levels are an essential factor that contribute to the negative well-being of older persons and 
their involvement in society. Literacy prevents social exclusion, especially when social interaction 
is made possible via various languages. (9) 
 
2.2.2. Health profile of older persons in South Africa 
As mentioned earlier, older persons are generally documented as a vulnerable group in need of 
special care and attention. The HIV/AIDS epidemic with resultant high mortality rates led to a 
‘hollowing out of a generation’ – a middle generation that traditionally took care of older people, now 
leaving  these older people – grandparents – to take care of  AIDS orphans.(10) The impact is 
demonstrated by a qualitative study in Western Cape townships, that found that grandmothers 
caring for a child with HIV/AIDS reported poorer socio-economic circumstances and health because 
of the economic and physical demands of caregiving (10-11).   
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 The increase in numbers of older persons in societies presents challenges which will result in 
greater problems in healthcare systems. (12) However, the challenge is predominantly significant 
in Africa, heightened by the concurrent problems of the highest global levels of poverty and the 
HIV/AIDS pandemic which affect the quality of life of millions of people and impact mainly older 
individuals who will need to combat a variety of co-morbidities. (13–14) In South Africa, the 
prevalence of NCD-related disability tends to increase with age, which increases the demand on 
health systems for the prevention and treatment of NCDs, including diabetes and their associated 
complications (15–16). In 2015 the three health conditions most common among the older South 
Africans were high blood pressure 45.3%, diabetes 15.8% and arthritis 13.8%. (17). 
 
2.3. Part 2: Diabetes mellitus in older persons 
In this section, the definition, classification, epidemiology, diagnosis, complications and co-morbidity 
of diabetes mellitus is discussed briefly.  
2.3.1. Definition and classification of diabetes 
Diabetes mellitus (DM)  defines a group of metabolic disorders characterised by increased blood 
glucose concentration. (18) Individuals living with diabetes have a higher risk of developing some 
life-threatening severe health problems resulting in higher medical care costs, a reduced quality of 
life and increased mortality. Persistently high blood glucose levels cause generalised vascular 
damage that affects the heart, eyes, kidneys and nerves and results in several complications. (18) 
There are three main types of diabetes: type 1 diabetes, type 2 diabetes and gestational diabetes 
(GDM): 
2.3.1.1. Type 1 diabetes mellitus  
Type 1 diabetes (T1DM), previously known as insulin-dependent or juvenile-onset diabetes, is an 
autoimmune disease in which the body's immune system reacts against and destroys the insulin-
producing beta cells in the islets  of Langerhans of the pancreas. (19) 
  2.3.1.2. Type 2 diabetes mellitus  
Type 2 diabetes mellitus (T2DM), earlier known as non-insulin dependent or mature-onset diabetes, 
is characterised by insulin resistance and relative insulin deficiency. (19) It has a genetic 
component, and lifestyle factors such as overweight, physical inactivity and inappropriate nutrition 
can trigger its development.(19) Internationally, it is the most prevalent form of diabetes, affecting 
85–95% of all diabetics in High-Income Countries (HICs), with a higher proportion in Low-Income 
Countries (LMICs). T2DM  occurs mainly in mature adults with the prevalence increasing in older 
age population.(19) 
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2.3.1.3. Gestational diabetes mellitus  
Gestational diabetes mellitus is carbohydrate intolerance of variable severity which is first 
diagnosed during pregnancy. It is often mentioned as the most frequent complication of pregnancy. 
(20)   
 2.3.2. Epidemiology of type 2 diabetes mellitus and an ageing 
population    
As seen in Figure 2–5, there are several risk factors proposed for the T2DM. Regardless of the 
genetic component, it is evident that many environmental and lifestyle factors can increase the 
possibility that a genetically susceptible individual will develop the disease in old age. (21) The 
results of large epidemiologic studies have demonstrated that diabetes is more likely to develop in 
older individuals who have a diet that is high in saturated fats and simple sugars and low in complex 
carbohydrates (22). Obesity with a central distribution of body fat, and a decrease in physical activity 
occur progressively with ageing, and both factors are associated with abnormal carbohydrate 
metabolism. (23)  
 
 Figure 2–3 Risk factors contributing to the high prevalence of T2DM in older persons (36)      
It was estimated that in 2017 there  were  451 million people with diabetes globally. These numbers 
were projected to increase to 693 million by 2045. (23) In 2017, it was estimated  that nearly half of 
all people (49.7%) living with DM were undiagnosed,  almost 5 million deaths worldwide were 
attributable to diabetes in the 20–99 years age range and  healthcare expenditure on people with 
diabetes was estimated to be USD 850 billion globally. (23)  
In 2017, an estimated 14.2 million people aged 20–79 in SSA were estimated to have diabetes, 
representing a prevalence of 2.1–6.7%. (23) The region  has the highest percentage of undiagnosed 
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cases of diabetes, with 66.7 % being unaware of their status. (24) The majority of individuals with 
diabetes (58.8 %) live in towns, although the population in the region (61.3 %) is mainly rural. With 
growing urbanisation and an ageing population, diabetes will pose an even greater threat. (24) 
There are extensive international data, for example, from Europe (DECODE), Asia (DECODA), 
Australia and the USA reporting a steady increase in the prevalence of diagnosed and undiagnosed 
type 2 diabetes among patients as they grow older, with values reaching a plateau or even declining 
slightly – in the very old. (25-28) In addition,   the prevalence of Impaired glucose tolerance (IGT) 
and impaired fasting glucose (IFG) both significant risk factors for the development of future 
diabetes, increase with age. (29) 
2.3.3. Diagnosis and diagnostic criteria of diabetes in older persons  
Current guidelines have a standard approach to the diagnosis and diagnostic criteria of diabetes. 
Table 2-3 shows latest WHO and International Diabetes Federation (IDF) criteria. The current cut‐
offs for the diagnosis of diabetes mellitus are ≥126 mg/dl (>7 mmol/l) for FPG, ≥200 mg/dl (≥11.1 
mmol/l) for 2h‐PG and ≥6.5% (≥48 mmol/mol) for HbA1c. (30) 
 
  Table 2–3 1999 WHO criteria for the diagnosis of diabetes (values in (mmol l) (30) 
 
Two specific guidelines provide diagnostic criteria or diabetes in the older persons: the 2004 
European Diabetes Working Party for Older People (EDWPOP) (31)  and the 2013 International 
Diabetes Federation (IDF) (older people with type 2 diabetes). (32) In the first case, these criteria 
arose from the WHO consultation (1999) and the 2004 American Diabetes Association (ADA) 
Expert Committee criteria. Later, the 2011 EDWPOP (31) clinical guideline for type 2 diabetes 
reinforced the concept that diagnosis of diabetes in the older persons should be in accordance by 
Diagnostic category Plasma glucose  Whole-blood glucose   
Venous Capillary Venous Capillary 
Diabetes         
Fasting or ≥7.0 ≥7.0 ≥6.1 ≥6.1 
2-h post load ≥11.1 ≥12.2 ≥10.0 ≥11.1 
 
IGT 
    
Fasting and <7.0 <7.0 <6.1 <6.1 
2-h post load 7.8–11.0 (incl.) 8.9–12.1 
(incl.) 
6.7–9.9 (incl.) 7.8–11.0 
(incl.) 
 
IFG 
    
Fasting and 6.1–6.9 (incl.) 6.1–6.9 
(incl.) 
5.6–6.0 (incl.) 5.6–6.0 
(incl.) 
2-h post load <7.8 <8.9 <6.7 <7.8 
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published national/international criteria and that no age‐modified criteria could be recognised. In 
the second case, IDF criteria came from 2006–2011 WHO guidelines. (31) 
2.3.4. Diabetes complications and multimorbidity in older persons   
The terms ‘co-morbidity’, ;multiple co-morbidity’, ‘multimorbidity’ and ‘multiple chronic conditions’ 
are used to define the presence of two or more medical conditions in the same patient and are very 
common in older persons, with more than half of them having three or more chronic conditions.(33–
34) Diabetes is associated with extensive morbidity from macro- and micro-vascular complications. 
Known risk factors for these include duration of diabetes, glycaemic control  and the presence of 
traditional risk factors such as smoking, hypercholesterolemia, and hypertension. (35)  In older 
people with diabetes, the risk of macrovascular complications (cardiovascular disease, 
cerebrovascular disease, and peripheral vascular disease) is two-fold higher than in with 
controls(52).  
Older persons with diabetes also have a higher prevalence of depression and impaired cognitive 
function when compared with age-matched controls without diabetes. (36) Depression in older 
persons with diabetes is a strong predictor of hospitalisation and death. (37–38) The changes in 
cognitive and affective function are closely correlated with lipid, blood pressure, and HbA1C values,  
and new studies suggest that improved glycemic control may enhance cognition and mood in this 
population group (39–41) Diabetes in older persons is a risk factor for vascular dementia and may 
also be a risk factor for Alzheimer's disease, though the latter is debatable. (42–44) 
When there is a cognitive decline the complexity of managing diseases increases considerably. 
This, together with the paucity of clear evidence-based treatment guidelines for the older person 
with diabetes, presents a significant challenge to health care professionals (45–48) This is, in part, 
because evidence-based guidelines designed for younger people who have diabetes cannot be 
simply generalised for the use of older persons without considering problems, such as 
multimorbidity, functional impairment, frailty and the need to assess individual goals, including the 
quality of life. (48)   
2.4. Part 3:  Diabetes care in sub-Saharan Africa 
 The health systems in most SSA countries are overwhelmed by the complex challenge of dealing 
with a considerable burden of acute and chronic infectious diseases and poverty while also 
addressing the increasing burden of NCDs, including diabetes. Most of the healthcare financial 
resources of these countries are focused on infectious diseases, such as tuberculosis, malaria and 
HIV/AIDS.(49-50)  
The Lancet Commission on Diabetes in Africa described an ‘inadequate availability of simple 
equipment for diagnosis and monitoring, a lack of sufficiently knowledgeable health-care providers, 
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insufficient availability of treatments, a dearth of locally appropriate guidelines, and few disease 
registries. Thus, access to diabetes care in SSA is not available to many of those who need it. As 
a result, people remain undiagnosed and those diagnosed with diabetes are frequently not receiving 
the advice and drugs they need. (51)    Still more people diagnosed with diabetes suffer devastating 
consequences such as amputation and blindness. Yet diabetes can be controlled and even 
prevented through the resourceful implementation of health promotion interventions focused on 
diabetes self-management education/support programmes. (52)  
2.4.1. Challenges of diabetes care in South Africa  
South Africa is undergoing the epidemiological transition typical of many low-to-middle-income 
countries, where rapid urbanisation, attendant changes in diets and levels of physical activity along 
with increased longevity have resulted in a significant increase in the incidence of chronic diseases 
of lifestyle. Diabetes and hypertension are the most common chronic health conditions among older 
people. This phenomenon is occurring in the context of high HIV prevalence, with co-morbidity 
being particularly pronounced among older persons. (53) A large percentage (40%) of this 
population is poor and dependent on state support for their health and welfare needs. (53)  
2.4.1.1. South African health care system  
The system of healthcare in South Africa consists of a government-funded public sector and private 
sector that work in parallel, and together consume 8·5% of the National Gross Domestic Product 
(GDP) (54). The public health sector is responsible for the provision of care to about 84% of the 
inhabitants and accounts for 4·2% of GDP, whereas the private sector consumes 4.3% of the 
national GDP for 16.4% of the inhabitants. Roughly 25% of uninsured persons pay out of pocket for 
private-sector care. Annual per capita expenditure on health ranges from US$ 1 400 in the private 
sector to about $ 140 in the public sector. (54)  
2.4.1.2. Health care services delivery for older persons in South Africa   
The SA government provides free healthcare services to older people in the public health sector 
(which caters for the 84% of South Africans who cannot afford private health insurance). (55) There 
are three categories of healthcare facilities currently used by older individuals. First, primary 
healthcare services are free to all older persons and deal with the prevention and care of conditions 
or diseases (55). Primary healthcare tasks affecting older persons include health promotion 
activities, the identification of individuals suffering from common chronic conditions or illnesses 
related to ageing, and therapeutic services for common chronic conditions. (55) Then, secondary 
healthcare facilities are also free to all those older persons receiving a social grant. Tasks of 
secondary healthcare facilities to older persons include diagnosis and treatment, referral to 
specialist care and rehabilitating services, etc. Thirdly, tertiary healthcare services provide specialist 
 20 
 
multi-disciplinary care for older persons with complex and multiple chronic conditions or diseases. 
(55)  
The types of healthcare services generally used by older persons aged 60 years and older by 
province are summarised in Figure 2–3. Approximately 85% of older persons aged 60 years and 
older utilised public clinics in Limpopo, while more than 70% in the Eastern Cape, KwaZulu-Natal, 
North West and Mpumalanga also made use of this type of facility. The use of public (district) 
hospitals was most common in the Western Cape (20%), followed by KwaZulu-Natal (8.6%). Private 
hospitals/clinics/doctors were most likely to be used by older persons living in the Western Cape at 
56.8 %,  with Gauteng at 46.8% and the Free State at 34.2%.(6) 
Figure 2–4 Types of health services used by older persons aged 60 years and older, by 
province, 2015 (6) 
Primary health services in SA are predominantly clinic-based and focus on acute conditions and 
are not well suited to managing the growing burden of chronic disease. Numerous studies have 
illustrated that NCDs and their risk factors are infrequently diagnosed and inadequately treated at 
the primary care level, resulting in high levels of uncontrolled hypertension, diabetes, hyperlipidemia 
and chronic respiratory disease. (56) Importantly, access to care is often a challenge for older 
individuals due to  the lack and/or cost of transport, particularly in rural areas, disability and child-
caring responsibilities Overcrowding and long waiting times at health facilities, fragmented or siloed 
care for multiple morbidities, and poor communication with healthcare providers are also commonly 
cited as barriers to care. (57)  
Furthermore, the public health sector is not prepared to deal with the multifaceted needs of older 
persons with co-morbidity. For instance,  in 2013  the National Health Facilities Baseline Audit 
reported (58) on a survey of 3 356 clinics and community health centres that found that most clinics 
had facility managers but nearly half of the clinics had no visiting doctors; 84% had no assistance 
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from a pharmacist or pharmacy assistant; 11% had no lay counsellors; 57% had no administrative 
support; and 79% had no information management staff. (58) In addition, given time and resource 
restrictions, fee structures and the typical nature of doctor-patient-relationship, many healthcare 
professionals, including private healthcare professionals, do not provide older persons with 
adequate care or struggle to identify frailty and dementia. (58)  
There is little specialised training in geriatrics in South Africa and limited undergraduate exposure 
to geriatric syndromes in medical training (59) There are only a few departments of geriatrics that 
exist in South African academic medical facilities.  Kalula et al. 2007  have criticised the current 
situation in South Africa, stating that ‘older persons care is not a priority in institutional planning and 
training curricula, and that most health professionals complete medical training without adequate 
exposure to geriatric medicine’. (60)  
 The Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA)   recently 
suggested that  ‘ [a] holistic individualised care plan for older persons, with the aim of sustaining 
independence should be sought’. (61) The increase in diabetes amongst disadvantaged people, 
including older persons, puts a massive demand for the provision of health education and diabetes 
care services on district hospitals and health centres and clinics. Therefore, practical guidelines and 
low-cost programmes for diabetes self-management education and support  are importantly needed 
to assist thet move from the hospital to the community. (61) 
 As shown in Figure 2–5, the WHO Innovative Care for Chronic Conditions Framework (ICCC) 
provides a robust platform for the development of such interventions in the healthcare system. (62) 
The ICCC model also suggests continuity and coordination of services between primary, secondary 
and tertiary care. This framework includes community, patient, healthcare and policy environment 
perspectives, and forms the foundation of South Africa’s primary health care re-engineering and 
strategic plan for chronic disease management integration. (62)  
Regrettably, however, it does not significantly incorporate any complexity related to multimorbidity. 
Such complex multimorbidity is a key challenge to current SA models of healthcare delivery and 
there is a need to ensure integrated care across disease pathways and across primary and 
secondary health care services. (63-65) Foremost is the need for a shift to a patient-centred and 
more age-friendly approach to strengthening self- management. (66) 
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                Figure 2–5 Innovative Care for Chronic Conditions Framework (ICCC) (62) 
2.5. Part 4: Diabetes care models for older persons 
 There is increasing evidence that supporting individuals with long-term chronic conditions, such as 
diabetes, to care for themselves leads to improvements in clinical outcomes and in their health-
related quality of life. Sinclair et al. (67) have suggested the principal goals of managing diabetes 
in older persons. The broad goals of diabetes management in older persons are not significantly 
different from those of younger individuals with diabetes. Controlling glycemia and management 
aimed at reducing the other risk factors for macrovascular and microvascular disease remain 
principal. However, diabetes care for older persons should be modified to a functional status, not to 
a co-morbid burden. (68–70) 
Self-management, education, and empowerment are important cornerstones of diabetes care in all 
national and international diabetes guidelines, with an emphasis on self-management care and 
education. (71) Healthcare providers have been encouraged to engage with people in their care 
and decisions about their management plan that should encompass the needs, goals and life 
experiences of the person with diabetes. (71) Diabetes self-management education (DSME) 
provides knowledge and the skills needed for self-management care activities that aim for optimal 
health outcomes and quality of life. The objectives of DSME are to support informed decision-
making, self-care behaviours and active collaboration with the healthcare providers. DSME is thus 
a critical component of care for all people with diabetes and is essential to improve patient health 
outcomes. (71) 
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2.5.1.Self-management care and support in older persons 
It is appropriate to look at the concept of self-care in the light of the ageing population. The WHO 
defines self-care as ‘the activities persons, families, and communities undertake with the aim of 
enhancing health, preventing disease, limiting disease, and restoring health’.(72) This definition 
reflects the fact that self-care skills and knowledge stem from lay experience and suggests that self-
care is a part of everyday living. Self-care may comprise behaviour and actions taken by those who 
are healthy, at risk of ill health, experiencing symptoms, diagnosed with a disease or receiving 
treatment. Therefore, it encompasses specific types of self-care, such as self-diagnosis, self-
management, self-medication and self-monitoring. (73)  
 It is after the self-care ability for older persons has been identified that planning can be done to 
deal with their unmet needs. (74) It has been revealed that self-care and self-care education has 
the potential for saving the limited resources that older persons need to spend on healthcare and 
for enhancing healthcare resources. (75–76) Dean et al. (77)  assume that the day-to-day 
management of diabetes is a routine regularly undertaken by the patient and supported by his/her 
family as well as the healthcare providers.  
This is, however, not always the case. It is essential that self-care actions regarding the meanings 
attached to them and the context in which they take place, the norms they are subject to and the 
resources available to the individuals be understood. (78–80) Furthermore, self-management 
support expands the role of healthcare professionals from delivering information and traditional 
patient education to include helping patients build confidence and make choices that lead to 
improved self-management and better outcomes. (81) It comprises knowledge, skills and 
confidence to make daily decisions, select and make behaviour changes and cope with the 
emotional aspects of their sickness within the context of their lives. (82) Consequently, healthcare 
providers would be focused on the impact of ageing on self-care management capabilities and 
support their patients adjust self-care management to adapt to psychosocial and physiological 
changes associated with ageing. (83-86) 
   2.5.2. Diabetes self-management education for older persons  
Older persons are under-represented in DSME research studies. As a result, the American 
Association of Diabetes Educators (AADE) and the American Geriatric Society (AGS) have 
formulated guidelines for DSME in the elderly, based mainly on expert consensus. (87-88)  
 At present, DSME in most African countries, including South Africa, is limited in scope, content and 
consistency and it is not clear how older persons manage their diabetes. (89–90)   A recent 
systematic review described the level of self-management care among people living with type 2 
diabetes in Africa. (91) In this review, 43 mostly observational studies met the inclusion criteria and 
 24 
 
the authors concluded that ‘diabetes self-management care in Africa is poor and therefore a serious 
threat to the health of people and the health systems capacity’. (91) This is because the studies 
demonstrated infrequent self-blood glucose monitoring (when this was available), low frequency or 
length of physical activity, moderate adherence to recommended dietary and medication behaviour, 
and a poor level of knowledge of diabetes-related complications.  The review also found that the 
studies did not address psychosocial aspects. (91) Questions remain, also, about the effectiveness 
of diabetes self-management care and educational/behavioural interventions for older diabetes 
persons, primarily regarding how normal cognitive decline and increased co-morbidities related the 
impacts of ageing and self-management care of diabetes in everyday life. What has, for example, 
not been studied optimally is the presence of complications and co-morbidities accompanying the 
aging process’ as well as how essential specific self-management care practices have been 
adapted to meet the needs of the elderly. (92) 
2.5.3 Self-management care challenges in older persons  
Self-management care and its maintenance among older persons with type 2 diabetes is 
challenging and demanding. Assessment of self-management ability must be evaluated from time 
to time during health-care provider and patient interaction. (93) According to the WHO, the best 
choices to avoid complications in low-resource settings (94) lie in the monitoring of blood sugar and 
checking the risk of cardiovascular disease (CVD)by counselling to promote a healthy life with diet, 
exercise and medicines. However, diabetes management must be carried out by both the individual 
affected by diabetes and by involving health care providers, through self-management care and 
altered behaviours. The latter includes, for instance, self-monitoring blood-glucose, diet and 
physical activity adjustments. Furthermore, diabetes self-management care must be individualised 
to best suit the diabetes goals of the diabetic. (95) Other components of self-management care in 
older persons that need attention include polypharmacy, depression and cognitive impairment. 
Consequently, interventions to best address management and education for older persons with 
diabetes are required. (95)   
In the next sections, the challenges faced by older persons in achieving optimum levels of 
knowledge and the skills needed for their self-care activities are discussed. 
2.5.3.1. Eating healthily 
Diet is a vital component of diabetes care for all ages, while nutritional guidelines do not differ for 
younger versus older persons, older individuals with diabetes may present with unique challenges 
that influence their ability to follow a healthy diet. (96) Older persons may be at risk for malnutrition 
due to cognitive dysfunction, depression and functional impairments leading to difficulties in making 
or consuming food. Notably, nutrition recommendations should consider the older individual’s 
unique culture, values, preferences, and individual goals and abilities.  (97)  Nutritional education 
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has been shown to improve glycaemic control. For example, in a study by Redmond et al., (98) the 
impact of nutrition education sessions intervention on older individuals was evaluated. They found 
that, following the intervention, the mean change in HbA1c levels for all participants decreased 
0.24±1.35% (p=0.11). Moreover, Chelbowy et. al. (99) demonstrated that older African-American 
females with T2DM complained of a lack of self-control related to diet restrictions, particularly at 
holiday and family parties. Importantly, they also found that social support was statistically 
significant in following a diabetes diet (p=0.01). All participants, however, stated that ’they believed 
healthy diet was best for the body though at the same time stated they were too expensive, so they 
did not eat adequate healthy foods’. (99) 
2.5.3.2. Being active     
 Although age and diabetes conspire to diminish fitness and strength, there are data indicating that 
lifestyle interventions may be beneficial to this group. In an Action for Health in Diabetes study, 
although subjects aged 65–76 years had lower gains in fitness with the rigorous lifestyle intervention 
than younger participants, they still improved their measures of fitness by a mean of over 15%. 
(100) In older persons, even light-intensity physical activity is linked with higher self-rated physical 
health and psychosocial well-being. (101)  
Older individuals with diabetes who are otherwise healthy and functional should be encouraged to 
exercise to targets recommended for all adults with diabetes. (102) An eight-year prospective study 
of adults with diabetes (n = 2896) showed that those who had walked for two hours per week had 
a 39% lower all‐cause death rate and a 34% decrease in CVD-related deaths. Notably, the size of 
these effects persisted after controlling for multiple factors. These included age, gender, obesity, 
functional limitations and other co-morbid conditions. (103) 
2.5.3.3. Medication adherence and polypharmacy 
A systematic review on older persons and medication adherence emphasised the issue of 
multimorbidity and polypharmacy and thus an increased likelihood of their mismanaging their 
medication (104). Furthermore, older individuals may ration the administration at the lowest possible 
dose rather than the prescribed dose – something which in diabetes management could have 
significant implications for glycaemic control and the potential for developing more complications. 
(105) Rhee et al., (105) using a retrospective assessment in n=1560 older individuals, highlighted 
that glycaemic control improved progressively with greater medication adherence and 1 263 
subjects were between 76%-100% adherent. However, these findings must be viewed with caution, 
as the benefits of medication adherence may have been confounded by the associated impact of 
adherence to diet, self-monitoring of blood glucose (SMBG) and exercise.  
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2.5.3.4. Cognitive impairment 
Older persons with cognitive impairment using insulin were significantly more likely not to know 
what to do in the setting of hypoglycemia and gave more incorrect answers when asked about 
diabetes management than those who were intact cognitively. Cognitive impairment may result in 
older individuals being less able to monitor their blood glucose levels, inject insulin (106) or adhere 
to their oral medication regimen. 
2.5.3.5. Depressive symptoms and distress 
The relationship between diabetes and depression seems to be bidirectional. In the Health, Aging, 
and Body Composition Study, where older persons (70–79 years) with diabetes showed an 
increased prevalence of depression compared with persons without diabetes (23.5% vs 19.0%, 
hazard ratio (HR) 1.31, 95% confidence interval (CI) 1.07–1.61). (107) In a meta-analysis of 16 
studies to analyse the risk of depression associated with diabetes, both the relative risk (RR) and 
HR were significant at 1.27 (95% CI 1.17–1.38) and 1.23 (CI 1.08–1.40) for incident depression 
associated with diabetes. (108)  It has been suggested that healthcare providers should actively 
look for symptoms of depression as older individuals with co-morbid diabetes and depression are 
willing to discuss their glycemic control but are reluctant to discuss their depressive symptoms and 
its effects on self-care. (109) 
2.5.3.6. Self-monitoring of blood glucose (SMBG) 
Some family members may need education about how to undertake diabetes self-management 
care tasks such as SMBG and administering insulin to enable them to support the person with 
diabetes. (110) However, the value of SMBG in people with T2DM is not proven, particularly in 
those not using insulin. (111–113) 
 To summarise, understanding the impact of the abovementioned challenges on diabetes self- 
management care is critical for improving diabetes treatment in older persons. The promotion of a 
healthy lifestyle with diet, exercise and adherence to prescribed medication is the best options to 
avoid complications and improve quality of life. Support for older individuals to stay in their 
households for as long as possible is provided through health promotion activities which focus on 
self-care management education and support.   
2.6. Part 5: Theories and models for health promotion 
This section aims to provide a brief overview of the literature on various theoretical models of health 
promotion. Over the past three decades, the body of research in health behaviour has grown fast, 
and health education and health promotion are documented increasingly as ways to meet public 
health objectives and improve the success of public health and medical interventions globally. (114)  
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Programmes to impact health behaviour, including health promotion and education programs, are 
most likely to benefit participants and communities when a theory of health behaviour guides the 
programme or intervention. Hubley et al. stated that ‘when we speak of the adaption and 
maintenance of attitudes and behaviours identified to promote health and well-being’ for older 
individuals, evidence-based health promotion programmes tailored to a specific community’s needs 
and context is what is discussed. (115-116) In a debate on health promotion and ageing, Haber et 
al. (117)  commented on the lack of age specificity in health promotion models and proposed that 
a model of health promotion for older persons need the following components: ageing, 
communication and collaboration, health behaviour change, health education, diversity and 
advocacy.  
2.6.1 Theories and models 
Theories of health promotion identify the targets for change and the methods for achieving these 
changes. Theories also inform the assessment of change efforts by helping to identify the outcomes 
to be measured, as well as the timing and methods of study to be used, (118) and these fall mainly 
in three categories:1. Individual level: Behaviour modification; the Health Belief Model; the 
Transtheoretical Model; Lay Beliefs; 2. Interpersonal level: the Theory of Reasoned Action; Social 
Learning Theory;3. Theoretical frameworks with multiple levels: an ecological model; the 
PRECEDE-PROCEED model. (118) The key elements of these approaches are listed in (Table 2–
6). 
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             Table 2–4 Key elements of theoretical models of health promotion (118) 
 
2.6.2.  Individual level theories 
Individual level theories generally are most appropriate for addressing predisposing factors. They 
help planners identify messages for direct communication methods such as mass media and face-
to-face education, as well as for newer technologies such as computer tailoring of health messages. 
(118) These theories  also involve the health-decision model that endeavours to describe health 
decisions and resultant behaviour; the self-regulation model based on  the locus of control theory; 
social cognitive theory, with self-efficacy as its core component; and a model of disease self-
management based on self-regulation of what is useful and what is not for the individual, given their 
specific goals. (119) 
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2.6.3.  Interpersonal level theories 
Interpersonal level theories are most appropriate for reinforcing factors, and they suggest indirect 
communication channels (for example, through significant others, social networks) and methods 
(for instance, train-the-trainer models, social support enhancement). Community level theories are 
appropriate for enabling factors, and they suggest environmental changes (for example, 
organisation and delivery of services; availability of policies; and regulations that govern 
behaviours) and methods such as community organising and advocacy. (120) 
2.6.4.  Programme and strategy planning models — multiple levels 
Planning models recognise the complexities of health behaviour. These are more consistent with a 
broad definition of health promotion that recognises the impact of many factors on health and health 
behaviours. These models are much broader than theories and, as such, are inclusive of theories. 
(120) They educate the practitioner about which theory or theories should be used and when and 
how they should be applied. (121) A particularly useful, widely applied, and easy-to-follow example 
of a planning model is the PRECEDE-PROCEED (PPM) planning model. 
2.6.4.1. The PRECEDE-PROCEED planning model. 
The PRECEDE-PROCEED model for health programme planning and evaluation is broadly taught 
and used in health promotion practice, with well over 1 000 published applications. (122) The 
PRECEDE framework was first described in the 1970s and subsequently revised in 2005 to respond 
to the growing interest in ecological and participatory methods that have become more widely 
appreciated as crucial elements of public health programmes. The PRECEDE-PROCEED planning 
model provides an eight-phase framework for health care professionals to determine, develop, 
implement and assess health promotion programmes, as well as the application of health promotion 
theories systematically within such programmes.  (122).  The PRECEDE-PROCEED model  has 
four assessment and planning phases to direct the health professionals in selecting what health 
problem to address, examining its underlying causes, and planning an intervention (Figure 1–5). 
(122)   
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    Figure 2–6. The Precede-Proceed model. From Green and Kreuter 2005 (122)   
Phase 1: Social assessment 
The social assessment identifies and evaluates potential areas for health action, through engaging 
the community in this diagnosis, using both objective and subjective information from many sources, 
the goal is to recognise the individual's priorities in improving their quality of lives (122) It 
commences with a systematic and inclusive assessment of the participants' social situation, with a 
clear emphasis on their self-perceived quality of life and the resources accessible to them that 
contribute to the health and health-related quality of life. Hence, this phase aims to attain insights 
into the social conditions of the participants and as well to assess their general hopes and health 
beliefs. Typically, this phase explores the participants' health-related needs and their general 
assumptions and goals for health and life. This process reveals social indicators that may compete 
with, or contribute to, the person's quality of life.(122) 
Phase 2: Epidemiological assessment 
The epidemiological assessment recognises and prioritises health issues and sets change 
objectives by : (1) identifying the health problems, issues, or aspirations on which the programme 
will focus; (2) uncovering the behavioural and environmental factors most likely to influence the 
identified priority health problems; and (3) translating those priorities into measurable aims and 
objectives for the programme being developed. (122) 
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Phase 3: An educational and ecological assessment 
After selecting the relevant behavioural and environmental factors for the programme, the 
framework guides planners to recognise the antecedent and reinforcing factors that should be in 
place to initiate and sustain the change process. These factors are classified as predisposing, 
reinforcing, and enabling and together they  influence the behavioural and environmental change 
that will occur. (122) 
 Predisposing factors: are antecedents to behaviour that provide the justification or motivation for 
the behaviour, they comprise individuals’ knowledge, attitudes, beliefs, personal preferences, 
existing skills, and self-efficacy beliefs.  
Reinforcing factors: are those factors following a behaviour that provide continuing reward or 
incentive for the persistence or repetition of the behaviour For instance social support, peer 
influence, significant others, and vicarious reinforcement.  
Enabling factors: are antecedents to behavioural or environmental change that allow a motivation 
or environmental policy to be realised. Enabling factors can affect behaviour directly or indirectly 
through an environmental factor. They involve programmes, services, and resources necessary for 
behavioural and environmental outcomes to be realised and, in some cases, the new skills required 
to enable behaviour change. (122) It should be possible by the end of Phase 3to select, sort and 
categorise the predisposing, reinforcing and enabling factors regarding their impact and potential 
to change health behaviour patterns. The outcome is a cascaded mapping of predisposing, 
reinforcing and enabling factors, in the order of their impact on behaviour and their subsequent 
effects on health and quality of life. (122) After this, targets for the health-promotion programme 
can be identified. 
Phase 4: Administrative policy and intervention-alignment assessment 
Green and Kreuter also recommend conducting an internal policy assessment within the planning 
organisation to confirm policies align with the proposed programme plan and to measure political 
forces likely to impact implementation. (122)  
Phases 5–8: Implementation and assessment 
Phases 5 to 8 of the model are not relevant to this study and will be only briefly discussed here. At 
this stage, the health promotion programme is prepared for the implementation phase  (Phase 5). 
Data collection plans should be ready for assessing the process, impact, and outcome of the 
programme, which are the last three phases in the PPM. Usually, process evaluation determines 
the extent to which the programme was implemented according to the protocol. Impact evaluation 
assesses changes in predisposing, reinforcing, and enabling factors, as well as in the behavioural 
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and environmental factors. Finally, outcome assessment determines the effect of the programme 
on health and quality-of-life indicators. (122-) 
2.7. Chapter summary  
The literature review has highlighted that population figures of older persons have been growing 
globally and particularly in SSA/SA. It is projected that in SA the proportion of its population aged 
60 years or older will increase from 7.2% to 15% of the total population over the next 35 years. As 
the prevalence of diabetes increases with age there will be an increase in the current high demand 
on health systems for the prevention and treatment of diabetes and its associated complications. 
There are major limitations to access to quality diabetes care in SSA and even in SA. There is little 
specific research in SA/SSA relating to diabetes in older people, and in the assessment and 
diagnoses of the related co-morbidity., The research designs and methods including needs 
assessment for this study are discussed in the following chapter. 
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Chapter 3 
Research design and methods 
 
3.1. Chapter outline 
This chapter outlines an overview of the application of the PRECEDE-PROCEED model in general. 
As the methods are discussed in detail in each of the five papers, a brief overview is provided in 
this chapter. 
3.2. Research Design 
A needs assessment is a critical element of planning a programme as it identifies, scrutinises, 
rationalises and selects gaps or deficiencies to be closed. (1) This research study is based on the 
theoretical framework of the PRECEDE-PROCEED model (PPM). (2) In the PPM, a complete 
needs assessment involving phases should be made before planning a health promotion 
intervention. Due to the limited resources available for the present body of work, only the PRECEDE 
four phases (Phase 1 to Phase 4) were completed. This study sets out to fill the current gaps in 
knowledge of diabetes in the older person in South Africa, with a view of developing a diabetes self-
care management programme targeted at this group and therefore limiting the impact of the disease 
and improving their health-related quality of life. The following section briefly describes the 
conducting of the needs assessment within the theoretical framework of the PRECEDE-PROCEED 
model. 
3.2.1. Applying the PRECEDE component of the PRECEDE-PROCEED model 
In this study, the needs assessment was conducted in four steps as seen in the accompanying 
figure. 3-1. In Phase 1, the social assessment, the  relationship between health and social issues 
is considered. The planner identifies a target population's social priorities which, in turn, reflect that 
population's quality-of-life priorities. To achieve this objective a survey was conducted to assess  
the association between diabetes and health-related quality of life and disability amongst South 
Africa’s older persons, as well as whether associations between other factors and these measures 
of well-being differed between older individuals with diabetes and those without (study 2). 
The task of the planner in Phase 2, the epidemiological assessment, is to recognise the specific 
health goals or difficulties that may contribute to the social goals or concerns identified in Phase 1. 
Objective indicators such as demographic patterns of health problems are used to ascertain how 
specific health problems are related to the subjectively appraised quality-of-life. Frequently, a 
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specific health problem such as diabetes has already been recognised as a priority by the target 
population, health professionals, or policymaker. In such cases, the program planning researcher 
begins with Phase 2 but must work back. This approach is adopted by looking at how the specific 
problems of diabetes are related to the broader health and social context of older individuals in 
Africa including South Africa. The task of the researcher in this phase is to recognise the specific 
health goals or difficulties that may contribute to the social goals or concerns identified in Phase 1. 
For pragmatic reasons the epidemiological assessment was limited to  a systematic review of the 
prevalence of type 2 diabetes mellitus among older people in the African continent to understand 
the extent of the burden on the continent (study 1) and presented in this thesis as (Chapter 4)  
In Phase 3, the educational and organisational assessment, the researcher evaluates the 
relationship between those factors that determine the behavioural and environmental objectives set 
in Phase 2. These may be grouped into three broad classes: predisposing, enabling, and reinforcing 
factors that influence behavioural or environment. Phases 2 and 3 result in the formulation of clear 
behavioural and environmental objectives for the program, and the educational and organisational 
strategies to be employed. To achieve those objectives, the reseacher conducted a cross sectional 
survey exploring the status of knowledge, self-management practice, and social support, as well to 
determine the relationship of social support, especially that of family and friends with their self-
management for South African older persons with type 2 diabetes (study 3). 
Phase 4, the administrative and policy assessment and  Intervention Alignment, marks the shift 
from the planning phases (PRECEDE) of the model to the action phases (PROCEED). When 
creating the programme plan, it is imperative to look at two levels of alignment between the 
assessment of determinants and the selection of interventions. First, at the macro level, the 
organizational systems that can affect the desired outcomes should be considered. Second, at the 
micro level, the focus is on individual, peer, family, and others who can influence the intended 
individuals health behaviors more directly.  The researcher limited this phase to Steps A and B, 
studies 4 and 5 respectively. . Step A (Study 4),  an administrative and policy assessment involved 
a documentary review and interviewing key informants to obtain an in-depth description of current  
policies and practices relating to  diabetes self-care management for older persons in South Africa. 
Step B (study 5), a systematic literature review which examined the effectiveness of existing peer 
and non-professional health worker-led diabetes self-management programmes in primary health 
care settings in LMICs and examined the implementation strategies and associated diabetes-
related health outcomes. 
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3.3. Justification of mixed method design choice in this thesis 
The methodological choice in this thesis is to use mixed methods research where the quantitative 
and qualitative methods are combined. (3) The rationale for mixing is that neither quantitative nor 
qualitative methods alone are sufficient to capture the trends nor the details of the situation, such 
as the complex issue of self-management care that targeted older persons in their dwellings and in 
a community healthcare setting. The thesis is organised  so as to present the quantitative studies 
first, and follow these with  a discussion of  the qualitative study and  the integration of the two 
approaches. (4–6) 
3.4. Justifications for using systematic reviews  
The decision for using systematic reviews (7) in this thesis is based on two critical issues. First, 
systematic reviews are recognised as an essential method for facilitating evidence-informed policy 
and practice because of their capacity to synthesis the results from multiple studies. (8) Secondly, 
there is a scarcity of data and methodological limitations around existing work within the field of 
research on diabetes self-management care for older persons within the chosen setting. (9) 
3.3.  Methodology of different phases/studies of the research study.  
  As has been noted in Figure 3–1, the sequence of the methodological approaches used in this 
research study are as follows: 
3.3.1.Phase 1: Social assessment 
Study 2:  Diabetes in South African older adults: prevalence and impact on their quality of life and 
functional disability – as assessed using SAGE Wave 1 data. 
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Figure 3-1. The flowchart shows the different phases of the PRECEDE model used in the study  
         Chapter 4 
Phase 2: 
Epidemiological 
assessment 
 
 
 
 
 
         Chapter 5 
Phase 1: 
Social  
assessment 
 
 
 
Chapter 6  
Phase 3: 
       Educational  
assessment 
 
Chapters 7 & 8 
Phase 4:  
Administrative  
and policy 
assessment and  
interventionalign
ment  
Objective 1: To conduct a systematic review and meta-
analysis of studies assessing the prevalence of type 2 
diabetes among older people in African countries 
   
Study design: Quantitative  
 
Method: Systematic review and Meta-analysis 
 
Objective 2:  To examine the association between 
self-report diabetes and each of health-related 
quality of life and disability amongst South Africa’s 
older adults. 
 
Study design:  Quantitative 
 
Method: secondary analyses of the WHO Study on 
global AGEing and adult health (SAGE) conducted 
in South Africa  
 
Objective 3: To investigate the status of knowledge, self-
management practice, and social support for South African older 
persons with type 2 diabetes and determine the relationship of 
social support, especially that of family and friends with their self-
management. 
 
Study design: Quantitative 
 
Method: questionnaire survey  
 
 
 
Step A: Objective 4: To identify and explore emerging policies and 
practices in diabetes self-management care for older persons in 
South Africa.  
Study design: Qualitative  
Method:    1. Documentary review             2. Key informant interviews   
Step B: Objective 5:  To conduct a systematic review assess peer and 
non-professional health worker-led diabetes self-management 
programmes in the low and middle-income country (LMIC) primary 
healthcare settings, examine the implementation strategies, and 
associated diabetes-related health outcomes. 
Study design: Quantitative                         
 Method: Systematic review   
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Methods  
Secondary analyses of data on 3 836 participants aged 50 years and older from the Study on global 
AGEing and adult health (SAGE) in South Africa Wave 1 (2007–2008) were conducted. (10) 
 Face-to-face interviews using a standardised questionnaire were used to collect information on 
socio-demographic characteristics, disability, subjective well-being, and other health measures and 
behavioural risk factors. The prevalence of self-report diabetes was first assessed. Then the 
association between diabetes and each of the WHO Quality of Life (WHOQoL) and WHO Disability 
Assessment Schedule (WHODAS) scores was examined with a control for selected socio-
demographic characteristics, health risk behaviours and the presence of co-morbid conditions. The 
regression models were used to assess whether diabetes moderates the relationships between 
these additional factors and WHOQoL/ WHODAS. (10) 
3.3.2. Phase 2:  Epidemiological assessment  
Study 1: The prevalence of type 2 diabetes among older people in Africa: a  systematic review and 
meta-analysis 
Methods   
A comprehensive search of PubMed⁄MEDLINE, CINAHL, and Google Scholar was conducted for 
cross-sectional or population-based diabetes  prevalence studies in Africa published from  1 
January 2000, to 30 June, 2015,  using the African search ﬁlter developed by Eisinga and 
colleagues and a range of search terms. Publications by key authors were also sought with citation 
searches on the websites of WHO and the IDF, the latter for the STEPwise approach to surveillance 
(STEPS) studies in Africa. No language restrictions were applied.The diagnosis of diabetes had to 
have been made by a physician or defined based on measured fasting plasma glucose (FPG), and 
the oral glucose tolerance test (OGTT). The  full  review protocol was published in a peer-reviewed 
journal (https://bmjopen.bmj.com/content/4/6/e004747) (Appendicx 1). (11) 
3.3.3. Phase 3: Educational and ecological assessment 
Study 3: Does social support affect knowledge and diabetes self-management practices in older 
persons with type 2 diabetes attending primary care clinics in Cape Town, South Africa? 
Methods  
This cross-sectional study was undertaken in the Cape Town Metropole primary care clinics. The 
sample comprised 406 people drawn from four community health centres (CHC) served by Groote 
Schuur Hospital at the tertiary level. The 100 participants were selected from each selected 
community health centre by a random sampling technique with as near an equal distribution of 
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males and females as possible. 
Fieldworkers administered a questionnaire to the participants in their home language to obtain 
sociodemographic and medical history data as well as information on diabetes knowledge, self-
management practice and social support. The fieldworkers also reviewed the participants’ clinic  
records for HbA1C and fasting blood glucose results. Signed consent to participate in the study was 
obtained before the administration of the study questionnaire.  
3.3.4. Phase 4: Administrative and policy assessment and intervention alignment  
 Step A of Phase Four: 
Study 4: A review of current policies and practice for the provision of diabetes care and self-
management support programmes for older South Africans 
Methods 
These involved 2 steps. The first, a documentary review of relevant policies, plans, clinical 
guidelines and commentaries; and the second,  interviews with key informants in the health services 
and Department of Health to get their perspectives on the current situation and the potential for a 
self-management programme tailored to the needs of older patients. The interviews were about 30 
to 45 minutes in duration and were conducted from December 2016 to April 2017. They were audio-
taped,  transcribed verbatim and analysed using the  method of qualitative content analysis.   
Step B of Phase Four: 
Study 5: The effectiveness of peer and community health worker-led self-management support 
programmes for improving diabetes health-related outcomes in adults in low-and-middle-income 
countries: A systematic review 
Method   
A literature search was conducted using the Cochrane Library, MEDLINE via PubMed, SCOPUS, 
CINAHL, PsycINFO, and Web of Science databases for studies published between 1 January 2000 
and 31December 2017 which evaluated community-based peer and community health worker-led 
diabetes self-management programmes (COMP-DSMP) in adults with diabetes in LMICs. 
Randomised and non-randomised controlled trials with at least three months follow-up and reporting 
on a behavioural, a primary psychological, and/or a clinical outcome was included. 
In addition, the implementation taxonomy frameworks by Proctor et al (12) were used for analysis 
and evaluation of the implementation strategies used in the included studies.   
This review is registered with the International Prospective Register of Systematic Reviews 
[registration number CRD42014007531]. Although the protocol was published in 2015 (Appendix 
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2) (13) (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513536/), the final methods used for the 
review were revised and the changes detailed in the methods section of (Chapter 8). 
 3.6. Data collection and analysis of the research study 
Due to the variety of data collected in this research study, both descriptive statistical and appropriate 
qualitative approaches were used for data analysis. These approaches will be discussed within the 
following individual studies chapters. 
 3.7. Ethics approval   
This research study was approved by the Human Ethics Committee of the University of Cape Town. 
HEC REF: 21/2013) and was conducted in accordance with the Declaration of Helsinki of 2013. 
Written consent was obtained from each participant (Appendix 3). 
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Chapter 4  
 
Study 1: The prevalence of type 2 diabetes among older 
people in Africa: a systematic review and meta-analysis 
 
Role of the candidate 
I, together with Professors Levitt, Engel and Kengne, was responsible for designing the protocol 
of the study. I did the literature search selected the studies, evaluated risk of bias and extracted 
the relevant information. I managed and cleaned the data and prepared it for analysis. I carried 
out the analyses, supported by Professor Andre Kengne. I drafted the manuscript, incorporating 
input from co-authors and I was responsible for finalising the final version of the manuscript for 
publication. 
Role of the co-authors 
MW, MEE, APK, and NSL designed the study. Dr Alfred Musekiwa (AM) independently selected 
the studies and extracted the relevant information. All authors synthesised the data. I wrote the 
first draft of the paper. MEE, APK, and NSL provided critical guidance on the analysis and overall 
direction of the study. All authors critically revised successive drafts of the paper and approved 
the final version. 
Publication Status: 
Published in The Lancet Diabetes & Endocrinology Journal: 
 Werfalli, M., Engel, M. E., Musekiwa, A., Kengne, A. P., & Levitt, N. S. (2016). The prevalence of 
type 2 diabetes among older people in Africa: a systematic review. Published in The Lancet Diabetes 
& Endocrinology. Available from 
https://www.thelancet.com/journals/landia/article/PIIS22138587(15)00363-0/fulltext.   
The review protocol of this study was published in BMJ Open: 
Werfalli M, Musekiwa A, Engel ME, et al. The prevalence of type 2 diabetes mellitus among older 
people in Africa: a systematic review study protocol. Published in BMJ Open 2014; 4: e004747. doi: 
10.1136/ bmiopen-2013-00474 Available from 
https://bmjopen.bmj.com/content/bmjopen/4/6/e004747.full.pdf. 
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4.1 Abstract  
Little information is available on the prevalence of diabetes in people aged 55 years or older living 
on the African continent. We did a systematic review of the prevalence of type 2 diabetes in studies 
reported from Jan 1, 2000, to June 30, 2015, to provide accurate data for monitoring future trends. 
We did a comprehensive literature search using an African search filter and extracted and 
synthesised data from full papers.  
Among 1473 identified citations, 41 studies providing 49 separate data contributions involving 
16 086 individuals met the inclusion criteria. The overall prevalence of diabetes was 13·7% (95% 
CI 11·3–16·3) and was higher in studies based on the oral glucose tolerance test (23·9%, 17·7–
30·7, 12 contributions with 3415 participants) than fasting blood glucose criteria (10·9%, 8·9–13·0, 
37 contributions with 12 671 participants; p<0·001). Prevalence was also higher in non-STEPS than 
in STEPS studies (17·1%, 95% CI 13·6–20·9)4 vs 9·6%, 6·6–13·0, p=0·003) and in urban than in 
rural settings (19·7%, 15·0–24·9 vs 7·9%, 4·6–12·0, p=0·0002), but did not differ significantly 
across age groups, sex, sample size, year of publication, region, or population coverage. These 
data highlight the need to reduce diabetes risk factors and implement adequate management 
strategies. In addition, we suggest that uniform diagnostic methods should be used across African 
countries and elsewhere to enable the assessment of trends in diabetes prevalence and the 
success of diabetes prevention strategies. A collaborative initiative is required between key 
international and national diabetes and geriatric organisations to improve diabetes care for the older 
population in Africa and worldwide. 
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      4.2. Introduction 
The International Diabetes Federation (IDF) estimated prevalence for type 2 diabetes in 2013, 
showed that the number of people affected worldwide has doubled over the past 20 years. Most 
(80%) live in low-income and middle-income countries. (1) In Africa, where all countries fall into 
these economic categories, diabetes already contributes substantially to morbidity and mortality, 
and the age-specific mortality rate is the highest in the world. (2–7) The rise in the number of 
individuals with type 2 diabetes in Africa, which is similar to that which has occurred in low-income 
and middle-income countries elsewhere in the world, has been attributed to ageing of the population 
and rapid change in environmental factors, (2) such as urbanisation, increasingly sedentary 
lifestyles, and unhealthy eating patterns. Although behaviour patterns and obesity can potentially 
be modified, ageing, which is one of the main drivers of diabetes, cannot. (3) In 2013, most 
individuals with diabetes in Africa were younger than 60 years, and the highest proportion (43·2%) 
comprised people aged 40–59 years. The small proportion of people aged 60–79 years in the region 
probably accounted for the fact that only 18·8% of people with diabetes fell into this age group. (1) 
Africa is often referred to as the youngest continent, which might contribute to the low prioritisation 
of ageing issues in national policies. (8) Yet the annual growth rate of people older than 55 years 
in Africa was estimated to be 3·1% greater than the global average between 2007 and 2015 and is 
predicted to be 3·3% greater between 2015 and 2050.  
Thus, there are around 64·5 million people in Africa aged 55 years or older in 2015, and there are 
likely to be more than 103 million and 205 million in 2030 and 2050, respectively. (7) Consequently, 
the diabetes prevalence in Africa is expected to be highest in the oldest individuals by 2035. (1) We 
did a systematic review to investigate the prevalence of type 2 diabetes in Africa in individuals older 
than 55 years, with the aim of providing accurate data for monitoring of future trends.   
4.3. Methods 
4.3.1. Literature search  
We aimed to identify prevalence studies in Africa published from Jan 1, 2000, to June 30, 2015, 
with use of the African search filter developed by Eisinga and colleagues. (9) The filter comprises 
African country names and truncated terms, such as “north* Africa”, to ensure that records indexed 
with regional rather than country-specific terms are also retrieved. We combined database medical 
subject headings (MeSH in PubMed ⁄ MEDLINE, CINAHL, and Google Scholar) with a range of 
search terms (Appendix 1). 
African country names were included in English and languages applicable to each country, for 
example ‘Ivory Coast‘ and ‘Côte d’Ivoire‘. Where country names have changed over time, old and 
new names were included, such as ‘Zaire’ and ’Democratic Republic of Congo’. (10) We searched 
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for publications by key authors with citation searches on the websites of WHO and the IDF, the 
latter for the STEPwise approach to surveillance (STEPS) surveys studies in Africa.  
The panel shows the basic concept, framework, and key goals of STEPS surveys. (11,12) We also 
searched the ISI Web of Knowledge. No language restrictions were applied. An expert librarian 
designed the search strategy framework and applied the appropriate bibliographic software. 
 
 Panel: Basic concept, framework, and key goals of the WHO STEPwise approach to 
surveillance (11,12).   
 
The STEPwise approach to Surveillance (STEPS) is WHO’s recommended a tool for 
surveillance of chronic non-communicable diseases and their risk factors. It aims to provide 
an entry point for low-income and middle-income countries to start chronic disease 
surveillance. It is also designed to help countries build and strengthen surveillance capacity. 
In all instances, STEPS targets adults aged 25–64 years and uses a representative sample of 
the study population, which allows generalisation of the results to the whole. STEPS has 
some flexibility, which enables each country to expand on the core variables and risk factors 
and to incorporate optional modules relevant to local or regional interests.  
 
The STEPS instrument has three different levels (or steps), all of which have core, expanded, 
and optional modules of risk factor assessment that are used depending on what can be 
accomplished in a given country. Step 1 uses a standardised questionnaire to gather 
demographic and behavioural information (tobacco and alcohol use, nutrition, and physical 
activity) in a household setting. Several extended options can be obtained, such as for 
demographics, ethnic origin, employment status, and household income; for behaviour, 
binge drinking, smokeless tobacco, and ex-smokers; and for diet, oil and fat consumption. 
Optional factors include mental and oral health and objective measures of physical activity. 
 
Step 2 contains simple physical measurements to assess anthropometry and blood 
pressure, which can also be obtained in the household setting (heart rate, hip circumference, 
and [optional] skin-fold thickness and physical fitness). Step 3 consists of biochemical 
measurements: “fasting blood sugar” is the core measurement; the extended tests include 
measurement of total cholesterol, HDL-cholesterol, and fasting triglycerides; and optional 
tests are the oral glucose tolerance test, urine examination, and measurement of salivary 
cotinine to assess tobacco intake. 
 
 
To be included in this systematic review, primary studies had to have used cross-sectional or 
population-based designs to assess the prevalence of type 2 diabetes among older adults 
(described in the report as older adults, or at least 70% of the study population aged 55 years or 
older) who were resident in countries in sub-Saharan or North Africa, irrespective of ethnic, 
socioeconomic, and educational backgrounds. The diagnosis of diabetes had to have been made 
by a physician or defined based on measured fasting plasma glucose (FPG), oral glucose tolerance 
test (OGTT), or self-report, according to WHO criteria (13). Studies had to report numeric data to 
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enable the calculation of prevalence. Those that used denominator data from other studies to 
calculate prevalence were excluded. Full-text articles identified as meeting the inclusion criteria on 
the basis of their titles and abstracts were obtained for further assessment by two reviewers (MW 
and AM), and those that did not meet the selection criteria were excluded (Figure 4–1). 
Disagreements were resolved through discussions between reviewers until consensus was 
reached. 
        
Figure 4-1 Selection of articles for inclusion in the systematic review 
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4.3.2. Assessment of risk bias in included studies 
 
We evaluated the methodological quality of included studies in terms of internal validity, external 
validity, response rate, and generalisability of study results.   We used the ten-item rating system 
developed by Hoy and colleagues (14) and modified by Werfalli and colleagues (15) (Appendix 5) 
to assess sampling, the sampling frame and size, outcome measurement, outcome assessment, 
response rate, and statistical reporting. (14) Each item was assigned a score of 1 (yes) or 0 (no), 
and scores were summed across items to generate an overall quality score that ranged from 0 to 
10. Each study was rated as having a low, moderate, or high risk of bias dependent on the number 
of questions answered as “yes” (low risk): studies at low risk of bias had scores higher than 8, 
moderate a score of 6–8, and high a score of 5 or lower. (15) Risk of selection and attrition biases 
were assessed according to the Cochrane guidelines, in Review Manager, version 5.2. Two 
reviewers (MW and MEE) independently assessed study quality, with disagreements being 
resolved by consensus.  
  4.3.3. Data extraction 
Two reviewers (MW and AM) independently selected studies and extracted relevant information. 
Disagreements were resolved by consensus or consultation with a third reviewer (NSL). Study 
characteristics documented included country name, year of publication, national population, region 
(rural or urban), age range, sex, study design, criteria for sample selection, sample size, 
ascertainment of diabetes status, and diagnostic criteria (Appendix 6). 
 4.3.4. Data synthesis and analysis 
Three reviewers (MW, APK, and NSL) did the statistical analysis and data synthesis. Unadjusted 
prevalence estimates and Standard Errors (SEs) were recalculated for type 2 diabetes in people 
aged 55 years or older (number of cases/sample size) based on the information on crude 
numerators and denominators provided in the individual studies. To keep the effect of studies with 
very small or extremely large prevalence estimates on the overall estimate to a minimum, we 
stabilised the variance of the study-specific prevalence with the Freeman-Tukey single arcsine 
transformation (16) before pooling the data with the random-effects meta-analysis model. (17) 
Heterogeneity between studies was assessed with Cochran’s Q statistic and the I square (I2) 
statistic, (18) which estimates the percentage of total variation across studies due to true between-
study differences rather than chance. I2 values greater than 60–70% generally indicates the 
presence of substantial heterogeneity. We explored sources of heterogeneity by comparing 
diabetes prevalence between subgroups defined by several study-level characteristics. We 
evaluated the presence of publication bias using the Egger test of bias. (19) We did all analyses 
with the meta package in R (version 3.0.3) (Table 4-1). 
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4.4. Findings 
4.4.1. Search results 
The searches identified 1554 citations. After screening of titles and abstracts and removal of 
duplicates, 640 studies were selected for further scrutiny, of which 165 were selected for full-text 
review. Of these, 41 met the inclusion criteria and were included in this systematic review (Figure 
4.1). (20–60)  
 
The reasons for exclusion of 124 studies are detailed in the (appendix 12). Of the 41 studies 
included, two 21,35 provided prevalence estimates separately for urban and rural participants, 
another four (28,43,47,60) provided estimates separately for two non-overlapping age groups, and 
one (51) provided prevalence estimates separately for two non-overlapping age groups for urban 
participants and two non-overlapping age groups for rural participants. These datasets were 
counted separately, leading to 49 data contributions being assessed in the main analyses. 
Generally, the overall risk of bias was low in studies (n=31) but was moderate in 11 and high in ﬁve 
(Appendix 7). Twenty-five of the studies included in this systematic review were published in peer-
reviewed journals (for the purpose of this Review we referred to them as non- STEPS studies), 20–
43 16 were STEPS studies,44–60 and one was a thesis (23) (Tables 4-2, 4-3). 
 For STEPS studies published in peer-reviewed journals, we used the latest published version that 
included the complete dataset. Of the 54 countries of the African continent, 30 (57%), accounting 
for 74·3%  of  the  total  population (7 535 million of 1 136 billion), 60 were represented in this 
systematic review: three studies from Algeria, two from Benin, two from Cameroon, three from 
Democratic Republic of the Congo, two from Ethiopia, two from Libya, one from Mozambique, three 
from South Africa, two from Tunisia, and one from each of Angola, Botswana, Burkina Faso, Canary 
Islands, Egypt, Gabon, Guinea, Kenya, Mayotte, Malawi, Mauritania, Mauritius, Niger, Nigeria, 
Reunion, Seychelles, Sudan, Tanzania, Togo, Uganda, and Zimbabwe. The analytical sample size 
ranged from 467 to 10 000.  
All STEPS studies used multistage cluster sampling techniques, and the response rates were 54.6–
100%. The non-STEPS studies used random sampling or multistage cluster sampling techniques 
and had response rates of 70–99%. Twelve studies used OGTT as the method of diabetes 
diagnosis, and 37 studies used FPG. Forty-eight studies used WHO 1998/1999 diagnostic criteria 
for type 2 diabetes and one study used WHO 1985 criteria. 30 (73%) studies were done in urban 
and rural areas, 17 (41%) were done only in urban areas, and eight (19%) only in rural areas.   
The definition of older people was 55–64 years in 21 (43%) studies, 55 years or older in six (12%) 
studies, 60 years or older in ten (20%) studies, 65 years or older in four (8%) studies. Some studies 
used more than one definition; for these studies and when the age bands were not mutually 
 57 
 
exclusive, the age band that included the greatest age range was used in the analysis (i.e., ≥55 
years when provided along with 55–64 years, or   60 years when provided along with ≥65 years 
old). Thus, our main analysis included 41 studies rather than the 49 data contributions. In the 
assessment of methodological quality, five contributions were deemed to be of poor methodological 
quality and were excluded from the analysis. Of the remaining 46 contributions included, 11 were 
deemed to be of moderate quality and 30 of high methodological quality (Appendix 8). 
4.4.2. Prevalence by age, sex, region, and type of residency. 
The overall prevalence of type 2 diabetes across the 49 contributions (n=16 086 participants) was 
13.7% (95% CI 11.3–16.3; Appendix 9) and did not differ significantly by age group (p=0.187) or 
sex (p=0・611; Appendix 9–11). When assessed by sex, the prevalence of diabetes was 14.3% 
(95% CI 11.9–17.0) overall (n=12 373), 13・6% (10.7–16.9) for men (n=5345), and 15.0% (11.2–
19.2) in women (n=7028). Prevalence of type 2 diabetes did not differ significantly (p=0.181) 
between sub-Saharan and north Africa (13.8%, 95% CI 13.2–14.3, 39 studies vs 16.6%, 11.7–22.3, 
ten studies).  By contrast, the overall prevalence of diabetes was significantly higher in urban than 
rural populations (19・7%,15.0–24.9, 17 studies vs 7.9%, 4.6–12.0, eight studies; p=0・0002). 
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Table 4–1 Summary and comparison statistics  
 
 
Groups Subgroups Age 
groups 
N 
studies 
N 
participants 
% (95% CI) I2 (95% CI) H (95% CI) P 
heterogeneity 
P-diff 
age 
groups 
p-diff 
subgroups 
P Egger 
test 
Overall None Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222  0.557 
  55-64 20 6520 11.9 (8.5-15.6) 94.9 (93.2-96.1) 4.41 (3.84-5.06) <0.0001 NA  0.303 
  55+ 6 1781 12.3 (6.7-19.1) 93.5 (88.6-96.3) 3.93 (2.96-5.22) <0.0001 NA  0.297 
  60+ 9 4971 19.9 (12.8-27.9) 97.6 (96.6-98.3) 6.44 (5.45-7.61) <0.0001 NA  0.117 
  65+ 4 1078 16.8 (6.7-30.2) 95.5 (91.3-97.6) 4.70 (3.39-6.51) <0.0001 NA  0.523 
            
Sex Overall Overall 56 11458 15.5 (12.7-18.4) 94.2 (93.1-95.1) 4.14 (3.81-4.51) <0.0001 0.048 0.718 0.198 
 Men Overall 28 4951 14.9 (11.6-18.4) 90.5 (87.5-92.8) 3.24 (2.82-3.73) <0.0001 0.035  0.721 
  55-64 15 2734 11.5 (8.2-15.2) 87.4 (80.9-91.7) 2.82 (2.29-3.47) <0.0001 NA  0.773 
  55+ 4 348 16.0 (4.8-31.8) 91.8 (82.3-96.2) 3.50 (2.37-5.15)  <0.0001 NA  0.443 
  60+ 5 1483 26.5 (16.6-37.8) 93.6 (87.9-96.6) 3.95 (2.88-5.41) <0.0001 NA  0.090 
  65+ 4 386 14.8 (3.9-30.5) 91.1 (80.4-96.0) 3.36 (2.26-4.99) <0.0001 NA  0.476 
 Women Overall 28 6507 16.0 (11.6-20.1) 95.9 (94.9-96.7) 4.94 (4.44-5.50) <0.0001 0.596  0.209 
  55-64 15 3002 13.6 (8.2-24.9) 95.6 (94.0-96.7) 4.75 (4.07-5.53) <0.0001 NA  0.934 
  55+ 4 533 13.9 (5.6-24.9) 88.2 (72.4-95.0) 2.92 (1.90-4.47) <0.0001 NA  0.284 
  60+ 5 2280 24.0 (9.5-2.3) 98.4 (97.7-99.9) 8.00 (6.53-9.81) <0.0001 NA  0.166 
  65+ 4 692 18.3 (8.7-30.5) 90.6 (79.6-95.8) 3.26 (2.18-4.88) <0.0001 NA  0.596 
            
Residency  Overall 18 5534 17.6 (13.1-22.4) 94.7 (92.9-96.0) 4.34 (3.74-5.03) <0.0001 0.006 0.003 0.113 
 Urban Overall 12 3503 21.0 (15.2-27.5) 94.4 (91.9-96.1) 4.22 (3.50-5.08) <0.0001 <0.000
1 
 0.230 
  55-64 3 664 18.1 (8.9-29.5) 91.4 (77.8-96.6) 3.40 (2.12-5.46) <0.0001 NA  0.676 
  55+ 2 306 12.4 (8.9-16.3) 0 0 0.638 NA  - 
  60+ 5 1940 23.7 (12.6-37.0) 96.5 (94.2-98.0) 5.38 (4.14-6.99) <0.0001 NA  0.188 
  65+ 2 593 29.4 (25.8-33.2) 0 1 0.707 NA  - 
 Rural Overall 6 2031 10.5 (7.1-14.5) 81.0 (59.1-91.1) 2.29 (1.56-3.36) 0.0003 0.018  0.201 
  55-64 1 122 5.7 (2.2-10.7) - - - -  - 
  55+ 1 380 6.6 (4.3-9.3) - - - -  - 
  60+ 3 1447 13.3 (7.2-20.7) 88.4 (67.7-95.8) 3.9 (1.76-4.88) 0.0002 NA  0.006 
  65+ 1 82 15.8 (8.6-24.6) - - - -  - 
            
Region Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 0.062 0.557 
 Central Overall 5 1580 8.6 (5.4-12.3) 75.4 (39.5-90.0) 2.02 (1.29-3.16) 0.003 0.008  0.942 
 Eastern Overall 11 2863 13.8 (8.0-20.9) 96.0 (94.3-97.2) 4.97 (4.17-5.93) <0.0001 0.0003  0.456 
 Northern Overall 10 6007 16.6 (11.7-22.3) 96.7 (95.3-97.7) 5.48 (4.60-6.53) <0.0001 0.001  0.381 
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 Southern Overall 5 1024 21.5 (9.6-36.4) 96.2 (93.5-97.8) 5.15 (3.93-6.74) <0.0001 <0.000
1 
 0.065 
 Western Overall 8 2876 11.3 (6.0-18.0) 96.2 (94.3-97.5) 5.14 (4.18-6.31) <0.0001 0.313  0.966 
            
Design data 
collection 
Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 0.042 0.557 
 Non-STEPS Overall 25 9471 16.4 (12.7-20.4) 95.9 (94.9-96.8) 4.95 (4.42-5.55) <0.0001 <0.000
1 
 0.273 
  55-64 8 2044 13.3 (8.6-18.9) 91.3 (85.3-94.9) 3.39 (2.61-4.41) <0.0001 NA  0.116 
  55+ 6 1781 12.3 (6.7-19.1) 93.5 (88.6-96.3) 3.93 (2.96-5.22) <0.0001 NA  0.297 
  60+ 9 4971 19.9 (12.8-27.9) 97.6 (96.6-98.3) 6.44 (5.45-7.61) <0.0001 NA  0.117 
  65+ 2 675 27.7 (24.4-31.2) 0 1 0.473 NA  NA 
 STEPS Overall 14 4879 10.4 (6.7-14.9) 95.4 (93.7-96.7) 4.67 (3.98-5.49) <0.0001 0.564  0.320 
  55-64 12 4476 11.0 (6.7-16.0) 96.0 (94.4-97.1) 4.98 (4.21-5.88) <0.0001 NA  0.474 
  55+ 0 - - - - - -  - 
  60+ 0 - - - - - -  - 
  65+ 2 403 7.5 (0.7-19.7) 90.5 3.24 0.001 NA  NA 
            
Type of 
population 
Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 0.937 0.557 
 Subnational Overall 23 8573 14.2 (10.8-17.8) 95.1 (93.8-96.2) 4.54 (4.00-5.15) <0.0001 0.755  0.142 
  55-64 8 2466 12.7 (7.5-19.0) 94.5 (91.2-96.5) 4.26 (3.38-5.36) <0.0001 NA  0.872 
  55+ 6 1781 12.3 (6.7-19.1) 93.5 (88.6-96.3) 3.93 (2.96-5.22) <0.0001 NA  0.297 
  60+ 6 3549 16.2 (10.3-23.1) 95.6 (92.7-97.4) 4.78 (3.71-6.15) <0.0001 NA  0.054 
  65+ 3 777 18.2 (4.1-39.1) 96.0 (91.4-98.1) 4.98 (3.40-7.30) <0.0001 NA  0.645 
 National Overall 16 5777 14.0 (9.5-19.1) 96.4 (95.3-97.3) 5.27 (4.59-6.06) <0.0001 0.058  0.238 
  55-64 12 4054 11.3 (7.1-16.4) 95.5 (93.6-96.8) 4.69 (3.94-5.58) <0.0001 NA  0.245 
  55+ 0 - - - - - -  - 
  60+ 3 1422 27.3 (14.8-41.9) 96.3 (92.1-98.2) 5.18 (3.56-7.52) <0.0001 NA  0.813 
  65+ 1 301 13.0 (9.4-17.0) NA NA <0.0001 -  - 
            
   Year 
published 
Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 0.484 0.557 
 Below 
Median 
(2008) 
Overall 17 7748 13.0 (9.1-17.4) 96.5 (95.4-97.3) 5.33 (4.66-6.09) <0.0001 0.272  0.898 
  55-64 8 3002 9.8 (5.3-15.4) 95.3 (92.7-97.0) 4.61 (3.70-5.74) <0.0001 NA  0.172 
  55+ 2 720 19.9 (2.9-46.5) 98.0 6.99 <0.0001 NA  - 
  60+ 5 3623 18.7 (9.9-29.6) 98.2 (97.3-98.8) 7.49 (6.06-9.27) <0.0001 NA  0.347 
  65+ 2 403 7.5 (0.7-19.7) 90.5 3.24 0.001 NA  - 
 Above 
median 
(2008) 
Overall 22 6572 14.5 (10.9-18.5) 94.7 (93.0-95.9) 4.33 (3.79-4.94) <0.0001 <0.000
1 
 0.412 
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  55-64 12 3548 15.0 (11.1-19.3) 95.3 (93.3-96.3) 4.60 (4.05-5.23) <0.0001 NA  0.339 
  55+ 4 1061 8.8 (5.9-12.2) 67.2 (4.3-88.7) 1.75 (1.02-2.98) 0.027 NA  0.186 
  60+ 4 1348 21.5 (7.2-40.7) 97.1 (94.8-98.4) 5.85 (4.39-7.79) <0.0001 NA  0.194 
  65+ 2 675 27.7 (24.4-31.2) 0 1 0.473 NA  - 
            
Sample size Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 0.148 0.557 
 Below 
Median (282) 
Overall 19 3232 16.3 (12.1-21.0) 91.6 (88.3-93.9) 3.44 (2.92-4.06) <0.0001 0.174  0.915 
  55-64 10 2106 12.9 (8.9-17.5) 88.4 (80.7-93.0) 2.93 (2.28-3.78) <0.0001 NA  0.146 
  55+ 3 501 18.3 (7.0-33.2) 93.2 (83.5-97.2) 3.84 (2.46-5.98) <0.0001 NA  0.685 
  60+ 4 446 26.6 (14.9-40.3) 89.5 (75.9-95.4) 3.08 (2.04-4.67) 0.056 NA  0.356 
  65+ 2 179 14.0 (0.0-50.5) 96.6 5.45 <0.0001 NA  - 
 Above 
median (282) 
Overall 20 11118 12.2 (8.8-16.1) 97.1 (96.4-97.7) 5.89 (5.25-6.61) <0.0001 0.054  0.661 
  55-64 10 4414 10.9 (6.2-16.7) 96.9 (95.6-97.8) 5.66 (4.77-6.71) <0.0001 NA  0.172 
  55+ 3 1280 7.7 (5.8-9.9) 48.0 (0.0-84.8) 1.39 (1.00-2.57) 0.146 NA  0.037 
  60+ 5 4525 15.5 (8.0-24.7) 98.4 (97.6-98.9) 7.91 (6.44-9.72) <0.0001 NA  0.017 
  65+ 2 899 19.8 (7.7-35.6) 96.2 5.14 <0.0001 NA  - 
            
Diagnostic 
methods 
Overall Overall 39 14350 14.1 (11.4-17.1) 95.8 (94.9-96.5) 4.87 (4.44-5.34) <0.0001 0.222 <0.0001 0.557 
 FPG Overall 27 10935 10.5 (8.3-12.9) 93.2 (91.1-94.7) 3.82 (3.36-4.35) <0.0001 0.625  0.711 
  55-64 16 5215 10.2 (6.8-14.1) 94.7 (92.7-96.1) 4.34 (3.71-5.08) <0.0001 NA  0.300 
  55+ 4 1206 9.6 (7.0-12.6) 57.8 (0-86.0) 1.54 (1.0-2.67) 0.0684 NA  0.500 
  60+ 5 4111 13.0 (8.6-18.1) 94.7 (90.5-97.1) 4.36 (3.24-5.87) <0.0001 NA  0.365 
  65+ 2 403 7.5 (0.7-19.7) 90.5  3.24 0.0012 NA  NA 
 OGTT Overall 12 3415 24.0 (17.7-30.7) 94.9 (92.6-96.4) 4.41 (3.68-5.29) <0.0001 0.116  0.947 
  55-64 4 1305 19.7 (14.2-25.8) 84.6 (61.7-93.8) 2.55 (1.62-4.03) 0.0002 NA  0.742 
  55+ 2 575 17.7 (0.7-49.2) 98.4  7.94 <0.0001 NA  NA 
  60+ 4 860 29.7 (18.3-42.5) 92.0 (82.8-96.3) 3.54 (2.41-5.21) <0.0001 NA  0.432 
  65+ 2 675 27.7 (24.4-31.2) 0 0 0.473 NA  NA 
            
Age Overall Overall 42 14704 13.8 (11.2-16.6) 95.5 (94.6-96.2) 4.70 (4.29-5.14) <0.0001 0.213 0.213 0.776 
 55-64 Overall 22 6757 11.5 (8.4-15.0) 94.4 (92.6-95.7) 4.22 (3.68-4.82) <0.0001 NA  0.245 
 55+ Overall 6 1781 12.3 (6.7-19.1) 93.5 (88.6-96.3) 3.93 (2.96-5.22) <0.0001 NA  0.297 
 60+ Overall 10 5088 19.0 (12.5-26.5) 97.3 (96.2-98.0) 6.08 (5.16-7.16) <0.0001 NA  0.144 
 65+ Overall 4 1078 16.8 (6.7-30.2) 95.5 (91.3-97.6) 4.70 (3.39-6.51) <0.0001 NA  0.523 
 
 61 
 
Table 4–2 Prevalence of type 2 diabetes in older populations assessed in studies not using the WHO STEPwise approach to 
surveillance 
Country Author Sampling Age  Prevalence (%) (95%CI) 
 
Diagnosis IFG and/ or 
IGT prevalence 
% (95% CI) 
Size Strategy Response 
Rate (%) 
Urban  Rural    Urban +Rural Method Criteria   
M  F  T M F T M F T    
Algeria 
 
 
Malek 2001  
 
1457 Random 
sampling 
90 55-64 
60+ 
- - - - - - - - 11.2 
12.0 
OGTT WHO 
1998 
17.43 for IGT 
Zaoui 2007 
 
7656 Random 
sampling 
NR  60+ 17.4 5.7 10.3 10.2 7.2 8.3 14.2 6.4 10.5 FPG WHO 
1985 
NR 
Angola Evaristo Neto 
2012 
 
709 Random 71 60 - 69 - - 14.6 - - - - - - FPG 
OGTT 
 
WHO 
1998 
20.8 for IGT 
Cameroon 
 
Nchanchou 
2008 (Thesis) 
1279 Multistage 
sampling 
 
>95 55+ 15.2 10.8 13.1 - - - - - - FPG WHO 
1998 
6.8 for IFG 
Canary Islands Boronat 2005 
 
1193 Random 
sampling 
86.3 55+ - - - - - - 39.6 26.3 32.8 FPG 
OGTT 
 
WHO 
1998 
5.1 for IFG 
10.6 for IGT 
DRC 
 
On’Kin 2008 
 
9770 Multistage 
sampling 
90.3 55 -64 
 
65 - 98 
 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
37.7 
 
36.1 
 
44.5 
 
30.6 
 
41.4 
 
33.4 
 
FPG 
OGTT 
 
WHO 
1998 
15 for IGT 
15.5 for IGT 
 
 
Katchunga 
2012 
 
711 Multistage 
sampling 
98.6 60+ 
 
- - - - - - - - 8.3 FPG 
 
WHO 
1998 
NR 
Ethiopia 
 
Muluneh 
2012 
 
5500 Random 
sampling 
81.3% 55+ - - - - - - - - 6.7 FPG WHO  
1998 
NR 
Guinea Balde 2007 2000 Multistage 77 55–64 - - - - - - - - 7.8  FPG WHO NR 
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  sampling 65+ 
     
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
- 
 
6.1 
 
1998 
Kenya 
 
Ayah 2013 
 
2061 Cluster 
sampling 
99 55+ 
55-64 
7.6 
2.0 
16.7 
17.9 
11.1 
 7.7 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
- 
 FPG WHO 
1998 
NR 
LaReUnion 
 
Favier 2005 
 
3600 Random 
sampling 
80.6 60+ - - - - - - 34.6 40.0 37.7 FPG 
OGTT 
 
WHO 
1998 
NR 
Libya 
 
Kadiki 2001 1002 Multistage 
sampling 
86.6 60+ - - 34.9 - - 28.3 30.2 17.8 24.5 OGTT 
 
WHO 
1998 
7.6 for IGT 
Mayotte 
 
Solet 2011 
 
1268 Random 
sampling 
70 60+ 
 
25.9 - -  - - - - - FPG WHO 
1998 
NR 
Mozambique Silva Matos 
2011 
 
2343 Random 
sampling 
NR 55-64 
 
- - 8.7 - - 5.7 - - - FPG WHO 
1998 
1.1 for IFG 
(U) 
5.1 for   IFG (R) 
 
Nigeria 
 
Ekpenyong 
2012 
 
2780 Random 
sampling 
97.3 55-64 
 
 
- - - - - - 14.3 34.8 21.5 FPG 
OGTT 
 
WHO 
1998 
NR 
Seychelles 
 
Faeh 2007 
 
1255 Random 
sampling 
80.2 55-64 
 
22.0 26.5 24.5 - - - - - - FPG 
OGTT 
WHO 
1998 
  
23.25 for IFG 
17.3 for IGT 
South Africa 
 
 
Erasmus 2012 
 
642 Random 
sampling 
87.6 60+ 
 
11.8 7.7 43.6 - - - - - - FPG 
OGTT 
WHO 
1998 
 
1.8 for IFG 
16.4 for IGT 
Peer 2012 
 
 
 
1099 Random 
sampling 
86 55-64 
65-74 
17.3 
42.9 
26.9 
34.7 
22.7 
31.2 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
- 
 
- 
OGTT WHO 
1998 
0.8 for IFG  
16.9for IGT 
1.1 for IFG  
19.9 for IGT 
 
Motala 2008 
 
1300 Cluster 
sampling 
78.9 55+ 
 
55-64 
 
- 
 
- 
- 
 
- 
- 
 
- 
6.3 
 
13.7 
7.7 
 
7.6 
6.6 
 
8.8 
- 
 
- 
- 
 
- 
- 
 
- 
FPG 
OGTT 
WHO 
 1998 
   
1.3 for IFG 
 8.8 for IGT 
1.8 for IFG 
12.7 for IGT 
Tunisia 
 
Bouguerra 
2007 
 
 
Hammami 
2012 
 
 
2729 
 
 
 
598 
multistage 
stratified  
 
 
multistage 
cluster 
sampling 
85.1 
 
 
 
96.3 
60+ 
 
 
 
65+ 
19.8 
 
 
 
32.0 
27.4 
 
 
 
28.0 
24.3 
 
 
 
29.3 
10.6 
 
 
 
15.2 
12.
4 
 
 
 
16.
3 
11.5 
 
 
 
15.9 
15.8 
 
 
 
29.2 
21.9 
 
 
 
26.5 
19.2 
 
 
 
27.4 
FPG 
 
 
 
FPG 
OGTT 
 
 
WHO 
1998 
 
 
WHO 
1998 
  
NR 
 
 
 
 
NR 
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Uganda Mayega 2013 1497 Random 
sampling 
90.4% 55-60 - - - - - - - - 9.2 FPG WHO 
1998 
8.6 for IFG 
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Table 4–3 Prevalence of type 2 diabetes in older populations assessed in studies using the WHO STEPwise approach to 
surveillance 
Country 
 
Survey   year Sampling Age 
Range 
Prevalence (%) (95%CI) 
 
Diagnosis IFG and/ or IGT 
prevalence % (95% CI) 
Size Stratgy Rate of 
response % 
Urban + Rural   
M F All Method Criteria 
Algeria 2003 (S) 4,097 Multi-stage cluster 
sampling 
3,820 
93.2 
55-64 
 
6.4 
 
5.1 
 
5.6 
 
FPG WHO 1998 NR 
Benin 
 
2008 (N) 6,842 Multi-stage cluster 
sampling 
6,511 
95.2 
55-64 
 
15.5 
 
17.7 
 
15.9 
 
FPG WHO 1998 NR 
Botswana 2007 (N) 4,003 Multi-stage cluster 
sampling 
2,820 70.4 55-64 
 
4.2 
 
8.2 
 
12.3 
 
FPG WHO 1998 NR 
DRC 2005 (S) 1,943 Multi-stage cluster 
sampling 
1,123 (57.8) 55-64 
65+ 
5.2 
2.1 
 
6.2 
3.7 
 
5.7 
2.9 
FPG WHO 1998 NR 
Egypt 
 
2006 (N) 10,000 Multi-stage cluster 
sampling 
9730 
97.3 
55-64 
 
17.2 
 
28.7 
 
22.6 
 
FPG WHO 1998 NR 
Gabon 
 
2009 (N) 2800 Multi-stage cluster 
sampling 
2708 
96.7 
55-64 
 
- - 22.2 FPG WHO 1998 NR 
Libya 
 
2009 (N) 3625 Multi-stage cluster 
sampling 
2646 
73.0 
55-64 
 
25.6 
 
33.4 
 
29.0 
 
FPG WHO 1998 NR 
Malawi 
 
2010 (N) 5206 Multi-stage cluster 
sampling 
2842 
54.6 
55-64 
 
0.0 
 
1.2 6.6 FPG WHO 1998 NR 
Mauritania 2006 (N) 2600 Multi-stage cluster 
sampling 
2500 
96.1 
55-64 
60-69 
70+ 
 
3.7 
36.2 
36.6 
3.2 
38.7 
42.9 
3.4 
37.6 
39.7 
FPG WHO 1998 NR 
Mauritius  2004 (N) 4500 Multi-stage cluster 
sampling 
4200 
93.3 
60-69 
70+ 
36.2 
36.6 
 
 
38.7 
42.9 
 
37.6 
39.7 
 
FPG  
OGTT 
WHO 1998 16.2 for IGT 
18.4 for IGT 
Niger  2008 (N) 3060 Multi-stage cluster 
sampling 
90.8 55-64 
 
4.4 0.8 3.2 FPG WHO 1998 NR 
Sudan 
 
2006 (S) 1573 Multi-stage cluster 
sampling 
921 
58.5 
55-64 
 
19.9 16.2 17.9 FPG WHO 1998 NR 
Togo 2010 (N) 4800 Multi-stage cluster 
sampling 
4370 
91.0 
55-64 
 
11.0 3.6 7.5 FPG WHO 1998 NR 
Zimbabwe 
 
2005  (N) 3000 
 
Multi-stage cluster 
sampling 
3081 
102 
55-64 
   
65+ 
15.7 
 
18.5 
14.0 
 
15 
14.4 
 
16.8 
 
FPG 
 
WHO 1998 
 
NR 
*Data extracted from peer reviewed published and unpuplished studies other than WHOSTEPS studies.   FPG, fasting plasma glucose; OGTT, oral glucose tolerance test; IFG, impaired fasting glucose (fasting plasma 
glucose: 5.6 to 6.9 mmol/l); IGT, impaired glucose tolerance (2-h post challenge glucose: 7.8–11.0 mmol/l); NR, not reported; M, Male ; F, Female;WHO 1998, the World Health Organization definition of diabetes in 1998 
(FPG _ 7.0 mmol/l and/or 2-h PG _ 11.1 mmol/l). 
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4.4.3. Prevalence by method of data collection (STEPS vs non-STEPS). 
The prevalence of type 2 diabetes was significantly lower in STEPS studies (p=0・003) than in 
non-STEPS studies (9.6%, 95% CI 6.6–13.0, 20 contributions vs 17.1%, 13.6–20.9, 29 
contributions; Figures 4-2,4-3). There was a significant difference across age groups in the non-
STEPS studies (p<0・0001), but not across the STEPS surveys (p=0・550, appendix 15). No 
difference in prevalence was seen between studies larger and smaller than the median sample 
size (p=0・592), although there was a significant age differential among studies above the 
median sample size (p=0・008,). Heterogeneity remained significant (p<0・0001) within the 
STEPS and non-STEPS age groups (Figures 4-2, 4-3). 
Figure 4–2 Meta-analysis results for prevalence of type 2 diabetes in studies using the 
WHO STEPwise approach to surveillance
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Figure 4–3 Meta-analysis results for prevalence of type 2 diabetes in studies not using 
the WHO STEPwise approach to surveillance.  
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4.4.4. Prevalence by diagnostic method (FPG vs OGTT) 
When diagnosed with FPG the prevalence of type 2 diabetes was 10.9% (95% CI 8.9–13.0; 37 
contributions) and when diagnosed with OGTT was 23・9% (17.7–30.7; 12 contributions, p-value 
for difference <0・0001; Figures 4-4, 4-5). When studies that used the same diagnostic method 
were compared, prevalence did not differ between age groups (p=0.410 for FPG and p=0.117 for 
OGTT). When the prevalence of diabetes was compared across the different regions (eastern, 
western, central, northern, and southern) after stratification by the diagnostic method, prevalence 
did not differ (p=0.139 for OGTT and p=0.070 for FPG), in line with the main analysis 
Figure 4–4. Meta-analysis results for prevalence of type 2 diabetes in studies in which 
diabetes diagnosis was based on fasting plasma glucose. 
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Figure 4–-5 Meta-analysis results for prevalence of type 2 diabetes in studies in which diabetes 
diagnosis was based on using the oral glucose tolerance test. 
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4.4.5. Investigation of the sources of heterogeneity 
Substantial heterogeneity was seen across the contributing studies overall, within subgroups for 
sex, age, residence, and median sample size, across diagnostic methods, and across data 
collection methods (all p<0・0001 for heterogeneity). We found no evidence of publication bias 
(Egger score) overall and in most age groups (Table 4–1). 
4.5. Discussion     
Our systematic review showed that type 2 diabetes is not rare in people aged 55 years and older 
across Africa. The estimated prevalence of diabetes was two times higher in studies that used 
OGTT than in those that used FPG to diagnose diabetes and was nearly twice as high in urban 
than in rural settings. The two main methods used to survey diabetes prevalence were also 
associated with different results: non-STEPs studies showed a prevalence 1.6 times higher than 
STEPS studies. Prevalence did not, however, differ by sex, sample size, year of publication, 
region, or population coverage. When stratified by age group, the prevalence of diabetes 
varied within some major subgroups, but not all. The prevalence and number of people affected 
by diabetes varies worldwide. The latest IDF Atlas reports that the highest number of people with 
diabetes between ages 20 and 79 years is in the western Pacific Region, where 138 million people 
are affected, although prevalence is 8.6%, which is close to the global estimate. The North 
American and Caribbean region has the highest prevalence at 11%, with an estimated 37 million 
people affected, followed by the Middle East and North African region, where prevalence is 9.2% 
and35 million people are affected. In Europe, the prevalence and number affected are estimated 
to be 8.5% and 56 million people, in South and Central America the values are 8.1% and 25 
million people, and in Africa 4.9% and 22 million people, which are the lowest values. (61)  
According to the Atlas, the three African countries with the highest prevalence are Gabon (10.7%), 
Reunion (15.4%), and Seychelles (12.1%). (62) The 2014 Atlas did not report the data stratified 
by age group or diagnostic method. (61)  
The overall estimated prevalence in this review of African studies fell within that for people aged 
60–79 years in 13 European countries in the DECODE study (63) and those aged 60–69 years 
in the Chinese and Japanese cohorts in the DECODA study. (64) The prevalence was, however, 
lower than that in people older than 65 years from the USA NHANES survey in 2006, (65) and in 
people aged 60–69 years in the Indian cohorts of the DECODA study (31.0% in the former, and 
41.4% and 34.6% in men and women in the latter).  
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The two times higher overall estimated prevalence of diabetes we found in African studies when the 
diagnosis was made with OGTT than with FPG criteria is in line with findings in previous reports. 
Many studies have reported that FPG and two h glucose concentrations from OGTT are not 
consistent in detecting diabetes in the same people. For example, in the DECODE study, (63) of the 
1517 people with newly diagnosed diabetes, 40% met only the FPG criterion, 31% met only the 2 h 
plasma glucose criterion, and 28% met both. Therefore, use of only FPG would not have identified 
around 30% of people with diabetes. Those investigators, therefore, concluded that diabetes would 
be underestimated in the older population in Europe if diagnoses were based on FPG. In the Rancho 
Bernardo study in the USA, (66) new diagnoses of diabetes were made more frequently with OGTT 
than with FPG;70% of women and 48% of men aged 50–89 years were diagnosed by 2 h plasma 
glucose alone. (66) The researchers noted that diabetes defined by OGTT alone is common in older 
adults since the results with OGTT increase with increasing age, which more than doubles the risk 
of fatal cardiovascular disease and of heart disease in older women. The use of FPG alone for 
screening or diagnosis of diabetes might not identify older adults in these risk groups and, therefore, 
they should be reassessed if a diagnosis was made with this method. These differences have 
important implications for Africa, where STEPS surveys were based on protocols that recommended 
the use of FPG as a core component of biochemical measurement, as such studies are becoming a 
growing source of information about diabetes prevalence data. Our data and those of previous 
studies suggest that if the use of FPG alone were followed in practice, half of the diabetes burden in 
the people older than 55 years would be missed. Comparison of mortality in people with a diagnosis 
of diabetes based on FPG or OGTT has consistently shown worse clinical outcomes with the latter. 
For example, in the DECODE study, (63) the hazard ratios for death in people with diabetes 
diagnosed by FPG were 1.6 (95% CI 1.4–1.8) for all-cause mortality, 1.6 (1.3–1.9) for cardiovascular 
mortality, and 1.6 (1.4–1.9) for non-cardiovascular mortality. For OGTT, the equivalent hazard ratios 
were 2.0 (1.7–2・3), 1.9 (1.5–2.4), and 2.1 (1.7–2.5), respectively. (63)  
On the basis of findings from three population-based longitudinal studies in Mauritius, Fiji, and Nauru, 
Shaw and colleagues (67) reported a 2.7-time increase in risk for all-cause mortality in men and 2.0 
times in women with newly diagnosed diabetes based on OGTT, compared with people with normal 
glucose tolerance. By contrast, people with diagnoses based on FPG had no increased risk. Similar 
findings have been reported in the Hoorn study. (68) Thus, OGTT should be used rather than FPG 
to diagnose new cases of diabetes. The higher prevalence of diabetes in urban than in rural settings 
is in agreement with findings from studies done in other countries (69–72). Urbanisation in Africa, as 
elsewhere, is associated with notable changes in lifestyle, including decreased physical activity. In 
rural African communities, full-time labour-intensive subsistence farming is a common means of 
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livelihood and transport is active i.e., walking or cycling—particularly in individuals with low 
socioeconomic status. In urban areas, although there is still little leisure time, active transport and 
the levels of occupation-related and total physical activity are substantially reduced compared with 
the rural setting. Additionally, living in rural and traditional environments is associated with 
consuming diets incorporating more fruit and vegetables than in urban settings (62,73–76). By 
contrast, diets in urban areas are associated with increased intake of animal fat and refined 
carbohydrates, including fast foods and sugar-sweetened foods and drinks, since, notwithstanding 
the widespread poverty in urban areas, access to these types of food is much easier than in rural 
areas. (77,78)  
Food insecurity, a risk factor for obesity, is an important issue for the urban poor in Africa. Although 
studies have revealed a strong positive relationship between obesity and high socioeconomic status, 
the obesity burden might be shifting to sections of the poor urban population, where people might 
have little knowledge and financial resources to adopt healthier lifestyles. (78–84) The implications 
of the rural-urban gradient in diabetes prevalence are profound for Africa, where countries are 
currently facing one of the most rapid rates of increased urbanisation worldwide. At present, the 
average annual rate of urbanisation is 3.2%, and it is predicted that 47.7% of the African population 
will be living in urbanised areas within 15 years, which equates to an estimated 744 million people 
living in cities by 2030. Therefore, a striking increase in the prevalence and number of adults with 
type 2 diabetes and associated risk factors is likely. (85)  
Our findings have important policy implications for Africa. Although the attention of policymakers is 
finally extending beyond HIV/AIDs, tuberculosis, and malaria to non-communicable diseases, the 
enormity of this latter epidemic, including diabetes, is not fully appreciated. Increased survival in 
people taking antiretroviral therapy and increased longevity in those who are HIV negative, together 
with urbanisation, will place an ever-increasing burden on the already stretched health-care services 
in Africa unless aggressive preventive strategies are put in place. If monitoring of secular trends in 
the incidence and prevalence of diabetes associated with the epidemiological transition across all 
African countries is to be successful, use of standardised methods will be necessary. African 
countries that have done STEPS surveys must be encouraged to move towards having a regular 
cycle of risk factor surveillance reflected in national reporting of non-communicable diseases, and 
especially plans of action for diabetes. The questionnaire items and measures used in STEPS and 
the indicators reported from STEPS surveys need to be periodically reviewed to adapt to the latest 
scientific standards and policy needs in different countries. (86,87) 
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The issue of which test to use for diabetes prevalence studies (OGTT, FPG, or HbA1c) in Africa is 
complex, because decisions have to take into account cost, convenience, and reliability. 
Measurement of trends over time will be made difficult if diagnostic criteria change. There is little 
doubt that HbA1c would be the simplest indicator for diabetes because it avoids the need for fasting 
and measurement of glucose concentrations at 2 h for an OGTT. HbA1c also has less within-
individual variation and better predicts microvascular and macrovascular complications than FPG 
and OGTT. The cut-off s for diabetes with HbA1c, however, have not been established for African 
populations, which is important to address. The use of HbA1c in epidemiological studies will only be 
viable once reliable, cost-effective, point-of-care equipment has been developed. Furthermore, if 
HbA1c were to become the standard test for diabetes prevalence studies, it would only be possible 
to assess trends once new baseline estimates with this method had been established. Irrespective 
of the diagnostic criteria or test used, future studies must assess the prevalence of type 2 diabetes 
according to uniform case definition and diagnostic methods and provide standardised prevalence 
values for older people across Africa to enable comparisons across the continent. 
 African countries also need encouragement to move from the subnational implementation of STEPS 
surveys to capturing national prevalence data. Increased collaboration between African governments 
and WHO is also needed to make the data collected from STEPS widely available so that they can 
be used to strengthen strategies for prevention and management of non-communicable diseases, 
including type 2 diabetes. (87) Indeed, there is a clear obligation to invest in surveillance, diabetes 
prevention, and creation of affordable, innovative models of health-care access and systems to halt 
the growing burden of diabetes in Africa. In the meantime, primary prevention should focus on targets 
suggested by evidence, such as improving access to health care, health education, and countering 
risk factors for vascular disease, including, hypertension and obesity in middle age, smoking, and 
physical inactivity. 
Our systematic review has several strengths. We used a comprehensive review protocol (15) and 
made extensive effort to identify all the available evidence without language restrictions. We reported 
this systematic review according to PRISMA guidelines. We applied an African search filter, 
searched multiple electronic databases, and used a rigorous approach to select studies for inclusion. 
Another important strength is that we controlled for the effect of multiple-publication bias in the 
analysis of the results by avoiding inclusion of duplicate publications that might have skewed the 
interpretation of the prevalence estimates. Similarly, we appraised the methodological quality of 
individual studies with standard quality assessment tools for prevalence studies. Use of an arcsine 
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transformation to stabilise the variance of primary studies before pooling limited the effects of studies 
with small and large prevalence values on the pooled estimates overall and across subgroups.  
Our findings should be interpreted in the context of some limitations. First, data on the prevalence of 
diabetes in people aged 55 years and older in Africa over the past 15 years are scarce and, therefore, 
describing trends of diabetes prevalence over time was not possible. Second, our ability to assess 
the quality of studies that we identified was limited by the methodological information provided, some 
of which was incomplete. Differing study sample sizes might partly explain variability in diabetes 
estimates. Third, we found notable heterogeneity in prevalence measures of type 2 diabetes, which 
was incompletely explained by subgroup analyses. Despite substantial differences, we could pool 
data to provide useful estimates. Fourth, most primary studies lacked data on key covariates that 
could have been used in meta regression analyses to explore further and control for the sources of 
variations in prevalence between studies. 
Our cut-off of age 55 years for the older population could be questioned. In reality, the definition of 
older is somewhat arbitrary. For example, the United Nations uses a cutoff of 60 years, whereas, for 
research purposes, the cut-off for older populations is frequently 60 or 65 years. (88) Traditional 
African definitions of a so-called older or elderly person correlate with the chronological ages of 50–
65 years, dependent on the setting, region, and country. (89) Age 50 years was used as the lower 
cut-off for the Minimum Data Set Project on Ageing in sub-Saharan Africa (90) because this threshold 
was thought to be more realistic than age 60 years for African populations. Furthermore, a collection 
of data from the age of 50 years might show emerging trends that would be of assistance to 
policymakers and for health-care planning. (90)  
Many parts of Africa have only recently entered demographic transition, which accounts for the 
evidence that older people represent just over 5% of the African population in 2014. (91,92) Yet, 
the ageing population in Africa is growing at a much faster pace than in any other continent and 
has been accompanied by an increase in the median population age and changes in the 
dependency ratio. Thus, the proportion of the population composed of children has decreased, 
and that of people aged 60 years and older has increased. By 2050, the older population in Africa 
is projected to more than triple to reach 205 million. Furthermore, the widespread access to 
antiretroviral therapy over the past 4–5 years in sub- Saharan Africa has already had a substantial 
effect on life expectancy and will contribute to the growing number of older people in Africa; thus, 
the number of people at risk of type 2 diabetes and cardiovascular disease will also increase. 
Indeed, the projected worldwide median life expectancy in people living with HIV is 75 years, 
which is only seven years less than that for the general population. (93) 
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We cannot give an accurate assessment of the contribution that diabetes in the older population 
makes to the total adult burden of diabetes in Africa but, on the basis of this review and population 
data, we estimate that 9 million Africans aged 55 years and older are living with diabetes in 2015. 
Accordingly, a concerted effort from multiple sectors will be crucial to ensuring improved health-
care delivery for people with diabetes to reduce the unacceptably high levels of morbidity and 
mortality in the African region. 
 4.6. Conclusion 
The substantial burden of diabetes in the older population is an important health issue for African 
countries. Uniform diagnostic methods are needed to assess trends in diabetes prevalence within 
and between countries. Such uniformity will better enable diabetes prevention strategies to be put 
in place and collaborative initiatives to be developed between key international and national 
diabetes and geriatric organisations that can do further research and, ultimately, improve diabetes 
care for older people in Africa and worldwide. 
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5.1. Abstract  
 
Background 
 Diabetes is a chronic disease with severe late complications. It is known to impact the 
quality of life and cause disability, which may affect an individual’s capacity to manage and 
maintain longer-term health and well-being. 
Objectives 
To examine the prevalence of self-reported diabetes, and the association between 
diabetes and each of health-related quality of life and disability amongst South Africa’s 
older adults. To study both the direct relationship between diabetes and these two 
measures, as well as moderation effects, i.e. whether associations between other factors 
and these measures of well-being differed between individuals with diabetes and those 
without. 
Methods 
Secondary analyses of data on participants aged 50 years and older from the Study on 
global AGEing and adult health (SAGE) in South Africa Wave 1 (2007–2008) were 
conducted. Prevalence of self-reported diabetes was assessed. Multivariable regressions 
describe the relationships between each of quality of life (WHOQoL) and disability 
(WHODAS), and diabetes, while controlling for selected socio-demographic 
characteristics, health risk behaviours and co-morbid conditions. In the regression models, 
we also investigated whether diabetes moderates the relationships between these 
additional factors and WHOQoL/ WHODAS. 
Results 
Self-reported diabetes prevalence was 9.2% (95% CI: 7.8,10.9) and increased with age. 
Having diabetes was associated with poorer WHOQoL scores (additive effect: −4.2; 95% 
CI: −9.2,0.9; p-value <0.001) and greater disability (multiplicative effect: 2.1; 95% CI: 
1.5,2.9; p-value <0.001). Lower quality of life and greater disability were both related to 
not being in a relationship, lower education, less wealth, lower physical activity and a larger 
number of chronic conditions. Conclusions: Diabetes is associated with lower quality of 
life and greater disability amongst older South Africans. Attention needs to be given to 
enhancing the capacity of health systems to meet the changing needs of ageing 
populations with diabetes in SA as well as facilitating social support networks in 
communities.  
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5.2. Background 
Populations are ageing worldwide, and the pace of the demographic transition is fastest 
in developing countries, including those in Africa. (1) The number of people aged 60 years 
and older in sub-Saharan Africa is projected to be double that in Northern Europe by 2050, 
and to rise faster than any other region, increasing almost fourfold: from 46 million in 2015 
to 157 million by 2050, (2) South Africa (SA) has one of the largest ageing populations in 
Africa with more than 1 in 6 individuals aged 50 years and older. Almost 8% of the current 
population is aged 60 years and older equating to approximately 4.2 million people and is 
projected to rise. The number of those aged 60 years and older is projected to rise to 10.1 
million (15%) by 2050 (3). Concomitant with people living longer and an expanding older 
section of the population is an increase in chronic morbidity. Type 2 diabetes mellitus is 
typically more common in older than younger adults. Rapid urbanisation is contributing to 
higher disease prevalence in numerous African countries with prevalence higher in older 
adults than in any other age groups. (4) Untreated or inadequately managed diabetes may 
lead to long-term complications, including blindness, kidney disease, peripheral 
neuropathy and macrovascular disease, in turn leading to amputations, stroke and heart 
attacks. Such complications contribute significantly to mortality, morbidity and health 
system costs. (5) Diabetes is currently the seventh leading cause of morbidity and mortality 
in South Africa, due to trends in obesity, poor diet, high fasting blood glucose and low 
physical activity levels. (6)  
Health care systems in many African countries are hard-pressed to provide adequate care 
to older patients with diabetes or indeed to prevent or delay the onset of the disease, in 
old age or earlier in the life course. Complications that arise from diabetes, particularly 
through inadequate management, have the potential to impact the quality of life ,(6) The 
World Health Organization (WHO) defined the health-related quality of life (HRQoL) as 
‘the individual’s perception of their position in life in the context of the cultural and value 
systems in which they lived and related to their goals, expectations, standards and 
concerns. (7) Provision of quality health care as a means to maintain the quality of life and 
well-being remains a challenge in South Africa, both in urban areas and in rural areas. The 
current public health care system is geared towards management of single acute diseases 
and not clients with complex multiple chronic conditions, such as more often seen in older 
than in younger patients. (8) Further complicating the situation, older clients’ 
dissatisfaction with service delivery at public healthcare facilities has been widely 
documented and pertains mainly to access barriers to care. (8) Adequate management of 
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diabetes to prevent complications that impact the quality of life requires a supportive, 
accessible health care system, especially at primary care level. (7,8) 
Quality of life (QoL) and disability are powerful predictors of a person’s capacity to manage 
and maintain longer-term health and well-being. QoL is a form of evaluative well-being that 
refers to perceptions of the quality or goodness of one’s life or one’s overall life satisfaction 
(9). Psychological well-being and health are closely related, possibly becoming more 
important at older ages. (9) Age-related disability is an umbrella term that encompasses 
decrements in bodily function, task performance and involvement in life situations. (10) 
Both HRQoL and disability are health-related outcomes which reflect the overall health of 
an individual, including those with diabetes. (10)  
The HRQoL reported by older people with chronic diseases such as diabetes may reflect 
its restrictive management regimen, disease sequelae, and impact of associated co-
morbidities. (11) This study aimed to fill a gap in knowledge regarding the relationship 
between diabetes and the wellbeing and functioning of South Africans aged 50 years and 
older. Using data from Wave 1 of the WHO Study on global AGEing and adult health 
(SAGE), we investigated the prevalence of self-report diabetes and the association 
between diabetes and each of the WHO Quality of Life (WHOQoL) and WHO Disability 
Assessment Schedule (WHODAS) scores. In the analysis, we controlled for selected 
socio-demographic characteristics, health risk behaviours and the presence of co-morbid 
conditions. We also explored whether the associations between these additional factors 
and WHOQoL and WHODAS differed between individuals with diabetes and those without 
– i.e. investigated the moderation of effects by diabetes status. 
5.3. Methods 
 
5.3.1. Data source 
Secondary analyses were undertaken of data from the WHO Study on global AGEing and 
adult health (SAGE), a longitudinal, multi-country study conducted in China, Ghana, India, 
Mexico, the Russian Federation and South Africa. SAGE collected individual- level data 
from nationally representative household samples of older adults (50 years and older) 
using a multistage cluster sampling design and included a smaller sample of younger 
adults (aged 18–49 years) for comparison purposes. (12) SAGE Wave 2 was conducted 
in 2014/2015 but data for this study was not available to the public at the time the current 
study was conducted. (13) Cross-sectional data from Wave 1 (2007/08) in South African 
adults aged 50 years and older were analysed. The sample comprised 4 037 participants, 
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3836 (90.9%) of whom were 50 years and older. The household response rate for South 
Africa was 67%, and individual response rates were 77%. (13) All participants aged 50 
years and older in the selected older households were invited to complete a personal 
interview. Proxy respondents (through cognitive screening) were identified for a 
subsample unable to complete an interview. Face-to-face interviews using a standardised 
questionnaire were used to collect information on socio-demographic characteristics, 
disability, subjective well-being, and other health measures and behavioural risk factors. 
Post-stratified weights were used to ensure that estimates were nationally representative. 
(14) 
5.3.2. Measurements 
The following measures were used to assess quality of life and level of disability: 
• Subjective well-being, or quality of life, was measured using the eight-item WHO Quality 
of Life Instrument (WHOQoL). (14) Outcomes from the eight questions were summed to 
obtain an overall WHOQoL score which was transformed to a 0–100 scale, where a score 
of 0 represents the worst quality of life, and a maximum score of 100 represents the 
highest quality of life. 
•  Disability level was measured using the 12-item WHO Disability Assessment Schedule 
(WHODAS) encompassing 6 domains of functioning; questions were summed to get an 
overall WHODAS score, initially a count ranging from 0 to 36. The score can be 
transformed onto a 0–100 scale, with 0 as no disability and 100 maximum disability. (15) 
The relationship between diabetes and WHOQoL and WHODAS was investigated, where 
diabetes status was determined through self-report, using the question ‘Has a health 
professional/doctor ever told you that you have diabetes?’ Additionally, participants 
reporting taking medication for diabetes were considered as having diabetes (or high blood 
sugar). 
The additional variables considered were as follows: 
● Selected socio-demographic characteristics were used as covariates in the analyses. 
These include age groups (50–59 years, 60–69 years, 70 years and older), sex (male, 
female), marital status (single, married/cohabiting, separated/divorced, widowed) and 
years of education (0–5 years,6–12 years, ≥ 13 years). ‘Same location’ was determined 
using the question ‘Have you always lived in this village/town/city?’ Employment status 
(ever worked, never worked) and wealth quintiles (lowest to highest) were also considered. 
Since direct socio-economic measures are available, ethnicity, historically used as a proxy 
for this in SA, is excluded from the models presented below. 
 86 
 
● Health-related variables included the use of tobacco (ever smoked, never smoked) and 
the use of alcohol (never drank, ever drank). A categorical variable indicating low, medium 
and high physical activity levels was constructed from the Global Physical Activity 
Questionnaire (GPAQ) included within SAGE. (16) 
● Self-reported chronic conditions were assigned based on similar questions to those used 
for diabetes but applied to the following conditions: arthritis, stroke, angina, chronic lung 
disease, asthma, hypertension, cataracts and depression. A count variable was also 
generated for each participant (collapsed into zero, one, two or more chronic conditions). 
5.3.3. Ethical clearance 
SAGE Wave 1 was approved by the HSRC Research Ethics Committee (South Africa) 
and the National Department of Health. SAGE was also approved by the WHO Ethical 
Review Committee. Respondents provided written informed consent. WHO SAGE granted 
the investigators’ permission for access to the de-identified data for secondary analysis in 
June 2014. 
5.4. Statistical analyses 
 
Data were analysed using R (version 3.1.3), (17) and the sampling design and probability 
weights were taken into account using R’s ‘survey’ package. (18) When additional model 
options were required, Stata (Stata/MP 13.1) (19) was used, utilising the suite of ‘svy’ 
commands. The methodology is briefly summarised below, and some further details 
provided in Appendix E of the supplementary material. WHOQoL and WHODAS were 
analysed in turn, using generalised linear models. For WHOQoL, a standard multiple linear 
regression model was implemented, while for WHODAS, a zero-inflated negative binomial 
regression model with a log link was fitted to the data. Model choice was guided by 
exploration of the data and comparing a few candidates’ models and confirmed to be 
adequate through residual diagnostic plots and comparisons of observed and model fitted 
scores (see Appendices C, D and H for some plots of the data and comparisons). The 
regression models aim to estimate the relationship between diabetes and each of the two 
measures of well-being, namely WHOQoL or WHODAS, while controlling for the socio-
demographic, health risk behaviour and chronic conditions variables listed above.  
They also aim to understand whether the relationships between these factors and the well-
being measures are modified by the presence of diabetes. Two sets of p-values are 
reported in results for each factor: (a) The p-value for ‘factor’ relates to testing whether 
that factor is related to well-being in any way; (b) The p-value for the ‘moderation effect’ 
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relates to testing whether diabetes moderates the relationship between that factor and the 
well-being score – i.e. whether the relationship is different between individuals with 
diabetes and those without. Because testing for moderation is of interest, the dataset was 
not stratified into those with diabetes and those without, but rather all data used in the 
model. In the initial fitting of the models, diabetes was allowed to moderate all effects and 
therefore distinct ‘diabetic’ and ‘non-diabetic’ group effect sizes are reported in the tables.  
To reduce the size of the model, for a given factor, when the p-value for the moderation 
effect was greater than 0.1, the moderation term was removed, and in these cases just 
one ‘all subjects’ effect size is reported below. To account for the zero-inflation for 
WHODAS (i.e. the excess of zero values compared to what is expected using a negative 
binomial distribution) an extra set of parameters was estimated and is reported. These 
odds ratios describe the impact of the factor on the extent of these zero values (no 
moderation by diabetes status allowed). Again, when the terms did not seem necessary 
(using a threshold of 0.1 on p-values) they were removed from the model, and therefore 
not all factors have associated odds ratios. List-wise deletion of observations with missing 
values resulted in 2848 observations for WHOQOL and 2866 observations for WHODAS. 
The most   common missing values were: 570 for education, 492 for place of residence 
and 123 for physical activity. 
5.5. Results 
The overall prevalence of self-reported diabetes was 9.2% (95% CI: 7.8,10.9). It increased 
with age: from 7.1% (95% CI: 5.4,9.2) amongst 50–59-year olds, to 10.6% (95% CI: 
8.0,14.0) amongst 60–69-year olds, to 12.4% (95% Cl: 9.1,16.7) amongst those 70 years 
and older. The socio-demographic characteristics, health risk behaviours and chronic 
conditions of all the participants, also stratified by diabetes status, are described in Table 
5-1. Half of the respondents were aged between 50–59 years (mean age 61.6 years, SD 
9.5), 56% were female, 56% were in a current partnership, and 46% had less than 5 years 
of formal education. The majority of respondents in both groups engaged in only low levels 
of physical activity (60%). People in the diabetes group had at least twofold higher rates 
of coexisting self-reported chronic conditions (arthritis, stroke, angina, chronic lung 
disease, asthma, hypertension, cataracts and depression) compared to the non-diabetes 
group.  
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Table 5–1 Number and percentage of participants by socio-demographic characteristics, 
self-reported health behaviours and comorbidities. 
  n (%) 
*Factor Category *All subjects Ever diagnosed with 
with diabetes 
 
No self-reported 
diabetes  
All participants   3836 (100.0) 341 (100.0) 3495 (100.0) 
Diabetes No 3362 (90.8)  3362 (100.0) 
 Yes 341 (9.2) 341 (100.0)  
Sex Female 2146 (55.9) 228 (67.0) 1850 (55.0) 
 Male 1690 (44.1) 113 (33.0) 1512 (45.0) 
Age 50-59 years 1913 (49.9) 130 (38.1) 1711 (50.9) 
 60-69 years 1174 (30.6) 121 (35.6) 1021 (30.4) 
 70+ years 749 (19.5) 89 (26.2) 630 (18.7) 
Marital status Single 539 (14.3) 45 (13.3) 471 (14.3) 
 Married/cohabiting 2108 (55.9) 170 (50.2) 1872 (56.7) 
 Separated/divorced 223 (5.9) 9 (2.8) 206 (6.2) 
 Widowed 900 (23.9) 114 (33.8) 754 (22.8) 
Years of education 0-5 years 1418 (46.4) 95 (35.0) 1288 (47.6) 
 6-12 years 1369 (44.8) 161 (58.9) 1168 (43.2) 
 13+ years 269 (8.8) 17 (6.1) 249 (9.2) 
Same location Yes 2141 (68.1) 190 (66.9) 1889 (67.9)  
No 1002 (31.9) 94 (33.1) 892 (32.1) 
Ever worked Yes 3237 (85.4) 286 (84.2) 2878 (85.6) 
 No 553 (14.6) 54 (15.8) 484 (14.4) 
Wealth quintile Poorest 790 (20.7) 39 (11.6) 704 (21.0) 
 Second 759 (19.9) 50 (14.8) 684 (20.5) 
 Middle 696 (18.2) 60 (17.6) 627 (18.7) 
 Fourth 757 (19.8) 87 (25.5) 650 (19.4) 
 Richest 815 (21.3) 103 (30.4) 681 (20.3) 
Tobacco No 2459 (66.4) 268 (78.8) 2188 (65.2) 
 Yes 1242 (33.6) 72 (21.2) 1169 (34.8) 
Alcohol No 2765 (74.7) 294 (86.5) 2468 (73.5) 
 Yes 934 (25.3) 46 (13.5) 889 (26.5) 
Physical activity Low  2154 (60.1)   220 (68.0)   1932 (59.3)  
  Moderate  436 (12.2)   41 (12.8)   395 (12.1)  
  High  996 (27.8)   62 (19.2)   933 (28.6)  
Arthritis No  2788 (75.3)   188 (55.1)   2600 (77.3)  
  Yes  915 (24.7)   153 (44.9)   762 (22.7)  
Stroke No  3553 (96.0)   317 (93.0)   3235 (96.3)  
  Yes  149 (4.0)   24 (7.0)   125 (3.7)  
Angina No  3508 (94.8)   299 (87.6)   3209 (95.5)  
  Yes  194 (5.2)   42 (12.4)   152 (4.5)  
Lung disease No  3596 (97.1)   312 (91.7)   3283 (97.7)  
  Yes  106 (2.9)   28 (8.3)   78 (2.3)  
Asthma No  3523 (95.1)   308 (90.5)   3213 (95.6)  
  Yes  181 (4.9)   32 (9.5)   148 (4.4)  
Depression No  3596 (97.1)   322 (94.6)   3272 (97.4)  
  Yes  106 (2.9)   18 (5.4)   88 (2.6)  
Hypertension No  2580 (69.7)   105 (30.7)   2474 (73.6)  
  Yes  1124 (30.3)   236 (69.3)   888 (26.4)  
Cataracts No  3528 (95.6)   290 (86.8)   3237 (96.5)  
  Yes  163 (4.4)   44 (13.2)   118 (3.5)  
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*Sum of ‘Diabetes and non-diabetes counts do not necessarily equal ‘All subjects’ counts 
because of missing data. * *For a factor, sum of counts for categories do not necessarily 
equal ‘All subjects’ counts because of missing data. 
To further describe the data, see Appendix A and Appendix B of the supplementary 
material for summary statistics for WHOQoL and WHODAS, stratified by diabetes status 
and other covariates. 
 The associations between factors and the average WHOQoL scores, as modelled using 
a multivariable regression, are shown in Table 2. The additive effect or regression 
coefficient describes the change in the average WHOQoL score associated with a change 
in factor (out of the reference category into another category) – and therefore positive 
values indicate increases in quality of life. There was strong evidence of lower quality of 
life when having diabetes (−4.2, 95% CI: −9.2,0.9; p-value < 0.001). Similarly, lower scores 
were associated with not being in a relationship, less formal education, less wealth, lower 
physical activity and more chronic conditions (see effect sizes in Table5-2, all p-values < 
0.02).  
Table 5–2 Association of diabetes, sociodemographic characteristics, self-reported 
health behaviours and comorbidities with WHOQOL (0-100) 
# chronic 
conditions 
0  1846 (50.1)   52 (15.4)   1793 (53.5)  
  1  1122 (30.5)   114 (34.0)   1008 (30.1)  
  2  460 (12.5)   105 (31.4)   355 (10.6)  
  3+  256 (7.0)   64 (19.2)   192 (5.7)  
  
 Additive effect / regression coefficient (95% CI)  a P-values    
Factor Category All subjects Non-diabetic 
group 
Diabetic group Factor Moderation 
effect b  
Diabetes No (ref)       <0.001 
  
N/A 
  Yes -4.2 (-9.2;0.9)     
Sex Female (ref)   
 
  0.047 
  
  
    Male -1.4 (-2.8; -
0.0) 
 
  
Age 50-59 years (ref)       0.046 
  
  
  
  
  
  60-69 years 1.7 (0.3;3.1) 
 
  
  70+ years 1.4 (-0.3;3.1)     
Marital status Single -2.6 (-4.8; -
0.5) 
 
  0.016 
  
  
  
  
  
  
  
  Married/cohabiting (ref)   
 
  
  Separated/divorced -1.2 (-4.2;1.8) 
 
  
  Widowed -2.5 (-4.1; -
0.8) 
 
  
Years of education 0-5 years (ref)       0.003 
  
  
  
  
  
  6-12 years 2.2 (0.6;3.7) 
 
  
  13+ years 5.0 (1.9;8.0)     
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a The p-value for ‘factor’ relates to testing whether that factor is related to well-being in any way. (2) 
The p-value for the ‘moderation effect’ relates to testing whether diabetes moderates the relationship 
between that factor and the well-being score – i.e. whether the relationship is different between 
individuals with diabetes and those without.  b P-values are expected to be small as the only 
moderation effects that are included in this model are those that had p-values <0.1 in a model 
containing all such interactions. Model output before exclusion of terms appears in the Appendix F of 
the supplementary material. 
There was some evidence of lower quality of life in males (p = 0.047). The impact of 
physical activity and number of chronic conditions differed by diabetes status (p-values: 
0.028 and 0.009 respectively). High levels of physical activity appear to correspond to 
higher quality of life only amongst those with diabetes (high versus moderate levels: 8.1, 
95% CI: 2.6,13.6. Additional chronic conditions had an effect on quality of life for all 
participants although the negative effect was more pronounced in those without self-
reported diabetes than in those with diabetes. The results from the zero-inflated negative 
binomial regression model for WHODAS are shown in Table5-3. 
 
 
 
 
 
Same location Yes (ref)       0.703 
  
  
    No 0.3 (-1.2;1.8)     
Past work Yes (ref)   
 
  0.003 
  
0.137 
    No   -4.2 (-6.6; -
1.8) 
-1.1 (-4.6;2.3) 
Wealth quintile Poorest   -6.8 (-9.1; -
4.4) 
-9.4 (-14.4; -4.3) <0.001 
  
  
  
  
0.139 
  
  
  
  
  Second   -2.7 (-5.2; -
0.3) 
-5.9 (-12.3;0.6) 
  Middle (ref)   
 
  
  Fourth   0.5 (-1.5;2.5) -2.6 (-6.6;1.4) 
  Richest   6.9 (4.2;9.6) 1.3 (-2.3;4.8) 
Tobacco No (ref)   
 
  0.62 
  
  
    Yes 0.4 (-1.2;2.1) 
 
  
Alcohol No (ref)       0.061 
  
  
    Yes -1.8 (-3.6;0.1)     
Physical activity Low   -3.3 (-5.3; -
1.3) 
0.2 (-3.0;3.4) <0.001 
  
  
0.028 
  
  
  Moderate (ref)   
 
  
  High   -0.1 (-2.2;2.0) 8.1 (2.6;13.6) 
# chronic 
conditions 
0 (ref)       <0.001 
  
  
  
0.009 
  
  
  
  1   -4.6 (-6.2; -
3.1) 
-1.8 (-5.9;2.2) 
  2   -6.6 (-8.4; -
4.7) 
-0.5 (-4.8;3.9) 
  3+   -6.8 (-9.9; -
3.7) 
0.4 (-3.8;4.6) 
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Table 5–3 Association of diabetes, sociodemographic characteristics, self-reported health 
behaviours and comorbidities with WHODAS (0-36) c 
  
Effect sizes (95% CI)  a P-values 
Factor Category Odds Ratio  
(OR) 
Multiplicative effect / exponentiated 
regression coefficient 
Factor Moderation 
effect
b 
All subjects Non-diabetic 
group 
Diabetic 
group 
Diabetes No (ref)         
  
  Yes   2.1 (1.5,2.9)     <0.001 
 
Sex Female (ref)   
  
  0.125 0.042 
  Male   
 
1.0 (0.9,1.2) 0.7 (0.6,1.0) 
  
Age 50-59 years         <0.001 
 
  60-69 years 0.8 (0.5,1.1) 1.1 (1.0,1.2) 
 
  
  
  70+ years 0.5 (0.3,0.9) 1.4 (1.3,1.5)     
  
Marital 
status 
Single 0.5 (0.3,0.9) 
 
1.1 (0.9,1.3) 1.0 (0.8,1.3) 0.008 0.045 
  Married/coh
abiting 
  
  
  
 
  Separated/di
vorced 
0.6 (0.2,1.4) 
 
1.0 (0.9,1.2) 0.6 (0.4,0.9) 
 
  Widowed 0.6 (0.4,0.8) 
 
1.1 (0.9,1.2) 0.9 (0.7,1.2) 
 
Years of 
education 
  
0-5 years         <0.001 0.000 
6-12 years 1.7 (1.2,2.5) 
 
0.9 (0.8,1.0) 0.9 (0.7,1.1) 
  
  13+ years 2.6 (1.5,4.5)   0.6 (0.5,0.8) 1.4 (1.0,1.9) 
  
Same   
Location  
 
 
location 
location 
Yes   
  
  0.010 
 
  No   1.1 (1.0,1.3)     
  
Past work Yes   
  
  0.005 
 
  No   1.3 (1.1,1.5) 
 
  
  
Wealth 
quintile 
poorest   1.2 (1.0,1.4)     0.034 
 
  second   1.1 (1.0,1.2) 
 
  
  
  middle   
  
  
  
  fourth   1.0 (0.9,1.1) 
 
  
  
  richest   0.9 (0.8,1.1)     
  
Tobacco No   
  
  0.274 0.108 
  Yes   
 
1.0 (0.9,1.2) 0.8 (0.5,1.1) 
  
Alcohol No         0.006 
 
  Yes   1.2 (1.1,1.4)     
  
Physical 
activity 
  
Low   
 
1.4 (1.2,1.6) 0.9 (0.8,1.2) <0.001 0.006 
Moderate   
  
  
  
  High   
 
0.8 (0.7,1.0) 0.7 (0.5,1.0) 
  
0         <0.001 0.003 
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a The p-value for ‘factor’ relates to testing whether that factor is related to well-being in any way. The 
p-value for the ‘moderation effect’ relates to testing whether diabetes moderates the relationship 
between that factor and the well-being score – i.e. whether the relationship is different between 
individuals with diabetes and those without. b P-values are expected to be small as the only moderation 
effects that are included in this model are those that had p-values < 0.1 in a model containing all such 
moderation effects. Model output before exclusion of terms appears in the Appendix G of the 
supplementary material. c for the regression model WHODAS score of 0–36 was retained. 
 
The odds ratio is the relative change in the odds of a zero-disability score (no disability), 
and the multiplicative effect or exponentiated regression coefficient is the relative change 
in the average score amongst the remaining individuals. Therefore, an odds ratio greater 
than 1 and multiplicative effect less than 1 together indicate a decrease in disability with a 
change in the factor (out of the reference category into another category). Diabetes was 
associated with greater disability (multiplicative effect: 2.1; 95% CI: 1.59,2.9; p-value: < 
0.001).  
There was also greater disability associated with being older, being single or widowed 
(although there are mixed results for those with diabetes), having more chronic conditions 
and having lower education levels (all p-values < 0.01, see Table 3 for effect sizes). 
Greater disability is also associated with no past employment, and having less wealth, any 
alcohol use and lower physical activity levels (multiplicative effects up to 1.3; p-values < 
0.05).  
The impact of marital status, education, physical activity and the number of chronic 
conditions differed by diabetes status (p-values < 0.05). Also, an increase in the number 
of chronic conditions is associated with large reductions in the odds of zero disability (OR 
for 3+ conditions versus 0 conditions: 0.1; 95% CI: 0.0, 0.3), thus implying greater 
disability. There was a clear increase in the disability of the remaining individuals amongst 
those without diabetes (multiplicative effect: 1.7; 95% CI: 1.4,2.0) but not in those with 
diabetes. 
 
# chronic 
conditions 
  
1 0.4 (0.3,0.5) 
 
1.3 (1.2,1.5) 0.9 (0.7,1.2) 
  
  2 0.2 (0.1,0.3) 
 
1.7 (1.5,1.9) 1.0 (0.8,1.3) 
  
  3+ 0.1 (0.0,0.3)   1.7 (1.4,2.0) 1.0 (0.8,1.4) 
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5.6. Discussion 
In this analysis of SAGE South Africa Wave 1 data, a 9.2% prevalence rate of self-reported 
diabetes was found. Individuals with diabetes had at least twofold higher rates of 
coexisting chronic conditions than those without diabetes. In addition, diabetes status per 
se was associated with poor quality of life and disability, as were socio-economic status 
(low education), being in a low wealth quintile, having a poor employment history, marital 
status (not being in a partnership), lifestyle habits (low physical activity, history of alcohol 
use) and co-morbid conditions. In accordance with previous studies, we found that having 
diabetes, (20–22) having lower formal education levels, (23–25) being in a low 
socioeconomic group, (26,27) not being in a marital relationship (28,29) and not having 
worked (30,31) were significantly associated with poor quality of life and a high level of 
disability, but unlike findings in other studies, (32–35) being older and being female were 
not associated with a high level of disability. The differences in findings in this study 
compared to others may relate to the use of different instruments to assess the quality of 
life and disability, as well as the use of diabetes-specific and generic measures across 
studies. In short, the study findings support a relationship between self-reported diabetes, 
QoL and disability, while controlling for a variety of factors such as socio-demographic 
characteristics, health risk behaviours and coexisting chronic conditions. 
The prevalence rate of self-reported diabetes in the study reflects some factors, including 
the participants’ low level of knowledge on diabetes, and access to diagnostic and care 
facilities. South African epidemiological studies have established about a 60% prevalence 
rate for previously diagnosed diabetes in urban areas, compared to a rate of about 15% 
in rural areas. The observation in our study that diabetes was more common in higher than 
in lower wealth quintiles supports previous findings in urban black Africans in Cape Town 
(36). However, our observation may similarly indicate this group’s greater access to health 
care as well as a change in lifestyle habits, such as poor, high-sugar diets and low physical 
activity, often accompanying urbanisation. 
Studies have shown that comorbid conditions, more than other factors, determined the 
quality of life of people with diabetes. For example, Rubin et al. noted that the presence of 
comorbid conditions could further interact with the severity of the disease and its 
complications to strongly influence different domains of quality of life. (37) We did not 
decompose the composite WHOQOL score to examine the contributions of the different 
domains, but the overall score suggested that the impact of comorbidities on QoL was 
considerable in older respondents regardless of diabetes status. A considerable proportion 
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of non-diabetes individuals reported more than one chronic condition (47%). The 
magnitude of the effect size of QoL reductions differed statistically between 4.6 and 6.8 
points as the number of chronic conditions increased from one to 3+. A gradient in QoL 
pertaining to the number of chronic diseases in the non-diabetes group was not found in 
individuals with diabetes which is probably due to (1) the relatively small size sample of 
the diabetes group (n=341), and (2) use of a self-report questionnaire to determine the 
status of the chronic condition and possible underestimation of prevalence. Nevertheless, 
comorbidities can profoundly affect older patients’ ability to care for their conditions and 
can pose significant barriers to lifestyle changes and accessing needed care. (38) 
The results of the study showed the statistically significant impact of level of education on 
the quality of life of older persons with diabetes. Other studies have similarly shown a 
positive correlation between levels of education and quality of life. It is conceivable that 
those with a higher education will have a better understanding of the illness and its effect 
on them, will be in a better financial position to avail themselves of quality treatment and 
will be more likely to adhere to treatment regimens and self-management of the condition. 
(39) 
Study participants with and without diabetes who had a high level of physical activity were 
found to have higher QoL scores. We are unable to determine whether this finding is due 
to cause or effect; it is well recognised that exercise nonetheless is associated with higher 
subjective well-being.(40-41) Being sedentary was found to impact the quality of life, which 
is consistent with other studies: for example, in older individuals, even light-intensity 
physical activity is related to higher self-rated physical health and psychosocial well-being. 
(42) Notably, the prevalence of a low level of physical activity in the South Africa data was 
higher er than in any other SAGE country (China, Ghana, India, Mexico, Russian 
Federation). (43) Although age and diabetes conspire to decrease fitness and strength, 
physical activity interventions improve functional status in older adults with and without 
diabetes. (44) 
In previous studies, diabetes represented not only a risk factor for disability but also a 
brake on health/autonomy recovery in older persons. (45) This association is partly 
explained in our study by the impact of diabetes itself, sociodemographic characteristics, 
risk factors, health behaviours and comorbidity on disability. Reasons for this effect are 
not clear. Findings from an earlier study showed a 100–150% increased incidence of 
disability among older women with diabetes compared to non-diabetic age peers. (46). 
Indeed, women with diabetes had a 78% increased risk of mobility-related disability and a 
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65% higher risk of activities of daily living (ADL) disability. (47) In a sample of over 1000 
managed-care patients with diabetes with lower formal education and low physical activity, 
each was associated with disability. However, the pathway between diabetes and physical 
disability is multifactorial, and it is not possible to differentiate cause and effect in a cross-
sectional study. (47) This study investigated the relation of the overall disability score and 
not to domain-specific disability as they relate to diabetes and other health and 
socioeconomic characteristics. 
The present study highlights a need to fill gaps in knowledge towards improving quality of 
life and meeting care needs in older adults with diabetes. A dearth of research on leading 
health issues such as diabetes in older adults in sub-Saharan Africa countries impacts 
health policy and planning. Evidence-based policy and planning on services for older 
clients is underdeveloped or lacking in the sub-continent, partially due to epidemiological 
and demographic transitions being recent and more rapid than in high-income countries. 
(48) Qualitative research is required to address research questions in depth relating to the 
impact of factors such as retirement, low income, living alone, age-friendly vs ageist 
attitudes of health professionals towards older clients, and the promotion of physical 
activity. Comparison of study outcomes on quality of life is a challenge due to the differing 
content validity of instruments used in different studies. 
This study has both strengths and limitations. Strength is that it was able to draw on data 
from SAGE which has a representative sample of South Africa. Quality of life is influenced 
by a person’s experience, beliefs, expectations and perceptions which are in turn 
influenced by socioeconomic status, cultural identity and literacy level. (49) It is for this 
reason that a standardised and well-tested instrument was used. Ethnicity may be used 
as a proxy for poor socioeconomic circumstances, in this study, we have a number of 
direct measures of socio-economic status, such as wealth quintile and education.  Due to 
the high number of missing values (13%) this study opted not to use race which is the 
proxy in other similar studies. Additional limitations are that SAGE was not specific for the 
study of diabetes. Glycated haemoglobin data from dried blood spots collected as part of 
SAGE and linked to the survey data would help identify those individuals with undiagnosed 
diabetes and strengthen future analyses. Specific complications associated with diabetes 
which cause disability and impact quality of life were not recorded in SAGE. As the data 
are cross-sectional, causality cannot be attributed from the recorded associations between 
diabetes and quality of life or disability. More importantly, longitudinal data in South Africa 
to examine the relationship more fully are required, and further qualitative and quantitative 
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research methods should be used to assess and refine existing instruments, and to 
articulate and describe measure outcomes. 
5.7. Conclusion 
Diabetes is associated with lower quality of life and greater disability amongst older South 
Africans. Attention needs to be given to improving quality of life for older people with 
diabetes in South Africa through accessing appropriate health care, providing essential 
medicine or equipment, promoting healthy eating and physical activity behaviours, and 
facilitating social support networks. There is a need to develop sustainable policies for 
healthy ageing at the local and national levels to integrate health and older people in all 
policy areas. This requires identifying research priorities, allocating resources, designing 
and testing of new integrated care models targeted at older people within the roll-out of 
universal health coverage. 
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                              Chapter 6 
 
Study 3: Does social support effect knowledge and 
diabetes self-management practices in older persons 
with Type 2 diabetes attending primary care clinics in 
Cape Town, South Africa? 
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6.1. Abstract 
Background  
In South Africa with one of the most rapidly ageing populations in Africa despite the 
demographic impact of the HIV/AIDS epidemic, diabetes is a major cause of morbidity and 
mortality. Self-management is challenging for all those with the condition but is likely to 
create a higher demand for those who may have existing co-morbidities associated with 
age, and long-standing chronic diseases. 
Objective  
To determine the relationship of social support, especially that of family and friends with 
their self-management. 
Methods 
This cross-sectional study was undertaken in the Cape Town metropole primary care 
clinics. The sample comprised 406 people drawn from four community health centres 
(CHC) that are served by Groote Schuur Hospital at the tertiary level.  
Results 
Of the 406 participants, 68.5% were females, 60.5% were living with a family member, and 
almost half were married. The mean duration of diabetes from diagnosis was eight years. 
More than half (57.4%) had no or only primary education. Half the participants (50.2%) 
had poor knowledge level in relation to symptoms and complications of diabetes. 
Multivariable linear regression showed older age was associated with knowledge (: -
1.893, 95% CI-3.754; -0.031) and higher income was associated with self-management 
practice (: 3.434, 95% CI 0.797; 6.070). Most participants received family support to 
follow aspects of diabetes self-management. The ordinal logistic regression indicated that 
family support was positively associated with the self-management practice score for 
following a diabetic meal plan, taking care of feet, physical activity, testing blood sugar 
and handling participants’ feelings about being diabetic, but not for taking medication. 
Conclusions  
Consideration needs to be given to developing and testing education programmes that 
focus on needs of older people with diabetes and emphases the role of family and friends. 
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6.2. Introduction  
 
Population ageing has been accompanied by a shift in disease profile to non-
communicable diseases (NCD), increased levels of disability, and an increasing loss of 
physical and cognitive functioning. (1) South Africa has one of the most rapidly ageing 
populations in Africa despite the demographic impact of the HIV/AIDS epidemic. It is 
expected that, by 2025, the proportion of the older population will increase by 10.5% to 
reach 5.23 million. (2,3) The latest estimates are that three-and-a-half million South 
Africans (about 6% of the population) have diabetes, and there are many more who are 
undiagnosed. This number is anticipated to grow by 30% by the year 2030. (4-6)   
According to the WHO Global Report on diabetes in 2016, the combination of increasing 
prevalence of diabetes and increasing life expectancy in many populations with diabetes 
may be leading to a shift in the types of morbidity that accompany diabetes, such as 
cancers and cognitive disability. (7) Inevitably, this will place further strain on both 
healthcare resources and health providers. 
In South Africa, 80% of the population receive their health care through the government 
funded public sector. (8) In general, community health centres (CHC) and smaller primary 
care clinics are the older persons’ first point of contact with the healthcare services. These 
are staffed according to their size and location and provide a comprehensive package of 
care. The CHCs are overcrowded and poorly resourced due to the multiple disease 
burden, leaving limited time for the front-line health workers to deal with the management 
of patients with diseases such as diabetes. (8) A qualitative study found that patients with 
diabetes in this setting were ill-equipped to play an active role in self-care due to their 
limited opportunities for education and counselling. (9) In this setting too, poor control of 
glycaemia and hypertension together with high levels of multimorbidity are commonly 
encountered. (10)  
Diabetes self-management practices (DSMP) form the foundation of diabetes care. These 
involve knowledge, skills and motivation as it requires, amongst others, adjustment of the 
diet, monitoring of blood glucose levels, where appropriate and an increase in physical 
exercise. (8,9) Sprague et al. found that the decreased priority given to patient education 
among older individuals, their support systems, and the healthcare community is a factor 
that negatively impacts their learning diabetes self-management. (11)  
A number of barriers associated with ageing reduce the older persons’ potential for 
engaging with traditional self-management education programmes such as lectures/group 
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sessions; for example, hearing and visual deterioration. Further self-management practice 
may be affected by reduced manual dexterity due to osteoarthritis which is common in this 
group (12,13) Therefore, older people might have fewer resources available to manage 
their condition than younger people and will then have a higher need for self-management 
support. (14) The loss of friends and family makes them more vulnerable to loneliness and 
social isolation. (15) 
Poor social support is associated not only with an increase in mortality, morbidity and 
psychological distress but a decrease in overall general health and well-being. (16) Several 
studies have found social support vital to SMP in people with chronic diseases. (17-19) 
Social support can be either emotional or physical. Emotional, social support is defined as 
the degree to which interpersonal relationships serve the purpose of providing emotional, 
informational or influential quality of life for the individual. (20) Physical support is defined 
as the forms and numbers of social relationships (marital status, the number of friends) 
and the degree of connection between these relationships (social network). 
 Most frequently social support for persons with diabetes covers aspects of active support 
and emotional encouragement with taking medications, monitoring blood glucose, foot and 
eye care, following diabetic meal plans and increasing physical activity. (21) This study 
was undertaken in older people with diabetes in South Africa to examine their knowledge 
about living with and managing their diabetes; and to determine the relationship of social 
support, especially that of family and friends with their self-management.  
6.3. Methods 
 
6.3.1. Study design and selection of participants 
 
This cross-sectional study was undertaken in the Cape Town metropole where working 
class people receive care through a network of primary care clinics. Eighteen community 
health centres (CHCs) formed the sampling frame for the study on the basis of them being 
served by Groote Schuur Hospital at the tertiary level. Four CHCs were selected based 
on population density of the older population in their drainage area as reported in the 
statistical censuses of 2011. (3) 
As a diabetes register system does not exist in the metropole, the population of adults 
(>60 years) with diabetes within it is not known. Consequently, calculation of a 
representative sample size was not possible. A purposive convenience sample of (n=406) 
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was drawn by a random sampling technique from those who attended the four CHCs with 
approximately (100) participants from each clinic.  
6.3.2. Instruments   
We adopted a validated questionnaire that has been tested in older adults in many low 
and middle-income countries including South Africa. (21-27) We piloted the 
appropriateness, reliability and clarity of the questionnaire in a sample of 40 participants 
(10%). The English version questionnaire was translated to Xhosa and Afrikaans, the 
languages of the study area. We used the Social Support subscale of the Diabetes Care 
Profile (DCP). (28) It includes twelve questions related to family and friend social support. 
Each question consists of one item making it a total of 12 items. Each item is measured 
on a 6-point Likert scale (Appendix A: supplementary materials).   
6.3.3. Data collection 
Six fieldworkers were responsible for data collection using questionnaires and a review of 
records for HbA1C and fasting blood glucose results. They were trained in the 
administration of data collection tools, research ethics and an approach to interviewing 
older persons. The fieldworkers were closely supervised by the research team to 
guarantee the quality of data collection. Signed consent to participate in the study was 
obtained before administration of the study questionnaire (Appendix B : supplementary 
materials-. A random sample of ten questionnaires was checked for completeness and 
correctness. 
6.4. Data analysis    
For each respondent, a single knowledge score (K) was calculated based on 11 questions. 
One point was allocated for each correct answer. Similarly, respondents’ diabetes self-
management practice scores (DSMP) were calculated for each correct answer.  
All points were summed to obtain a practice score for each respondent, ranging from 0-
11. The questionnaire measures the degree to which the respondent perceives their family 
and/or friends provide support. The social support subscale was calculated into a 
summative score by combining variables with Likert scale questions (12 items) that 
measured the reported level of tangible and emotional social support (SS) received from 
either family or friends. Reliability measured for the 12 items (Cronbach’s alpha) was 0. 
852.  
The K, DSMP and SS scores were each converted to three indices ranging from 0-100. 
An overall HbA1c level in the last three visits was calculated as the average of the three 
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separate readings. Glycaemic control was considered good, acceptable or poor when the 
HbA1c level was lower than 7.5 between 7.5-8.5 % or greater than 8.5%, respectively. 
(29) Similarly, three blood glucose readings were captured from the database. Data was 
managed and analysed using SPSS Statistics version 23. (30)  and Stata 15.1 (Stata Corp 
College Station, TX, USA). Categorical data was summarised as frequency and 
proportions, and continuous data as mean and standard deviation (SD). Unpaired t-tests 
and one-way analysis of variance (ANOVA) were used to compare knowledge, self-
management practice and social support scores between two and three (or more) group 
variables respectively.  
 Ordinal logistic regression was used to determine associations between outcomes 
(knowledge, self-management practice) with components of social support scale. 
Multivariable linear regression was used to evaluate the associations between outcomes 
(knowledge, self-management practice) and sociodemographic variables (gender, age 
group, education level, income, living environment, glycaemic control, and social support. 
Variable selection for the linear regression analysis was based on previous literature which 
suggested that the variables may be associated with main outcomes. Regression 
estimates were reported with 95% CIs.  Statistical significance was indicated by p<0.05. 
6.5. Results: 
 
6.5.1. Descriptive and bivariate analysis. 
 
Patients’ demographic profile and clinical characteristics. 
Socio-demographic and clinical characteristics of the study sample are presented in table 
6-1. Of the 406 participants, 68.5% were females, 60.5% were living with a family member, 
and almost half were married. Two hundred thirty-three (57.4%) had less than 7 years of 
education. Unsurprisingly most of the participants were pensioners 374 (92%) and 348 
(84%) reported family income ≤R 1500. (US$107).  
The mean duration of diabetes from diagnosis was eight years. Sixty-two percent were 
using oral therapy for glycaemic control, 31% combined insulin and oral agents and 7% 
insulin alone. The majority were taking medication for other conditions: 306 (75.4%) for 
hypertension, 138 (34%) for other chronic diseases and 61 (15%) for heart problems. The 
HbA1c was higher than 8.5% in nearly 185 (47.7%) of the participants, <7.5% in 112 
(28.9%) and 7.5-8.5% in 91 (23.4%).  
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There were relationships between age group and a history of being hospitalised in the past 
12 months (P-value 0.042). Women were more likely than men to have had low and high 
blood sugar (21% vs 11%, p=0.016) and (53% vs 37%p= 0.004) respectively.   
Table 6-1 Socio-demographic and clinical characteristics of the study participants 
   Age group  Gender 
Variable N (%)   P-value  P-value 
Socio-demographic characteristics 
Age group (Years)      
60-69 257 63.5%    
70-79 121 29.8%    
80 or above 28 6.7%    
Sex: Female  278 68.5%    
Marital status    0.000 0.000 
Single 44 10.7%  
Married 209 51.9%  
Divorced 38 9.2%  
Separated 27 6.5%  
Co-habiting 88 21.7%  
Level of Education    0.35 0.002 
≤ 7 years  233 57.4%  
9-12 years 162 39.9%  
≥ 13 years  11 2.7%  
Employment status    0.315 0.109 
Pensioner: Yes 374 92.0%  
Who are you living with        0.000 0.000 
Spouse 52 12.8%  
Family member  246 60.5%  
Friend 9 2.2%  
Alone 25 6.3%  
More than one  74 18.2%  
Monthly family income    0.113 0.20 
≤R1 500 348 85.7%  
>R1 500 58 14.3%  
Clinical characteristics 
Diabetes duration    0.050 0.28 
Less than 5 years 125 31.0%    
5-10 years 158 39.2%    
>10 years 120 29.7%    
Taking prescribed medication: Yes 403 99.3%  0.90 0.24 
Type of prescribed medication    0.39 0.80 
Insulin injections 28 6.9%    
Pills 250 62.0%    
Both 125 31.0%    
Have you experienced low blood sugar: Yes 73 18.0%  0.31 0.016 
Have you experienced high blood sugar: Yes 195 48.0%  0.088 0.004 
Receiving medication for hypertension: Yes 306 75.4%  0.46 0.006 
Receiving medication for heart disease: Yes 61 15.0%  0.33 0.78 
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Knowledge, diabetes self-management practices, Social support scores 
Overall the level of knowledge was poor in 204 (50.2%) (Table 6-2). The deficiencies were 
particularly noticeable in relation to symptoms of diabetes and complications of diabetes 
and hypertension. There was a better level of knowledge about aspects of self-
management e.g., a healthy diet and foot care; with 61.3% and 64.8% of respondents 
correctly answering questions about walking barefoot and daily foot inspection 
respectively (Figures 6-1a and 6-1b). 
 
Table 6–2 Knowledge, self-management practice, social support scores. 
 
 
 
 
Receiving medication for other chronic 
disease(s): Yes 
145 35.7%  0.21 0.27 
Hospitalised in past 12 months: Yes  24 5.0%  0.042 0.36 
Glycaemic level (HBA1c)    0.45 0.22 
<7.5% 112 28.9%    
7.5-8.5% 91 23.5%    
>8.5% 185 47.7%    
 N % 
Knowledge (K) Poor K 0-14) 204 50.2% 
Good K (15-30) 202 49.8% 
Total 406 100.0% 
Self-management practice (SMP) Poor SMP (1-5) 162 39.9% 
Good SMP (6-11) 244 60.1% 
Total 406 100.0% 
Social support (SS) Poor Social support (0-3.5) 94 23.2% 
Good SS (4-6) 312 76.8% 
Total 406 100.0% 
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Figure 6-1a Distribution of correct answers to questions on Knowledge on Symptoms and 
Complications of Diabetes and hypertension (n = 406)  
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Figure 6–1b Distribution of correct answers to questions on diabetes self-
management knowledge (n = 406).   
 
 
 111 
 
Over three-quarters of participants (312 (76.8%)) had good social support (Table 6- 2). 
The majority of participants agreed that their family supported them to follow all aspects 
of self-care included in the questionnaire and encouraged them in managing their 
diabetes. Similarly, 233 (57.5%) were assessed as having a good level of physical 
exercise and almost two-thirds (262) of the participants were following a diabetic 
eating plan (Table 6- 3).   
 Only 74 (18.4%) reported that their family nagged them about their diabetes and 71 (18%) 
reported that their family felt uncomfortable about them because of their diabetes (Table 
6-4). The mean diabetes knowledge, self-management practice and social support scores 
of the participants by socio-demographic and clinical characteristics are presented in 
Table S1 and S2 respectively in supplements The mean knowledge score was significantly 
lower for a single (41.2 (SD= 2.9)) compared to married respondents (46.7 (SD =12.5)) or 
those in a companionship (49.4 (SD =12.7)). The mean knowledge score was greater for 
participants with higher education level and those who had experienced high or low blood 
sugar (p=0.005 and p=0.001 respectively), and those receiving medications for chronic 
diseases other than hypertension (p= 0.038) than their counterparts.   
Table 6- 3. Self-management practice of lifestyle risk factors. 
 
Being hospitalised in the last 12 months was associated with higher mean self-
management practice than those not hospitalised (54.5 (SD =17.7) vs 43.6 (SD = 22.1) 
p=0.042). However; receiving medication for heart disease was associated with a lower 
    
Age group Gender 
 N % P-value P-value 
Physical activity in the 
past week 
Never (0 days) 20 4.9% 0.49 0.97 
Seldom (1-2 days) 77 19.0%   
Sometimes (3-4 days) 75 18.5%   
Often (5-7 days) 233 57.5%   
Following diabetic 
eating plan 
Yes 262 64.5% 0.51 0.85 
No 144 35.5%   
How often do YOU test 
your blood glucose 
Occasionally or 1-2x per 
week 
163 40.1% 0.64 0.004 
Once a day 60 14.8%   
3-4x per day 29 7.1%   
Smoking status Currently smoking 112 27.7% 0.007 0.000 
Previously smoked 147 36.3%   
Never smoked 146 36.0%   
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mean score for self-management practice than their respective counterparts (48.7 SD 
=18.8 vs 54.7 SD =17.9) p=0.017).  The social support score means also differed 
significantly with living arrangements; it was lowest in those living with a spouse (67.7 SD 
= 21.0), intermediate in those living alone (75.0 SD =21.5) and highest in those living in 
multiple household members (82.3 SD =18.0 p = 0.001). On the other hand, there were 
no significant associations between diabetic knowledge, self-management practice and 
social support score with duration of diabetes, the type of medication used to treat 
diabetes, or receiving treatment for hypertension. 
 
6.5.2. The multivariable regression models.  
The ordinal logistic regression models of knowledge, self-management practice and the 
components of social support scale are given in Table 6-5. The table shows the effect of 
the K and SMP indices on the 12 individual SS components, which were measured on a 
Likert scale. Social support was positively associated with the self-management practice 
score for following a diabetic meal plan, taking care of feet, physical activity, handling 
participants’ feelings about being diabetic and testing blood sugar, but not for taking 
medication. Family and/or friend emotional support (nagging, encouraging /reassuring and 
handling feelings about being diabetic) were positively associated with knowledge score. 
Multivariable linear regression analysis (Supplement, Table 3 and 4) showed older age 
was associated with knowledge (: -1.893, 95% CI-3.754; -0.031) and higher income was 
associated with self-management practice (: 3.434, 95% CI 0.797; 6.070). There were 
no significant associations of socio-demographic variables, HbA1c and social support with 
knowledge or self-management practice
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Table 6–4 Social support assessment of the Study Participants (n = 406). 
 
 
 
 
 
 
 
 
 
 
 
 
(My family or friends help and support me a lot to):  
 
Strongly 
Disagree 
(N) % 
Somewhat 
Disagree 
(N) % 
Neutral 
       (N) % 
Somewhat 
Agree 
       (N) % 
Strongly 
Agree 
  (N) % 
 
a. Follow my meal plan. 
 
(40)  10.0% 
 
(11) 2.7% 
 
(27) 6.7% 
 
(42)10.4% (279) 69.4% 
 
b. Take my medicine. 
 
(43)  10.6% 
 
(10)  2.5% 
 
(33) 8.1% 
 
(30) 7.4% 
 
(275) 67.7% 
 
c. Take care of my feet. 
 
(61) 15.3% 
 
(20) 5.0% 
 
(34)  8.5% 
 
(45) 11.3% 
 
 (226) 56.5% 
 
d. Get enough physical activity. 
 
(71) 17.7% 
 
(25) 6.2% 
 
(24)  6.0% 
 
(68) 17.0% 
 
(196) 48.9% 
 
e. Test my sugar. 
 
(95)  24.4% 
 
  (9)  2.3% 
 
(40) 10.3% 
 
(24) 62% 
 
     (175) 45.0% 
 
f. Handle my feelings about diabetes. 
 
(35)  8.7% 
 
(11)  2.3% 
 
(22)  10.3% 
 
 (66 )16.4% 
 
(264) 65.7% 
 My family or friends:  
 
a. Accept me and my diabetes. 
 
(1)  0.2% 
 
(1) 0 .2% 
 
(2) 0.5% 
 
(4) 1.0% 
 
(392) 65.7% 
 
 
b. feels uncomfortable about me because of my diabetes. 
 
(296) 73.4% 
 
(13)3.2% 
 
(8) 2.0% 
 
(13) 3.2% 
 
(71) 17.6% 
 
c. Encourage or reassure me about my diabetes. 
 
(22) 5.5% 
 
(4)1.0% 
 
(19)   4.7% 
 
(33) 8.2% 
 
(320) 79.4% 
 
d. Discourage or upset me about my diabetes. 
 
(342) 84.9% 
 
(18) 4.5% 
 
(5)1.2% 
 
(20)5.0% 
 
(14)3.5% 
 
e. Listen to me when I want to talk about my diabetes. 
(23) 5.7% (7) 1.7% (38)   9.4% (30)7.4% (293) 72.7% 
 
f. Nag me about diabetes. 
(286) 71.0% (20)5.0% (21) 5.2% (33) 8.2% (41)10.2% 
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Table 6–5 The ordinal logistic regression models of knowledge, self-management practice with the components of social 
support scale. 
 
 Knowledge Index  Self-Management Practices Index 
Parameter Estimates    95% Confidence 
Interval 
   95% Confidence 
Interval 
 
 Estimate Std. 
Error 
Sig. Lower 
Bound 
Upper 
Bound 
Estimate Std. 
Error 
Sig. Lower 
Bound 
Upper 
Bound 
Pseudo R2 
My family or friends help and 
support me a lot to: 
   
a. Follow my meal plan. .000 .008 .972 -.016 .015  .024 .006 .000 .012 .037 0.023-0.053 
b. Take my medicine. .000 .008 .970 -.015 .016 .006 .006 .273 -.005 .018 0.001-0.003 
c. Take care of my feet. -.004 .007 .563 -.017 .009 .018 .005 .000 .008 .028 0.014-0.037 
d. Get enough physical activity. -.002 .006 .769 -.014 .010 .017 .005 .000 .008 .027 0.013-0.035 
e. Test my sugar. -.011 .007 .114 -.024 .003 .012 .005 .017 .002 .021 0.009-0.024 
f. Handle my feelings about 
diabetes. 
.015 .007 .042 .001 .029 .021 .006 .000 .010 .032 0.022-0.051 
My family or friends:   
a. Accept me and my diabetes. -.164 .298 .582 -.749 .421  .250 .212 .240 -.167 .666 0.004-0.019 
b. feels uncomfortable about me 
because of my diabetes. 
-.003 .009 .721 -.022 .015 .001 .007 .860 -.012 .015 0.00-0.001 
c. Encourage or reassure me 
about my diabetes. 
.033 .012 .006 .009 .056 .013 .009 .166 -.005 .031 0.016-0.030 
d. Discourage or upset me about 
my diabetes. 
-.020 .019 .301 -.057 .018 .001 .014 .925 -.027 .030 0.002-0.004 
e. Listen to me when I want to 
talk about my diabetes. 
.010 .009 .295 -.009 .028 .004 .007 .548 -.010 .018 0.002-0.005 
f. Nag me about diabetes. .023 .009 .013 .005 .040  -.001 .006 .829 -.013 .010 0.009-0.020 
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6.6. Discussion 
In this study, half of the participants had a poor knowledge about diabetes and its 
complications. Just under two-thirds were assessed as having a good level of physical 
exercise and two-third of the participants were following a diabetic eating plan. Three 
quarters perceived that their family supported them to follow all aspects of self-care 
management. Being in the high-income group was associated with good level of self-
management practice. Finally, social support was positively associated with both 
knowledge and a number of self-care aspects. The deficiencies noted in the participant's 
knowledge relating to the complications of diabetes and hypertension are alarming. 
 It suggests that whatever diabetes educational opportunities participants, particularly the 
older group, have been exposed to, have not been effective. There are many potential 
reasons for this. For instance, the high patient numbers and multiple disease burden in 
primary care clinics, are likely to negatively impact on the time available for patient 
education by health promoters, nurses or doctors. (29,30) Other factors to be taken into 
consideration include lack of attendance at educational sessions when they take place, 
communication barriers, such as poor hearing, lack of concentration, inability to engage 
with the material presented and use of didactic modes of communication. (31) 
 The participants’ seemed to have a better knowledge of self-management practice such 
as foot care and healthy eating. Whether this is because these messages are practical 
and easier to convey or that the information comes from multiple sources and not only 
health care workers is uncertain.  
To date, there is a scarcity of evidence regarding diabetes self-management education 
and support in older adults. (32) Some studies that included older persons suggest that 
this group needs diabetes self-management education that stresses problem-solving skills 
rather than “rules” to follow. For example, The Diabetes Education and Self-Management 
Ongoing and Newly Diagnosed (DESMOND) educators observed that older persons 
contributed to the group and brought valuable experience, but that they may have required 
a different approach at times. (33) 
Sinclair et al. reported that older people benefitted more than middle-aged people from a 
highly-structured group diabetes self-management education intervention with embedded 
cognitive behavioural strategies compared to standard group education or individual 
sessions with dietitians and nurse educators. (34) As older persons may have difficulties 
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concentrating and understanding abstract concepts, there is a need for educational 
material to be provided in the form of simple messages, delivered in a style that engages 
the person with diabetes and is personalized to their needs, with the emphasis on what 
they need to know, rather than all there is to know about diabetes. (35,36) Notably, these 
concepts to enhance knowledge and self-management practices are not unique to the 
older person with diabetes and are relevant in all societies. Income and financial issues 
are possible barriers to optimum self-management for many older diabetic patients 
because of the costs of blood glucose testing, medication and following diet 
recommendations. (37) 
We found that almost 75% of participants perceived that their family supported them to 
follow all aspects of self-care management. This may be of an advantage in many cultures 
such as in South Africa where strong family relationships and family caring are important 
and highly valued. (38) A cohesive and supportive family may provide older diabetic 
patients with an opportunity to express feelings and fears. (38) When DSMP is reviewed 
as a shared responsibility with the whole family, older persons may adopt DSMP activities 
more easily and feel more self-confident in managing diabetes. (39,40) As family-focused 
interventions may be more effective in improving DSMP performance than individual-
focused interventions (41,42) including family members or friends in education 
programmes should be considered. (43) 
The shortage of professional health care workers in South Africa highlights the need to 
develop alternative delivery models for education and self-management for people with 
diabetes who attend primary care services. These include using the services of community 
health workers (CHWs) and peer supporters and should draw on previous lessons learnt. 
(44) For example, while a pragmatic trial of a group diabetes education programme led by 
health promoters in Cape Town improved blood pressure, but not self‐efficacy, locus of 
control or glycaemia control; process evaluation suggested numerous problems. 
 These were finding suitable space for group education, with patient attendance and with 
full adoption of a guiding style by the health promoters. Thus, groups held outside of 
primary care clinics in the community and led by well-trained CHWs or peers may be a 
better option, so too may the active participation by family members in these groups. (44) 
In addition, the emphasis on diabetes prevention programs in middle-aged people must 
be highlighted, because it will enable the next generation of older persons to live with a 
reduced diabetes burden. (45) For these reasons, South Africa's health care system needs 
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to transform its services offered to the large number of older persons to reduce health care 
costs and ensure quality of life.(46) 
6.6.1. Study strengths and limitation.  
This study contributes to an understanding and fills a gap in the current knowledge, relating 
to diabetes self-management practices, and perceived social support from family and 
friends and diabetes care for older people in South Africa. However, the study has some 
limitations. First, as a cross-sectional survey design, our study could not assess cause 
and effect. Second, the measurements of self-report rather than direct observation of self-
care practices are recognised as a limitation. In addition, the use of a convenience sample 
drawn from a population who attend a diabetes clinic excludes those who did not attend. 
Third, our study was limited to one region and may not be representative of all older South 
Africans with diabetes. Future research should focus on developing and evaluating 
family/friends focused community-based multi-disciplinary education programmes to 
improve DSMP among older individuals attending primary care clinics with a view to 
enhancing the quality of life and to reduce disability. (47) 
6.7. Conclusions  
Consideration needs to be given to developing and evaluating education programmes that 
focus on the needs of older people with diabetes mellitus and emphases the role of family 
and friends. However, it is imperative to introduce programmes at a younger age so that 
diabetes self-management strategies are embedded as a life course perspective to 
enhance positive outcomes for persons living with diabetes.  
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 7-1 Abstract  
  
Introduction  
One of the most important primary health challenges currently affecting older people in South Africa 
(SA) is the increasing prevalence of non-communicable disease (NCD).  Research is needed to 
investigate the current state of care and self-management support available to older 
diabetic patients in SA and the potential for interventions promoting self-management and 
community involvement. 
Methods  
This study aimed to review current policies and programmes as they relate to older people 
with diabetes. It involved a documentary review and qualitative individual interviews with 
key informants in the health services and Department of Health. 
Results  
Several national initiatives have sought to advance the health of older people, but they 
have only been partially successful. There are however multiple efforts to re-orientate the 
healthcare system to focus more effectively on NCDs, which benefit older patients with 
diabetes. The establishment of community-based services to provide self-management 
support, promote health and ease access to medicine helps overcome many of the 
commonly cited barriers to care experienced by older patients.  What may be equally 
important is that practitioners gain the communication skills and educational resources to 
effectively educate and counsel patients on lifestyle behaviour change and self-care 
management. 
Conclusion  
This paper alerts policymakers and clinicians to some of the specific issues considered to 
be pertinent and important in the care and management of older diabetic patients. Many 
of these would also be applicable to older patients with other chronic conditions.   
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7.2. Background 
South Africa is undergoing the epidemiological transition typical of many low-to-middle 
income countries. Rapid urbanisation, attendant changes in diets and levels of physical 
activity along with population ageing have resulted in a significant increase in the burden 
of non-communicable disease (NCD), alongside a high prevalence of HIV, and violence 
and injuries, maternal and child mortality (1).  
Diabetes is associated with  high levels of morbidity, multiple therapies and functional 
deterioration and as such, poses challenges to health care systems, individual patients 
and their families. (2)  Older persons are defined  as individuals who are 60 years and 
older. (3) For the older person, the complexity of managing diabetes is often exacerbated 
by increased frailty, functional limitation, changes in mental health and increased 
dependence (2) Social issues such as loss of independence, removal from the home 
environment and institutionalisation also commonly affect the quality of life and wellbeing 
of older people with diabetes and their ability to self-manage the condition. (3) Access to 
care is also often a challenge for older people, because of a lack of or the cost of transport, 
particularly in rural areas, as well as increasing physical disability and child caring 
responsibilities. Overcrowding and long waiting times at health facilities, fragmented or 
siloed care for multiple morbidities and poor communication with healthcare providers are 
further barriers to care. (4-5) All these issues impact on the capacity of older diabetes 
patients for self-care and glycemic control. They also contribute to poor health outcomes 
and the high costs of diabetes treatment and care. Interventions which address the unique 
needs of older people with diabetes may, therefore, be warranted and may help reduce 
diabetes-related morbidity and associated healthcare costs. (6) 
The only SA document which specifically addresses the unique needs of the older diabetic 
patient is the 2017 Society for Endocrinology, Metabolism and Diabetes of South Africa 
(SEMDSA) guideline. (7) According to the guidelines, the comprehensive goals of diabetes 
management in older individuals are not significantly different from those of their younger 
counterparts, with glycaemic control and the reduction of other risk factors for 
macrovascular and microvascular disease remaining key factors for optimal management. 
Lifestyle modification is still advised and if there are no contra-indications, physical activity 
should be an integral part of the treatment plan. The SA guidelines are in line with the 
treatment recommendations in the Position Statement on behalf of the International 
Association of Gerontology and Geriatrics, the European Diabetes Working Party for Older 
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People, and the International Task Force of Experts of Diabetes. (8) They recommend 
regular comprehensive geriatric assessments to identify related functional loss and the 
impact of disability, as well as regular screening for mood disorder and nutritional 
assessments. 
Research is needed to investigate the current state of care and self-management support 
available to older diabetic patients in SA, the degree to which their needs are being met 
and the potential for interventions promoting self-management and community 
involvement in line with WHO Innovative care for chronic conditions (ICCC) Framework(9) 
This study aimed to review current policies, programmes and any other interventions as 
they relate to older people with diabetes with a view to assess the potential for the 
development of a self-management programme for older persons attending, public sector 
primary health care services in Cape Town, South Africa. 
7.3. Methods  
    This study followed a qualitative, exploratory, descriptive design, using the methods of 
documentary review and individual interviews with key informants.  
1. Documentary review  
A search was conducted with the aim of sourcing all documents which addressed the 
health needs of older people in South Africa, and more specifically, the needs of older 
people with diabetes. These included national and provincial government policy and 
planning documents, clinical guidelines for the treatment and management of diabetes, as 
well as commentaries or reviews of the SA health services compiled by civil society 
stakeholders/organisations. Relevant documents were sourced from SA government 
websites and internet searches using the keywords “older people in South Africa and 
health; SA policy on ageing; older persons and diabetes in SA/Western Cape.” Also, 
several documents were provided by the key informants, either during the interviews or 
subsequently by email. 
2. Key informant interviews 
Qualitative, individual, face-to-face interviews were conducted with purposively selected 
key informants, who were chosen for their knowledge of the topic and their responsibility 
for implementation of national/provincial policies or programmes relating to diabetes in 
the public health sector, or for clinical practice in primary care clinics. Individuals were 
identified with the assistance of the Head of the Endocrinology Department at Groote 
Schuur hospital in Cape Town.  Interviews were conducted in a private room at the 
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department  and in three referring public sector, primary healthcare clinics (Retreat; 
Woodstock, Heideveld). An interview guide was developed to explore informants’ 
knowledge of and views regarding diabetes self-management programmes for older 
persons attending, public sector primary health care services (Appendix A). The 
interviews were about 30-45 minutes in duration and were conducted from December 
2016 to April 2017. They were audio-taped and then transcribed verbatim. 
7.4. Data analysis 
The method of qualitative content analysis was used to describe and interpret the data 
from the selected documents and the individual interviews. (10) The analysis proceeded 
through the following steps: 1) reading through all the interview transcripts and documents 
to get a sense of the whole 2) systematically identifying and coding relevant ‘meaning 
units’ and developing a coding list 3) collating the coded data into categories and grouping 
these under higher order categories or more abstract headings 4) the coherent integration 
of the analysis into a descriptive account of the mainly manifest content of the data 5) the 
selection of compelling quotes to illustrate and summarise the findings in tables. In the 
initial stages, the authors MW and KM analysed the data independently and after that, 
cooperated closely in developing an interpretive and descriptive account of the findings 
for the manuscript. 
ETHICS 
The study was approved by the Human Ethics Committee of the University of Cape Town. 
(HEC REF: 21/2013), and written consent was obtained from each participant interviewed. 
7.5. Findings  
The findings below integrate information sourced through the documentary review and 
findings from the key informant interviews. They describe current policies, plans, 
guidelines and programmes which have relevance to the health needs and provision of 
care of older people with diabetes. Interviews were conducted with a total of 5 individuals: 
a senior official and policymaker in the Department of National Health; a Director of 
Chronic Disease in the Western Cape Provincial Health Department; a family physician 
responsible for a primary care clinic in the Cape Town metro, a medical officer and a health 
promoter. The researchers have approached other key informants but unfortunately, they 
didn’t respond regardless to the emails reminders that were sent to them weekly. The key 
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to the labelling of these key informants is found in Table 1. The documents that were 
included in the documentary review are listed in Supplementary Table 1. 
Table 7-1 The key to the labelling of key informants 
 
1. Theme one: National initiatives for the advancement of the health and 
wellbeing of older persons in South Africa 
An important milestone in advancing the interests of older people as a distinct group 
occurred in 2002 when SA signed the Declaration on Ageing at the Second World 
Assembly on Ageing in Madrid. (11). This served as the basis for the 2002 SA Plan of 
Action of Aging. The plan gives government the primary responsibility for implementation 
of the recommendations, but stressed that partnerships with civil society, academic 
institutions, the private sector and older persons themselves are critical to achieving its 
goals. (11) In the section on health, the plan recommends that the National Department of 
Health (NDOH) review all health policies and strategies to ensure that services are more 
responsive to the specific needs of older people. There are specific recommendations that 
the NDOH should develop and implement programmes for the management of chronic 
health conditions that are more prevalent in old age and for the promotion of healthy and 
active lifestyles among older individuals to prevent illness and functional decline and in so 
doing, generally improve quality of life. (12). 
The next important national intervention was the passing of the Older Person’s Act in 2006, 
which provides for the protection of the elderly’s rights and the criminalisation of abuse. 
This was followed by programmes to educate the public on the rights of older persons in 
all provinces, the development of a national protocol on the management of abuse of older 
persons; the drawing up of minimum standards for residential care and plans to promote 
Key 
informant 
Position 
KI 1 Director of Chronic Disease programme in the Western Cape Provincial Department of 
Health 
 
KI 2 A senior official in the National Department of Health, responsible for NCD health policy and 
guidelines 
 
KI 3 A family physician working in the primary care clinic in the Cape Town metro 
 
KI 4 Operational manager of primary care clinic in the Cape Town metro 
 
KI 5 Health Promoter in primary care clinic in the Cape Town metro 
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the respect of older people at government service points (Operation Dignity). (13) A 
parliamentary briefing by the Department of Social Development in 2013, provides further 
insight into the implementation of the Act and its challenges. (14) 
According to Goodrick, (15) these initiatives have only been partially successful in putting 
the health and welfare of older people higher on the national agenda and in improving the 
material and social well-being of the older South African population. This, he argues, is 
attributable primarily to policy prioritising the country's young population, the focus on 
HIV/AIDS and an overall lack of awareness of the potential socio-economic and fiscal 
implications of population ageing. In his view, until ageing concerns are mainstreamed in 
policies, the development of services and facilities for the aged will remain relatively 
neglected. Further, a 2013 UN review of the Madrid International Plan of Action on Ageing 
concluded that there had been a decline in the well-being of older persons in Africa, 
including South Africa since 2008.  this is due mainly to demographic shifts, an increased 
burden of disease and inadequate government intervention. (16) 
2. Theme two: National government action to address diabetes and other NCDs   
The NDOH has drafted a Strategic Plan for the Prevention and Control of NCDs (2013), 
which is closely aligned to UN/WHO recommendations and places a strong emphasis on 
intervention in three distinct areas. Evidence suggests can produce rapid gains in 
reversing the NCD epidemic: 1) The prevention of NCDs and the promotion of health at a 
population, community and individual level to address the broader social determinants of 
health; 2) improved control of NCDs through the strengthening of the primary health 
system; and 3) comprehensive monitoring of NCDs and their risk factors.(17) At the  
population level, legislative and fiscal measures are in place to control tobacco, salt, trans-
fats and sugar in beverages. Policy development on alcohol has, however, been slow, 
mainly because of opposition from the industry. These interventions have had a positive 
impact, but more aggressive efforts are needed to ensure compliance. (18) Several 
aspects of NCD surveillance need strengthening, notably the quality and completeness of 
information on mortality, the more regular monitoring of NCD risk factors and quality of 
care. (18)  
2.1. Primary Health Care Re-engineering policy 
As part of the NCD plan, the NDOH has introduced the Primary Health Care Re-
engineering policy with the aim of strengthening the response to NCDs at this level in the 
health system. The policy envisages health facility-based chronic care teams working with 
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Ward-based Outreach Teams (WBOTS), comprising nurses and community health 
workers (CHWs) to deliver integrated NCD services, including follow up and ongoing 
support to individuals in their households and communities. According to the SA Health 
Review (SAHR), while there has been an increase in the number of primary healthcare 
facilities with functional chronic care teams and WBOTS, at this point, it is not clear how 
widely CHWs have been deployed and how well prepared they are for scaled-up 
community-based NCD prevention and management. (19) Several studies in SA have 
demonstrated the capacity of CHWs to effectively execute specific NCD related tasks, 
such as screening and health education, but they have also shown that there is a wide 
variation in their scope of practice and level of training, insufficient support and supervision 
and a lack of resources and supplies necessary for the performance of many of their tasks. 
(19-20) Generally, patients still rely heavily on health facilities for NCD management and 
are still accessing healthcare at inappropriate levels. (20-22). Quality improvement 
interventions in public health facilities are being implemented, to meet the quality norms 
and standards to varying degrees. These include: (1) the scaling up of the Ideal Clinic 
model; (2) infrastructure improvement across the health sector; and (3) implementation of 
the WHO’s Workload Indicators for Staffing Needs instrument. From a treatment 
perspective, the integrated chronic disease management (ICDM) model is a central part 
of the ideal clinic and re-engineering of primary care as a vehicle to improve the 
management of chronic conditions including NCD (23,24) 
2.2. Practical Approach to Care Kit (PACK) 
A further aspect the re-engineering strategy is the implementation of the Practical 
Approach to Care Kit (PACK) in all primary care facilities. PACK is a programme 
comprising clinical guidance, an implementation strategy, health systems strengthening 
and monitoring and evaluation components. PACK Western Cape Adult started as a 
research project in the Eden district of the province and was subsequently launched as a 
provincial programme in March 2014 (21). These are integrated, evidence-based clinical 
guidelines, which aim to improve the diagnosis and management of the most common 
conditions in primary care, including NCDs. A process evaluation in 2016 showed that 
there was widespread use of the guideline and that it was perceived as very useful by 
clinicians. (21) KI 1 confirmed a positive response to PACK in the Western Cape and 
reported that it had been rolled out across the province. In the Western Cape province, 
the monitoring and evaluation of clinical and managerial performance in relation to chronic 
disease care is achieved through the Integrated Audit for Chronic Disease. The audit has 
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been implemented across the province and is modelled on the Standard Treatment 
Guidelines, the Essential Medicines List and the PACK guideline. It includes the 
monitoring of 5 chronic conditions, namely: Diabetes; Hypertension, Asthma, COPD and 
Epilepsy and there is a section on patient satisfaction. By 2015, 187 primary health care 
facilities in the province were participating in the annual audit. According to KI 1, the audit 
has helped put systems, infrastructure and equipment in place to implement clinical 
guidelines and improve NCD outcomes. From audit, I can see there is an improvement. 
Over the years, I have seen the effort that has been put in, and it is now paying off. It is 
slow, but it is paying off. (KI 1) This opinion is borne out by an evaluation conducted by 
Essel et al. 2015 (23) which showed that in districts where audits had been conducted for 
a period of time, there were marked improvements in clinical processes compared to 
districts that had only recently begun doing audits. (23) 
2.3. Advocating an integrated approach  
Our key informant from the National Department of Health (KI 2) spent much of his 
interview explaining national efforts to promote a more integrated approach for chronic 
conditions:  
We understand that there are many comorbidities and we cannot continue to just treat 
diabetes or HIV for example, on its own. If there is specialised care for diabetes, for HIV 
and all the other common co-morbidities, how many different vertical and parallel services 
would we have? So, we are moving towards a much more integrated chronic care service. 
(KI 2)   
He did not just refer to medical services:  
We would like this service to be as comprehensive as possible and include education and 
information and assisting with lifestyle change so that patients get more holistic care…. 
Whilst there are specifics related to each disease, what is common (to the main chronic 
conditions) is that people need to take their medicine regularly, change their lifestyles and 
attend support groups. Self-management is extremely important because that means that 
patients rely on health workers less and come in less often, which give practitioners more 
time with individual patients. (KI 2)  
The provision of specific services for older diabetes patients was not supported by the key 
informants: I don’t think we should set up different, parallel services for older people with 
diabetes. In our context, that is not a feasible option.” (KI 2) It was, however, argued that 
the move towards integration of care would be of particular benefit to the older patient, 
“the older one gets, the more chronic problems one is going to get and if you are going to 
be coming to see different practitioners on different days, your ability to control your health 
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is going to get worse. You will need transport money each time and wait in more queues. 
That is going to put more stress on you and your family. So yes, the integrated model 
works extremely well for older people. I think it is a real bonus for them. (KI 2). 
2.4. Community-based services 
National policy fully endorses the role of NGOs in providing community-based health 
promotion and patient support: Around the prevention and early detection of NCDs and 
the running of support groups, I have absolutely no doubt that the state needs to work 
hand in glove with NGOs. (KI 2)  
A further component of the national NCD policy is the Central Chronic Medicine 
Dispensing and Distribution (CCMDD) programme, which aims to more efficiently 
dispense medicines to chronic patients at external, convenient pick-up points, such as 
community venues and private pharmacies. (24) Where this is working efficiently, the 
programme has shown to reduce the need for stable HIV, hypertension and diabetes 
patients to visit public PHC clinics on a monthly basis to collect their medicines, with the 
positive effect of decongesting the clinics and reducing waiting times. (24)  
In summing up the advantages of the integrated care policy, KI 2 said, by integrating the 
treatment of common chronic conditions and building self-assistance into our system by 
getting people to collect their medication and participate in self-management programmes, 
the fewer assessments patients will need. That should give the practitioner more quality 
time with each patient and more time for health promotion activities…that is the model we 
are aiming for. (KI 2). 
2.5 Implementation of national policy 
While the (CCMDD) programme has been initiated in most provinces, it is not clear to what 
extent other aspects of the policy to integrate chronic care have been implemented. (24) 
As KI 2 explained, the actual application of the national policy depends on the political will 
and ability of the provincial departments and the district structures to comply. As a result, 
there is significant variation in implementation across the nine provinces. There has been 
some resistance to the change in approach, but this has diminished over time, and where 
the policy has been implemented, reports are that it has decreased waiting times and 
increased patient satisfaction. KI 2 reported that: We’ve still got some people arguing that 
diabetes, HIV or mental health are too different… that the one is more important or 
complex to treat, but once you put them together and people do this for a while, it seems 
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to work. We are getting less complaints now. So, we (the national department) are quite 
happy with the direction things are taking. (KI 2)   
3. Theme three: The current model for diabetes care in the Western Cape 
province 
3.1. Facility-level 
According to KI  1, who was an official in the Western Cape Department of Health with 
responsibility for policy implementation on chronic disease and geriatric care, the 
Department is working towards the implementation of the national policy to integrate 
chronic care. At the district level, the department has established multidisciplinary Chronic 
Disease Management teams, which are led by family physicians and include medical 
officers, clinical nurse practitioners, pharmacists, social workers and rehabilitation staff. 
The other key informants confirmed that this team has the primary responsibility for 
diabetes care at the primary care clinic. In each larger geographical service area, there is 
an Area Committee, which is a large forum with representatives from all levels of the 
healthcare service. Within those forums, there are different working groups, including one 
working on the integration of chronic disease care at a primary care level.   
There has been lots of consultation. People are buying into this new policy direction. We 
have a new policy called the Integrated Management of Chronic Conditions (IMCC), which 
covers chronic communicable and non-communicable disease, as well as mental health…  
The policy commits to a whole of society approach to address social determinants and a 
systems approach to drive the reorientation of the health system to more effectively 
address NCDs. At the level of the health service, the following components are specified: 
the delivery of a comprehensive, integrated package of care using a life course approach; 
good clinical governance and the provision of person-centered, self-management support. 
Central to achieving the goal of improved NCD outcomes is a productive interaction 
between a well prepared and proactive provider and a well-informed, empowered patient. 
3.1.1. Diabetes Lifestyle Education Collaboration and Action (D-LECA) 
programme 
In line with this policy, the Diabetes Lifestyle Education Collaboration and Action (D-LECA) 
programme is being adapted to include other chronic conditions. D-LECA is currently 
being piloted in three community health centres in the metro district as a structured 
educational and self-management programme for newly diagnosed diabetic patients. 
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According to the family physician interviewed, everyone in the multi-disciplinary chronic 
care team plays their part in assisting diabetes patients with self-management. Planning 
is underway for a phased, scale-up of the adapted version of D-LECA to all facilities in the 
province. The intention is to combine the resources used in D-LECA and the HIV - ART 
programme to form a new, holistic and comprehensive self-management programme for 
chronic conditions. This would move away from a narrow focus on adherence, to 
empowering patients for self-care and lifestyle change: D-LECA is about empowering 
people to get ready to self-manage. The bottom line is, we obviously want people to 
maintain good health. (KI 1). A tender has been won by to the Department of Family 
Medicine and Primary care at the University of Stellenbosch to train a group of master 
trainers in patient-centered, brief behaviour changes counselling. The plan is to upscale 
the HIV lay counsellors who already work in primary care facilities so that they can 
undertake education and counselling for a range of chronic conditions, principally 
diabetes, hypertension, COPD and HIV.  Other categories of health workers will also 
receive this training.  
3.1.2. The Chronic Disease Clubs. 
In response to the question regarding which of diabetes self-management programmes or 
services are already in place in the province, all key informants mentioned the Chronic 
Disease Clubs. Whilst the stated aim of these clubs is to equip diabetic patients with the 
knowledge and skills to manage their diabetes, it was clear that currently, they focus 
mainly on adherence (as with the HIV clubs). The clubs can be either facility based, or 
community-based and are geared to provide stable chronic disease patients with 
opportunities to access their medication and have their blood pressure and glucose 
monitored monthly. Some of them may offer limited health education. As with D-LECA, the 
Department’s intention is to broaden the scope of these clubs so that they offer support 
for the management of both communicable and non-communicable chronic disease. 
According to the family physician, these clubs are not working optimally at present: They 
are not sufficiently effective. Whilst the nurses are respectful (towards the patients), they 
just want to get through the queue. Patients are also often keen to get home as soon as 
possible. Also, patients respect information from doctors more. She suggested that for the 
clubs to become more effective, “the nurses need ongoing training and help from lay 
workers. A specific doctor should also be allocated to a group and be used as a resource. 
The priority is to allow for sufficient time for staff to listen to patients – to their questions, 
experiences and concerns (KI 3).  
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She added that the clubs should be fora for patients to share ideas on how to problem 
solve around common barriers as well as providing for activities, such as cooking 
demonstrations; exercise classes and fruit and vegetable co-operatives. She further 
suggested that positive role models and dieticians be invited periodically to give talks and 
distribute resources. The clinic manager thought it was essential that more staff received 
in-depth training in diabetes to be able to run these clubs more effectively as a means of 
promoting diabetes self-management. The health promoter’s view was that lay health 
workers should play a more prominent role in counselling in both the clubs and the clinics 
as they can help the healthcare providers get to know the challenges that these clients are 
facing. They consider the patient’s cultural background, their beliefs and values and help 
with language and cultural barriers. This makes the patients feel more comfortable. (KI 5) 
She added that she thought there should be greater community involvement in the running 
of the diabetes clubs or groups and that the Department should aim to establish clubs in 
every local community. 
3.2. Community-Based Services (CBS)  
At the community level, the provincial Departments of Health have outsourced a package 
of services for chronic disease patients to non-government organisations (NGOs). These 
NGOs are paid to render a service to a specific community. The NGO pays and manages 
its own staff, but the Department works closely with them and plays an oversight role. A 
CBS coordinator, who is a nurse employed by DOH, liaises with the NGOs and Social 
Service sites run by the Department of Social Development in her area and reports to the 
CBS programme manager working in the DOH district management structure.  
The package of services delivered by NGOs in the Western Cape province varies (as is 
the case in other provinces too): It could be just providing medication, which has been pre-
packaged by the Chronic Dispensing Units. On a monthly basis, patients will go to a group 
at a hall, a library or Service Site and fetch their medication. The NGO comes to fetch  
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Figure 7-1: summarises all main themes (from the doc review and the KI interviews). 
medication from the facility. There are tight control measures in place to ensure the 
medicines are kept under certain conditions and patients sign for their medication. The 
nurses oversee this process, and Community Health Workers (CHWs) deliver the service. 
Or patients could also, in addition, receive education on healthy lifestyle and medication. 
These groups have different names: they might be called a Self-Management Group or an 
Empowerment Group or a Wellness Group. (KI 1).  
However, again, the Department intends to expand the scope of the work done by the 
CHWs, the idea is for CHWs to do medication, as well as primary and secondary NCD 
prevention work in the community. CHWS currently working with HIV patients need to be 
upscaled to become general counsellors for chronic disease, just like the counsellors at 
the facility level. But now, we are not quite there (KI 1). The Western Cape Department of 
Health has also initiated the Western Cape on Wellness Initiative (WOW!) to prevent and 
reduce the risk of NCDs by promoting physical activity and a healthy diet in the community. 
Among its activities are training people to establish food gardens; convening a variety of 
popular physical activities in public spaces and health promotion media campaigns. Figure 
7-1: summarises all main themes (from the doc review and the KI interviews). 
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4. Theme four: Self-management of diabetes among older patients 
4.1. Specific programmes for older patients  
Within the primary health services in the Western Cape, there are no programmes which 
address the specific needs of older diabetes patients. KI 1 stated that older people are not 
addressed as a separate group. For me the only problem for older people is just the waiting 
times at the facility We do have an approach that older people and people with disabilities 
must be taken out of the queue and helped, but it does not always happen like that. It is 
the responsibility of the staff at the facility to see whether they can reduce the waiting times 
for older people. (KI 1). Fast-tracking older people in queues was confirmed as 
recommended practice by KI 2. 
4.2. Department of Health-Social Services partnership  
KI 1 also mentioned that the Department of Health partners with the Department of Social 
Development to run community-based groups for older people. The Department of Social 
Development have groups for older people called Service Sites, where older people still 
living at home go to socialise and others which are run at old age homes. These are usually 
run by NGOs paid by Social Development. We have combined forces with them so that 
we can start providing medication and lifestyle education to chronic patients through NGOs 
at those sites. In that way, we can avoid starting another group. Social Development has 
also organised the Golden Games to help older people stay fit and active. There are heats 
throughout the year and then one big competition a year. (KI 1).  
4.3. Barriers to effective self-management for older persons 
There was consensus among KIs that generally older patients wanted to be compliant, but 
they faced numerous barriers in managing their condition. Many of them are hardly 
managing themselves: they are very dependent on their families in terms of preparing their 
meals, taking medication and attending follow up appointments. (KI 5). For clinicians, the 
most pressing issue was the lack of time for consultation with chronic patients, especially 
with those suffering from multi-morbidities. The family physician emphasised that 
currently, patients are given information in a didactic fashion with little consideration of 
their individual situation or daily lived experience. Clinicians need to take time to listen to 
the patient. If the doctor does not understand the patient’s concerns or experiences, then 
the advice may be inappropriate. You also need time to go through the meds, so they 
understand the rationale and there needs to be shared decision-making so that there is 
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agreement on what meds the patient is willing to take and what can be stopped. (KI 3.) To 
enhance her own capacity to manage older diabetes patients, she stressed that what she 
needed most was more time to develop a personal relationship with the patient and their 
family and to be able to offer greater continuity of care. The health promoter argued that 
community health workers should be relied on to assist with self-management as they can 
spend more time getting to understand the patient’s context and capacity: Patients would 
get more involved (in self-management) if they were in a partnership (with a healthcare 
provider), where they had time to ask questions and where their cultural backgrounds, 
values and beliefs were understood. (KI 5). He was worried that there was currently a 
shortage of staff to run self-management programmes and implored the Department to 
employ more diabetes educators.  
Further barriers to self-management commonly experienced by older patients are listed in 
supplementary Table 2 (study4). The key informants also offered their ideas as to how 
these barriers could be overcome (Figure 7-2). 
Figure 7–2 Barriers to effective self-management for older persons: the views of key 
informants. 
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7.6. DISCUSSION  
The epidemiological transition in SA from acute, communicable disease to the prominence 
of chronic NCDs in an ageing population is resulting in an increased demand for long-term 
health care, institutional and family support. (23) This situation is recognised by policy 
makers, managers and practitioners alike and there are multiple efforts both nationally and 
provincially to re-orientate the healthcare system to focus more effectively on NCDs. This 
is evidenced by the re-engineering of primary care, which aims to provide integrated 
services for common chronic conditions; enhance the skills of healthcare practitioners to 
manage chronic conditions and multi-morbidity; improve access to medicine through the 
CCMDD programme; strengthen self- management and form strong linkages with  
communities through NGOs and CHWs, to fill a critical gap in support services that are not 
provided by organised health care. It was clear from the key informant interviews that, 
whilst the re-organisation of primary care in this way may not be fully established, it is 
currently underway at least in the Western Cape province.   
The policymakers interviewed made it clear that it is highly unlikely that they would 
consider introducing a specific programme for older diabetes patients. However, this group 
does stand to benefit from many of the interventions being implemented as part of the 
NCD Strategic Plan. As multimorbidity is a consistent feature of NCDs among the older 
individuals, the integration and coordination of chronic care services is indicated. (25) 
The establishment of community-based services to provide self-management support, 
promote health and ease access to medicine, as well as providing home visits by district-
based CHWs helps overcome many of the barriers to care experienced by older patients. 
It enables services to be delivered early and close to home, decreases waiting times, 
reduces transport and other associated costs for individuals and provides for continuity of 
care. (19) For the health system, gains include cost saving with disease averted by health 
promotion and early detection, reduced facility visits and less overcrowding, making more 
time available for individual consultations. (19) As our one key informant stated, this would 
make it more feasible for practitioners to interact with patients and play a more active role 
in enhancing health literacy, health promotion and self-management. What was not 
mentioned by the key informants, but which may be of equal importance is that 
practitioners gain appropriate communication skills and educational resources to 
effectively educate and counsel patients on lifestyle behaviour change and self-care. 
These factors have been reported by patients and healthcare providers alike to be 
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significant sources of frustration and to have a negative impact on the quality of NCD care. 
(26–28)  
To cater to a growing population of older people, the healthcare system also needs to be 
made more-aged friendly, particularly at the primary care level. According to Samson, 
many healthcare workers have negative attitudes towards older people and as a result, 
manageable health issues are overlooked or attributed to the ageing process, resulting in 
low levels of functioning, poorer health outcomes and diminished quality of life. (29)  
The available research on the question of how to improve the care of older patients with 
diabetes, highlights several important considerations. Poor health literacy related to low 
educational attainment and limited access to media among older patients is a known 
contributing factor to suboptimal diabetes outcomes among this group. (30) Older patients 
may therefore require additional time for health education and self-management support, 
which is tailored to their cognitive and functional status (older patients with multiple co-
morbidities are especially likely to become confused about their treatment). For example, 
a 2015 survey of diabetes patients >60 years attending public sector primary health care 
clinics in Cape Town, found very poor knowledge of diabetes complications, its causes 
and self-management practices. (31) This was both indicative of their low levels of formal 
education (67% had less than 5 years of schooling) and the extremely limited time and 
resources health care providers had to educate and counsel diabetic patients. (31) It has 
been argued that since older patients need more time for communication with providers, 
health services should be more responsive to and centred on their needs and that support  
needs to be provided in the community from healthcare workers who understand the local 
context and language. (32) Community-based support groups run by lay health workers 
have been shown to be particularly helpful in providing such extended support for older 
people. For example, Gilden et al (1992) (33) reported that older diabetic patients who 
attended a series of educational and social support groups had better knowledge, greater 
family involvement and improved quality of life; experienced less depression and stress 
and achieved greater glycemic control than a control group. It is also recommended that 
there be greater recognition of and support for the important role of the family and non-
professional caregivers in keeping older patients functionally independent and at home, 
thereby reducing health and social care costs (34).  They should be included in support 
groups and consultations with healthcare providers, where the older patient’s ability to self-
manage is frequently reviewed. (34) Older patients have been found to be at high risk of 
nutritional deficiency, with undernutrition and over-nutrition, as well as food insecurity. (35) 
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This suggest that nutritional status and the risk of hypoglycaemia should be included in 
such reviews. (33) As a group, older diabetic patients are also at higher risk of untreated 
depression and/or anxiety, indicating that greater attention be afforded to the screening 
and treatment of mental health among older patients with diabetes. (36) 
7.7. Conclusion  
Whilst there have been some significant policy interventions pertaining to the protection of 
the health and welfare of older persons in SA, the needs of this vulnerable group remain 
relatively low on the list of priorities in terms of focus and resource allocation. In this 
context, older people, as a distinct group, are also not a strong focus in current health 
policy relating to the provision of NCD care. However, the various initiatives currently 
underway to re-engineer the healthcare system in SA to more effectively deal with NCDs, 
will go some way to meeting the identified needs of older diabetic patients and to 
addressing their barriers to care. However, as part of this re-modelling exercise, it is 
perhaps opportune for the health department to consult older chronic care patients and 
involve them in decision making and the planning of services. This paper alerts 
policymakers and clinicians to some of the specific issues considered to be pertinent and 
important in the care and management of older diabetic patients. Many of these would 
also be applicable to older patients with other chronic conditions.   
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Study 5: The effectiveness of peer and community health worker-led 
self-management support programs for improving diabetes health-
related outcomes in adults in low-and-middle-income countries: 
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8.1. Abstract    
   
Objective: Community-based peer and community health worker-led diabetes self-management 
programs (COMP-DSMP) can benefit diabetes care, but the supporting evidence has been 
inadequately assessed. This systematic review explores the nature of COMP-DSMP in low and 
middle-income countries’ (LMIC) primary care settings and evaluates implementation strategies 
and diabetes-related health outcomes.  
Methods: We searched the Cochrane Library, PubMed-MEDLINE, SCOPUS, CINAHL PsycINFO 
Database, International Clinical Trials Registry Platform, Clinical trials.gov, Pan African Clinical 
Trials Registry (PACTR) and HINARI (Health InterNetwork Access to Research Initiative) for 
studies that evaluated a COMP-DSMP in adults with either type 1 or type 2 diabetes in World 
Bank-defined LMIC from January 2000 to December 2017. Randomised and non-randomised 
controlled trials with at least three months follow up and reporting on a behavioural, a primary 
psychological, and/or a clinical outcome were included. Implementation strategies were analysed 
using the standardised implementation framework by Proctor et al. Heterogeneity in study 
designs, outcomes, the scale of measurements, and measurement times precluded meta-
analysis; thus, a narrative description of studies is provided.   
Results: Of the 803 records identified, ten studies with 5008 participants were included. COMP-
DSMPs were inconsistently associated with improvements in clinical, behavioural and 
psychological outcomes. Many of the included studies were evaluated as being of low quality, 
most had a substantial risk of bias and there was significant heterogeneity of the intervention 
characteristics (for example, peer definition, selection, recruitment, training and type, dose and 
duration of delivered intervention), such that generalization was not possible.  
Conclusions: The evidence supporting the use of COMP-DSMP for people with diabetes in LMIC 
is equivocal. Well-designed and implemented trials are urgently needed to determine whether 
such programs should form an integral part of diabetes care strategies, which necessitates better 
funding and training of researchers. 
Registration: This review registered with the International Prospective Register of Systematic 
Reviews [registration number CRD42014007531]. 
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8. 2. Introduction  
Over the past decade, diabetes prevalence has risen faster in low- and middle-income countries 
(LMIC) than in high-income countries (HIC). (1) Currently, about 80% of people with diabetes 
worldwide live in LMIC and projections suggest that some of these countries will experience more 
than a twofold increase in the number of people affected over the next 20 years.(1) People living 
with diabetes need not only medical treatment from their health care providers; equally important 
is self-management and sustaining complex self-care behaviours. These behaviours (under the 
umbrella of “self-management”) include following complicated medication regimens and often 
embarking on significant lifestyle changes in diet and exercise programs, monitoring and 
responding to symptoms, and coping effectively with stress. (2-4) 
Evaluation of diabetes self-management programs has shown improved health outcomes and 
reduced utilisation of health services. (5–7) However, without continuous support, many adults 
will not succeed in managing their condition well, leading to worse health outcomes, including 
expensive hospitalisations and avoidable complications, (8) It is critical for health care providers 
and the settings where they work to have the resources and a systematic referral process to 
ensure that patients with diabetes consistently receive both diabetes self-management education 
(DSME) and diabetes self-management support (DSMS). DSME is defined as the ongoing 
procedure of facilitating the knowledge, skill, and ability necessary for diabetes self-care, while 
DSMS is defined as activities assisting the diabetic patient in implementing and sustaining the 
behaviours needed to manage his/her condition on an ongoing basis beyond or outside of formal 
self-management training. The type of support provided can be behavioural, educational, 
psychosocial, or clinical (9). The initial DSME is typically provided by a healthcare professional, 
whereas ongoing support can be provided by personnel without a formal health tertiary education 
(9). However, health resources, infrastructure, and well-equipped health staff are often limited in 
LMIC which complicate the delivery and sustainability of DSME and DSMS.(10) 
A potential solution for delivering diabetes self-management support could be task-shifting. This 
is the process whereby tasks are moved, where appropriate, to less specialised health workers 
and is thus expected to reduce health care expenses while improving health care coverage. (11) 
Lay health workers from the community such as ‘patient-peers’ or community health workers 
(CHW) are ideally suited for such task-shifting since existing research suggests that such 
programs are an effective and relatively inexpensive means to help patients manage chronic 
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conditions. (12, 13) Furthermore, these programs have been recommended by the World Health 
Organization review committee on peer support in diabetes as a resourceful way for diabetes 
management. (14)  
Existing COMP-DSMPs involve two types of closely related lay health care workers; ‘patient-
peers’ (here called ‘peers’) and community health workers (CHW). For the purpose of this review, 
Dennis’s (15) comprehensive definition of peer support, as used in a recent Cochrane review, 
(16) is employed. Dennis defines peer support as “provision of emotional, appraisal and 
informational assistance by a created social network member who possesses experiential 
knowledge of a specific behaviour or stressor and similar characteristics as the target population, 
to address a health-related issue of a potentially or stressed focal person”. (15) To possess this 
experiential knowledge, peers must be affected by the same condition as the patient population 
they serve. In the context of diabetes, peers often have diabetes themselves or have a family 
member with diabetes. Their support can help metabolic control by sharing, discussing, 
identifying, and facilitating behaviours, which can improve diabetes self-management and 
overcome obstacles to care and self-care. (17)  
CHWs constitute another form of lay health workers based in the local community. WHO defines 
CHWs as health workers without a tertiary education health certificate, who are members of the 
communities where they work and are supported by the health system, although not necessarily 
part of its organisation. (18) In contrast to peers, CHWs does not necessarily have the experiential 
knowledge of being a patient. Yet, similar to peers, CHWs speak the language and share culture 
and community with the patients with whom they work. Like peer-support, CHW-support varies 
widely across different contexts and may include both self-management support as well as direct 
patient care. (19, 20) Furthermore, both CHW and peer-support interventions (here collectively 
referred to as COMP-DSMPs) differ in the extent and type of formal training that peers/CHWs 
receive; in whether peers/CHW are paid members of a healthcare team or volunteers; in the type 
and extent of time commitment required of the peers/CHW; and in the principal method of peer 
support (for example, face-to-face contact versus telephone contact) .(21) 
A considerable body of evidence from well-designed RCTs, mainly in HIC, demonstrate improved 
clinical and behavioural outcomes such as glycaemic control in diabetes populations receiving 
peer/CHWs support (22–31) This is further supported by several systematic reviews. A systematic 
review conducted by Zhang et al. (32) suggested that home-visit-intervention and curriculum-
combined-reinforcement-intervention performed by peers had a better effect on 
improving glycaemic control compared to conventional care . Furthermore, a systematic review 
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by Norris et al. reported positive changes in lifestyle and self-care in some studies of CHW-led 
interventions for diabetes self-management. Although limited data on economic outcomes is 
available, several studies demonstrated a reduction in health care expenses as a result of the 
CHW-led intervention (33).  
At present, there are no systematic reviews of peer/CHW support programs for diabetes focusing 
on LMICs. Furthermore, most systematic reviews to date have not applied a standardised 
framework for analysing and evaluating the implementation strategies across studies. Systematic 
categorisation and assessment of implementation outcomes are critical for assessing whether an 
implementation strategy has been applied successfully since an intervention will not be successful 
unless both the implementation of the strategy in a given context and the components of the 
strategy itself are effective. (34) In the case of failure, it is essential to know if this was due to the 
intervention being ineffective in the new setting (intervention failure), or if an intervention was 
deployed incorrectly (implementation failure). (35) To bridge this gap in the existing literature, this 
systematic review aims to employ a standardised taxonomy for analysing and evaluating COMP-
DSMPs implementation strategies in LMIC for diabetes self-management. We strive to answer 
the following questions: What are the effects of COMP-DSMPs on the clinical and behavioural 
outcomes of adults with diabetes, and how consistent are those effects across existing studies? 
What were the program designs used and how were the implementation outcomes assessed?   
8.3. METHODS 
A full study protocol was developed and published in a peer-reviewed journal. (36) The systematic 
review has been slightly modified from the protocol. Firstly, a meta-analysis was precluded by the 
quality of the included studies. Secondly, the research question addressing ‘how COM-DSMP can 
help improving quality of diabetes care’ has been modified to addressing ‘the program designs 
used, and the implementation outcomes assessed’ since there was insufficient information on the 
quality of care in the included studies. Finally, implementation taxonomy frameworks by Proctor 
et al. (40) have been adopted for analysis and evaluation of the implementation strategies. This 
review follows the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) (37) and is registered with the International Prospective Register of Systematic 
Reviews [registration number CRD42014007531]. 
8.3.1. Search strategy  
We searched the Cochrane Library, MEDLINE via PubMed, SCOPUS, CINAHL, PsycINFO, and 
Web of Science databases for studies published between 1 January 2000 and 31December 2017, 
which evaluated COMP-DSMPs in adults with diabetes in LMIC. Drawing on a combination of 
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free-text search terms, Medical Subject Headings and database-specific subject headings, we 
developed a sensitive search strategy for multiple electronic databases (Additional file 1), 
combining synonyms for ‘diabetes’, ‘peer support’, ‘community health worker’, ‘intervention’ and 
‘LMIC’. 
Other database resources such as Google Scholar, WHO, Peer for Progress, International 
Clinical Trials Registry Platform, Clinicaltrials.gov, Pan African Clinical Trials Registry (PACTR) 
and HINARI (Health InterNetwork Access to Research Initiative) for LMIC were searched 
(Additional File 1). We similarly explored the reference lists of key articles and journals. 
8.3.2. Selection of studies. 
Titles and/or abstracts of studies were identified using the search strategy, and those from 
additional sources were screened independently by two reviewers (MW, PR). They individually 
assessed the eligibility of the articles first based on the title and abstract and later on full-text. Any 
disagreement between the two reviewers was resolved through discussion with a third author 
(NSL) on the study team. 
Inclusion criteria  
• Types of studies: Studies that measured the effects of COMP-DSMPs in randomised 
controlled trials (RCTs), non-randomised controlled trials and quasi-randomised controlled 
trials were included. The quasi-randomised controlled trials included controlled studies 
with a comparison group and uncontrolled studies with ‘before and after’ study designs. 
We included both controlled and non-controlled before and after studies because they are 
accepted research designs for improvement strategies and are widely used, especially so 
in LMIC where the resources are not available to conduct RCTs, (38)  
• Types of participants/population: Only studies from LMIC based on the World Bank 
classification of country income groups were included. (39) Study participants had to be 
≥18 years of age and have either type 1 or type 2 diabetes, but not gestational diabetes 
nor diabetes due to other causes. We included type 1 and type 2 diabetes because several 
studies from LMIC do not differentiate between these two diagnoses.  
• Types of interventions: Studies that reported contact with an individual or a group of 
peers (paid or voluntary) offering COMP-DSMP with a minimum follow-up period of three 
months were included. Peers could be CHW, peer leader, lay health advisor, lay health 
educators, or peer coaches. Peer support that was exclusively telephone- and web-based 
were excluded. Interventions led or facilitated by a professional (or non-peer) were 
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included, providing that the focus of the intervention was to provide peer-to-peer 
interaction. Studies in which peer support was part of a multicomponent/complex 
intervention, where the effects of the peer support element could not be isolated, were 
excluded. 
• Types of control/comparator groups: Studies, in which the control/comparator group 
received usual care or professional health worker-led diabetes self-management support 
(and not peer-support) with a follow-up period of three months or more were included.  
• Types of outcomes: Studies that reported at least one of the following outcomes were 
included. Behavioural – such as physical activity/fitness, glucose monitoring, adherence 
to medication, improved nutrition, and self-care. Psychological – such as self-efficacy, 
knowledge, attitudes, quality of life, confidence, self-esteem, well-being, vitality, social 
functioning, coping, as assessed by validated measures. Clinical – such as fasting and 
random blood sugar levels, glycated haemoglobin (HbA1c), cholesterol, blood pressure, 
body mass index (BMI), symptoms of hypoglycaemia and hyperglycaemia, and 
hospitalisations or clinical visits.   
• Language: Restricted to English  
• Time restriction: We decided to restrict the search to the period following the changes to 
the diabetes diagnostic criteria in 1999 based on the WHO Expert Committee on Diagnosis 
and Classification of Diabetes. Thus, all studies from January 2000 to December 2017 
were eligible if the other inclusion criteria were met.  
8.3.3. Assessment of risk of bias of studies 
Four reviewers (MW, PR, NP, and KB) independently evaluated and reported on the risk of bias 
as described in the Cochrane Handbook for Systematic Reviews of Interventions according to the 
criteria and associated categorisations contained therein (Additional File 2), (38) A consensus 
was reached after discussion and consultation with another reviewer (ME). The detailed reporting 
included the following variables: Sequence generation, allocation concealment, blinding 
(participants, providers, outcome assessors and data analysts), completeness of outcome data 
and selective reporting (38) (Additional File 3).  
8.3.4. Data extraction and synthesis 
The following data  were extracted independently by three reviewers (MW, PR and NP): author, 
year of publication, geographic region, study design, description of the intervention (including 
process, cost of programme, cost-effectiveness if available, context of intervention (i.e., primary 
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health facility), details about group leader (demographics, training, professional status, etc.), 
details about participants (including number of each group, baseline health information, 
demographic characteristics), length of intervention and follow-up, definition of peer used and  
health outcomes. The data abstraction forms based on the Cochrane Consumers and 
Communication Review Group’s Data Extraction Template for Cochrane Reviews were modified 
to fit this review. A consensus was reached by discussion and consultation with other reviewers 
(ME, NSL) where necessary.  
8.4. Taxonomy for analysing implementation strategies:  
The taxonomy used to investigate and evaluate the implementation strategy of each study is 
based on previously published conceptual frameworks by Proctor et al. (40-42) Proctor et al. (40) 
propose guidelines for naming, defining, and operationalising implementation strategies in terms 
of seven dimensions; actor, the action, action targets, temporality, dose, implementation 
outcomes addressed, and theoretical justification. For this review we categorised and analysed 
the included studies by applying six of the proposed dimensions (table 2), whilst ‘implementation 
outcomes addressed’ are separately analysed by the taxonomy proposed by Proctor et al. (42) 
(Table 3). Although the conceptual framework is intended for researchers planning 
implementation strategies, it allows for systematic investigation, evaluation and comparison of the 
nature of the implementation strategies in the included studies. Furthermore, it enables 
investigation of whether the studies suffer from commonly reported problems in current 
implementation research such as inconsistent labelling, poor descriptions, and unclear 
justification for specific implementation strategies. The actors are defined as the stakeholder 
delivering the strategy; the actions are defined as those actions enacted by the actors; action 
targets are the population targeted by the intervention and how the actions are supposed to impact 
this population; temporality is defined as the phased nature of implementation meaning at which 
stage was the strategy used relative to other stages; dose is defined as the frequency and 
intensity of the implementation strategy such as the amount of time spent with an external 
facilitator; and theoretical justification is defined as the justification or rationale for the 
implementation strategy, which can be theoretical, empirical, and/or pragmatical.  
8.4.1. Taxonomy for evaluating the implementation strategies:  
We systematically investigated whether studies reported on the eight implementation outcomes 
prescribed by Proctor et al (42): acceptability (i.e. the perception among stakeholders that an 
intervention is agreeable), appropriateness (i.e. the perceived fit or relevance of the intervention 
in a setting or for a particular target audience or issue), feasibility ( i.e. the extent to which an 
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intervention can be carried out in a specific setting or organisation) , adoption (i.e. the intention, 
initial decision, or action to try to employ a new intervention), penetration (i.e. the degree to which 
the population who is eligible to benefit from an intervention actually receives it),  sustainability 
(i.e. the extent to which an intervention is maintained or institutionalised in a given setting), 
implementation costs (i.e. the incremental cost of the delivery strategy), and implementation 
fidelity (i.e. the extent to which an intervention is delivered as planned). We assessed 
implementation fidelity (IF), using the models of Carroll et al. (43) and Schoenwald et al. (44) 
8.5. Statistical analysis. 
Comparisons between groups for continuous outcomes were conducted using mean differences 
(MD) and their corresponding 95% confidence intervals and p-values. For binary outcomes, 
proportions or percentages were compared using Chi-square tests. Most studies used regression 
analyses to compare outcomes between the study groups with adjustments for multiple 
comparisons, baseline, and confounding variables, and in these cases, we used the p-values 
reported by the study authors. However, differences in study designs, outcomes, the scale of 
measurements, and measurement times precluded meta-analysis. We, therefore, provide a 
narrative summary of the findings across studies. 
8.6. Results   
 
8.6.1. Summary of the searches 
A flow consort diagram of the studies selected for inclusion is summarised in Figure 1. A total of 
803 records were identified from searches. After removal of duplicates, title and abstract 
screening, 238 articles were selected for further evaluation via full text, of these 228 full text 
articles were excluded; 192 were not from LMIC, 17 did not include patients with diabetes, 6 
assessed outcome measures not relevant to the study criteria, 3 were reviews or protocol papers 
and 2 were co-led by professionals and peers. Thus, only ten studies met the inclusion criteria 
and were included in the systematic review. These studies were published in the period from 
2008-15 based on patient populations in the following countries: South Africa (n=2), Cameroon 
(n=1), Uganda (n=1), China (n=2), Cambodia (n=1) Argentina (n=1), Guatemala (n=1) and 
Jamaica (n=1). The included studies comprised three RCTs, (45-47) one non-randomised parallel 
arms intervention study (48) and six pretest-posttest studies. (49-54) The sample sizes in the 
studies varied from 19 to 2714; in total there were 5008 participants in this review. Seven studies 
investigated support provided by peers, while the remaining three studies explored support 
provided by CHWs. 
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8.6.2. Quality of included studies  
 
The studies included were mostly of low quality. Four studies did not discuss sources of bias or 
limitations of the study findings, (50, 52, 53, 54) while two others did not provide details on the 
randomisation techniques. (45, 46) Only one study, less et al., reported rate of lost to follow-up, 
which was 15%. (54) Performance bias blinding (participants and personnel) was rated as high 
risk in all studies except Zhong et al., (45) where performance bias blinding was evaluated 
unclear.  
The studies exhibited substantial heterogeneity in study design with only three of the ten included 
studies being RCTs. The outcomes measured, except for biological variables such as HbA1c, 
were insufficiently defined and reported for assessment in many of the studies; in many studies, 
outcomes were self-reported and different instruments and methods were used to record the data. 
A summary of the risk of bias in selected studies is illustrated in Table 1.  
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Figure 8–1 The PRISMA Flow Diagram depicting the flow of information through 
the different phases of the systematic review  
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                         Table 8–1 Risk of bias for included studies 
                 
NCR: Not clearly risk   
 
8.6.3. Taxonomy of Implementation of peer support strategies. 
Table 2 illustrates the taxonomy of the peer/CHW support implementation strategies in the 
included studies based on the framework by Proctor et al. (40)    
Actor – who delivers the strategy? 
Across the studies, the actors providing the support varied; in seven studies actors were peers 
(45,46,48,50-53), while in three studies the support was provided by CHWs. (47,49,54) In the 
peer-led interventions, peers were often volunteers selected based on their knowledge, 
experience, and adherence to medication and lifestyle changes (45, 46,48, 52,53) and thus 
functioned as role models for patients. Only in one study (51), peers were deliberately selected 
Authors -year Selection 
bias 
Random 
sequence 
generation 
 
Selection bias 
(Allocation 
concealment) 
Detection bias 
Blinding (outcome 
assessment) 
Attrition bias  
Incomplete 
outcome data 
Reporting 
bias 
Selective 
reporting 
Performance 
bias Blinding 
(participants 
and personnel) 
 
Zhong et al., 2015 (45) NCR NCR High  High  Low NCR 
Gargliardino et al, 2014 (46) NCR NCR High NCR Low High 
Mash et al., 2014 
(47) 
Low NCR High Low Low High  
Assah 2015 
(48) 
High High High NCR High High 
Micikas et al., 2014 (49) High  High  High  NCR High  High 
Baumann et al., 2014 (50) High   High  High Low   Low High 
Huixia et al., 2008 (51) High   High   High NCR Low High  
Eggermont et al., 2011 (52) High  High  High   NCR Low High   
Rotheram- et al., Borus 2012 
(53) 
High  High  High   Low Low High   
Less et al., 
2010 (54) 
High High High Low Low High     
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based on their everyday life challenges being similar to those of the patients, while another study 
did not describe the skill-level of the peers. (50) 
No description of the CHWs in the three included studies was given, other than they were non-
professional health workers (i.e. without a formal health tertiary education) from the local 
community. In all the studies, the peers/CHWs received training prior to commencing the 
intervention; most training courses lasted a few days. In one study, Eggermont et al. (52) training 
lasted six weeks. However, in this study, peers also played crucial roles in screening and 
monitoring clinical measures in patients in addition to providing DSME and DSMS.  
Actions – which actions do the actors enact?  
Across the studies, the peers/CHW aimed at equipping the patients with knowledge, support and 
skills to manage their diabetes. Thus, the peers/CHW provided DSMS and DSME. In most of the 
studies, peers/CHW led the group and discussion meetings, (45,46,48, 49, 52, 53, 54) as well as 
more informal activities such as organising physical activities and cooking classes. In all studies, 
peers/CHW provided emotional and/or social support through informal contact with the patient 
through in-person interactions and/or telephone contact. In two studies emotional and social 
support formed the basis of the intervention, (50,51) Two studies (50,53) emphasised a deep-
grounded one-to-one contact; where peer educators in Baumann et al. (50) were paired with 
patient peers, peers facilitated the establishment of buddy pairs between patients in Rotheram-
Borus et al. (53). In the remaining interventions, the actions by peers/CHWs targeted both groups 
and individuals depending on the form of activity. In terms of the types of studies, the interventions 
were group-based in the three RCTs (45-47) and in five of the seven non-RCT studies; the 
remaining two non-RCTs were one-to-one interventions. (50,54)  
Targets of action – Who/what are the actors attempting to impact? 
All interventions aimed at enhancing emotional and social support for and improving self-care 
behaviours and management in adults with diabetes. Furthermore, by improving emotional/social 
support and self-management, the studies aimed to improve clinical outcomes such as glycaemic 
control, blood pressure, and BMI. Most of the studies targeted T2DM patients exclusively, while 
two studies did not distinguish between T1DM and T2DM. (52, 53) In two studies the intervention 
specifically targeted patients without major comorbidities, (4645) while the intervention in one 
study (52) targeted diabetes patients, of whom some also had hypertension. In one study the 
intervention targeted older adults (60 years and above) exclusively. (51) 
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Temporality – when does the strategy take place? 
In all studies, the actions by the actors (i.e. peers/CHW) were commenced following their own 
training. Only a single study, Shen (2008), outlined the relative time from completion of peer/CHW 
training and the commencement of the interventions. (51)  
Dose – what is the frequency and intensity of the intervention?  
The intervention strategies varied in duration and frequency; the strategies ranged from weekly 
40-minute group discussions (46) to weekly teaching sessions (90-120 min each) and group 
discussions. (51) The follow-up periods varied between 3 months to twenty-four months (three 
months (51), four months (49,50) and six months, (48,55,54) 12 months (45-47) and 24 months. 
(53)  
Justification – which (theoretical, empirical, pragmatic) justification is provided for the 
choice of implementation strategy? 
Most of the studies justified the utilisation of a peer/CHW based intervention for diabetes by 
referring to existing literature, which highlights peer/CHW based interventions can contribute to 
improving chronic conditions. Furthermore, most studies justified the peer/CHW based 
intervention by referring to studies showing that such interventions provide a low-cost, flexible 
means to improve care for chronic conditions in resource-constrained health systems. A few 
studies also conducted formative research including focus groups and individual interviews in the 
communities to aid the development of interventions. The formative research illustrated that 
peer/CHW interventions were desired and/or suited for the given communities. (53;51;45;49)
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Table 8–2 Taxonomy of implementation of peer support strategies in LMIC by mode of delivery. 
 
Study ID 
&    design  
Country Actors 
Who delivers the 
strategy? 
Actions 
Which actions do the 
actors enact? 
Targets of action 
Who/what are the 
actors attempting to 
impact? 
Temporality 
At which 
phase is the 
strategy 
used? 
Dose 
At which 
frequency and 
intensity is the 
strategy used? 
Justification 
Which (theoretical, 
empirical, pragmatic) 
justification/rationale is 
provided for the choice 
of implementation 
strategy? 
Assah et 
al., 2015 
 
Non-RCT  
 
(45) 
Cameroo
n 
Peers – volunteers 
with diabetes 
selected based on 
their compliance with 
treatment, good 
glycaemic and 
metabolic control, 
and their experience. 
Received 2-day 
training workshop. 
Actions–actors led 
group meetings on self-
management and 
conducted personal 
and telephone-based 
support.  
Targets - actions were 
aimed at improving self-
care behaviours; 
knowledge; clinical 
outcomes (glycaemic 
levels, blood pressure, 
lipids); providing 
emotional and social 
support for adults with 
poorly controlled T2DM.  
N/A Dose –Group 
meetings - monthly 
for 6 months.  
Personal + 
telephone 
encounters - 5 
monthly over 6 
months.  
Justification – Research 
shows that peer-support 
care models provide low-
cost, flexible means to 
supplement formal health 
care support for chronic 
diseases.   
Baumann 
et al., 2015  
Pre-post 
quasi-
experimen
tal study 
 
(50)  
Uganda Peers (called 
champions) – people 
with diabetes who 
were able to read and 
speak English and 
receive 2 days 
training in 
communication, 
emotional support, 
and assistance with 
daily management. 
Other selection 
criteria not specified.  
Actions – actors were 
matched with patient 
peers and provided 
emotional support and 
assistance with daily 
management through 
facilitating personal and 
telephone.  
Targets – actions were 
aimed at improving 
diabetes self-care 
behaviours, glycaemic 
control, social support, 
emotional well-being, 
and linkage to health-
care providers for adults 
with T2DM.  
N/A Dose – Contact 
between peers and 
partners 
(telephone/in 
person) - at least 
once a week over 4 
months.  
Justification – WHO 
suggests that peer 
support is a promising 
approach toward 
achieving self-care goals 
in a developing world 
setting with shortage of 
health workers, which is 
supported empirically.   
Eggermon
t, 2011  
 
Pre/post 
 
Cambodi
a 
Peers – recently 
recovered from years 
of serious illness from 
poor glycaemic 
Actions – actors 
educated and provided 
skills of self-
management; 
supported adaptation of 
Targets – actions aimed 
to improve health 
outcomes (blood 
glucose, blood pressure, 
BMI), ability to control 
N/A.  Dose – Classes – 6 
in the home of peer 
educator.  
Justification–Peer 
support models are 
theoretically promising for 
resource constrained 
health systems and 
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(52) control. Received 6 
weeks of training.  
life-style including 
nutrition and daily 
exercise; and mediated 
contact to professional 
health staff when 
needed.  
disease, and empower 
people with diabetes 
(some also had 
hypertension).  
Monitor glucose 
levels – twice 
monthly  
Time period not 
specified.  
underpins patient-
centeredness, supported 
by some empirical 
evidence.  
Gagliardin
o et al., 
2013  
 
RCT  
 
(46) 
Argentina Peers – patients with 
diabetes recruited on 
the basis of their 
excellent diabetes 
control, self-
motivation, 
communication and 
support skills. 
Recruited from an 
NGO devoted to 
education of people 
with diabetes. 
Received 3-days 
training in DSM and 
communication.  
Actions–actors 
implemented a diabetes 
educational program, 
provided psychological 
and behavioural 
support through phone-
calls to patients and 
face-to-face interviews 
in small groups.  
Targets – The actions 
aimed at improving and 
sustaining self-care 
behaviours and hereby 
clinical outcomes in 
adults (25-75yr) with 
T2DM, who had been 
followed for at least 2yr 
by physicians without 
major co-morbidities.  
N/A 
 
Dose – Educational 
course – 4-week 
program (4 
modules, 90–
120min). 1 
reinforcement 
session 6 months 
after. 
Calls – weekly for 6 
months post-course, 
biweekly next 3 
months, and 
monthly for last 3 
months.  
Interviews – 
bimonthly for 1-yr 
post-course.  
Justification –Research 
shows that diabetes self-
management education is 
effective for improving 
clinical outcomes and 
quality of life of people 
with diabetes, but many 
organizations are not 
equipped to manage its 
implementation. This gap 
can be bridged by peer 
programs, supported by 
research from other 
chronic conditions.     
Rotheram-
Borus et 
al., 2012  
 
Pre/post 
 
(53) 
South 
Africa  
Peers – volunteers 
with diabetes who 
had lost weight and 
increased exercise 
after T2DM 
diagnosis.  
Actions – actors a) led 
psychoeducational 
group sessions, b) 
facilitated buddy pairs 
between women with 
diabetes in order for 
these women to 
support each other’s 
behaviour change via 
telephone text-
communication.   
Targets – Actions aimed 
at enhancing self-
management for women 
with diabetes (1 T1D, 
rest T2DM) who had 
suffered diabetes 
symptoms for more than 
5yr. Further, actions 
aimed to facilitate 
successful buddy pairs, 
where women with 
diabetes would support 
each other’s behaviour 
change and hereby 
clinical outcomes.  
N/A Dose –
Psychoeducational 
group sessions/ 
Informational 
support meetings – 
12 weekly meetings.  
Text-messages – 
daily. Time period 
not specified.  
Justification –Research 
suggests that peer 
support can bring 
significant improvements 
in chronic disease 
diagnosis and care. 
Formative research 
informed the adaption of 
the ‘Power to Prevent 
Program’ to the study 
setting.  
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Shen, 2008 
 
Pre/post 
 
 
(51) 
China  Peers – older people 
with T2DM, living in the 
same community, non-
health professionals. 
They were very similar 
to general participants.  
Actions – actors led a 
social support and self-
efficacy enhancing group 
activities (SSS-activities). 
Actors facilitated 
frequent informal contact 
and collective peer group 
meetings.  
Targets –Older people 
with T2D (≥60yr). Actions 
are targeted at changing 
self-management 
behaviours and 
subsequent improvement 
of health outcomes by 
influencing self-efficacy 
and social support.  
Temporality - 
Informal peer-
led SSS-
activities 
started at the 
same time as 
basic diabetes 
information 
(BDI) by 
health 
professionals. 
Formal SSS-
activities 1wk 
after ended 
BDI sessions.    
Dose – SSS activities 
lasted 12 weeks. 
Informal contact- at 
least once a week. 
Collective group 
meetings held 
fortnightly from 5-
12th week of study.  
Justification –- Social 
cognitive theory used as a 
framework. Research shows 
that peer education can be 
used in health promotion 
and disease prevention 
programs to lower costs of 
health education programs. 
Formative research 
provided the basis for 
development of a peer-led 
T2D self-management 
program.  
Zhong et 
al., 2015  
 
RCT 
(45)  
China Peers – volunteers, 
who were retired 
adults diagnosed with 
diabetes for a mean of 
9.3yr, had received 
training for 3 days in 
basic skills and DSM. 
Generally adhered to 
medication and 
behavioural 
management regimens.  
Actions – actors led 
educational meetings on 
DSM, discussion 
meetings, and organized 
informal health 
promotion and support 
activities such as physical 
activities. 
Targets – Actions aimed at 
assisting and encouraging 
daily diabetes 
management; providing 
ongoing social and 
emotional support; linking 
community resources and 
primary care for adults 
(>15yr) with T2DM without 
major co-morbidities.   
 
N/A  Dose – Educational 
meetings – 12 bi-
weekly over 6 
months. 1.5-2h 
Discussion groups – 
12 bi-weekly over 6 
months  
Informal activities – 
not specified.  
Justification – Research 
suggests that peer support 
can improve diabetes 
management. Furthermore, 
a formative evaluation 
conducted prior to the 
study indicated substantial 
support for the peer-led 
support program.  
Less et al., 
2010  
 
Pre/post  
 
 (54) 
Jamaica  CHW – community 
health workers 
classified as local 
people who were not 
expected to move away 
from their 
communities. Received 
training and had to 
complete a 
standardized 
questionnaire/test.  
Actions – actors provided 
education in DSM 
through group and one-
to-one sessions either at 
the clinic or in the 
patients’ homes, when 
patients could not come 
to clinic.  
Targets – Actions aimed at 
increasing knowledge and 
improve control amongst 
T2DM patients.  
N/A Dose – Group 
sessions and one-to-
one interactions – 
frequency not 
specified, lasted 6 
months.  
 
Justification – Due to high 
net migration rates, training 
and retaining diabetes 
educators as part of 
primary health care system 
is not feasible. Peer- or lay 
educators may bridge this 
gap.  
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Mash et al., 
2014 
 
RCT 
(47) 
South 
Africa 
CHW (Health 
promoters) – lay 
people employed by 
community health 
centres. They were 
trained (6-day 
workshop).  
Actions–actor-led 
sessions of group 
diabetes education using 
a guiding style of 
communication and 
provided counselling.  
Targets – Actions aimed at 
enhancing self-
management and thus 
health outcomes for adults 
with T2DM.  
N/A  60min monthly 
sessions over 4 
months.  
 
Justification – Poor and 
limited health infrastructure 
in LMIC requires task-
shifting to cope with the 
burden of diabetes.  
Micikas et 
al., 2015 
 
Pre/post 
 
(49) 
Guatemal
a 
CHW – nature of these 
not specified. The 
actors were selected 
from a group of 
community health 
workers based on 
interviews. The 
selected CHW received 
further training.   
Actions – actors led 
education (diabetes club 
meetings including self-
management education, 
emotional support, 
physical activities); 
advocacy (home visits 
including emotional and 
medication support); and 
pre-consults in the clinics 
with nurse.  
Targets – Actions aimed at 
improving education, 
support, and ultimately 
the health and quality of 
life of T2DM patients.   
N/A  Club Meetings – 
weekly  
Home-visits – weekly 
Pre-consults – 
monthly  
Intervention period is 
not specified but 
intervention was 
evaluated after 4 
months.  
 
Justification – Research 
shows that community 
health interventions are an 
essential component of 
chronic disease 
management. Assessments 
in the intervention villages 
further underpinned the 
residents’ strong desire for 
services provided by 
community health workers.  
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8.6.4. Implementation Outcomes 
A comprehensive assessment of implementation outcomes, in terms of acceptability, adoption, 
appropriateness, feasibility, implementation cost, penetration and sustainability, is shown in Table 
3. Most of the included studies assessed only a few of these outcomes. As an example, 
implementation cost was only measured in one study, (54) while implementation adoption, 
appropriateness and penetration were measured in two studies. (45,50) Acceptability and 
feasibility were most commonly measured (both were measured in four studies (45, 49, 53, 52) 
8.6.5. Diabetes-related outcomes  
The diabetes-related outcomes described by study design, (RCT and non-RCT design) are 
summarised in Table 4 and detailed below.  
 
8.6.5.1. Randomised controlled trials (Table 4)  
  
Clinical outcomes 
HbA1c  
Of the 3 RCTs, only Mash et al. assessed HbA1c and found a 0.01% weighted mean reduction 
in HbA1c between intervention and control groups, which was neither statistically nor clinically 
significant. (47) 
Fasting glucose and 2-hour postprandial glucose (FPG/PPG) 
 Zhong et al. was the only RCT, which examined changes in fasting glucose levels. The study 
showed a reduction from 7.68mmol/L to 6.76 mmol/L for the intervention group, while those in the 
control groups exhibited a slight increase from 6.38 mmol/L to 6.66 mmol/L. (45) The difference 
between these two patterns was statistically significant (p <.001), but the authors did not report 
on its clinical relevance. 
Blood pressure  
Two of three RCTs, Zhong et al. and Mash et al., (45,47) reported on blood pressure. These 
studies found significant reductions in systolic blood pressure (SBP) and diastolic blood pressure 
(DBP) in the peer/CHW-led interventions compared to the control groups. 
Zhong et al (45) reported a significant reduction in SBP in their interventional group (136-128 
mmHg) compared to the control group (130-131 mmHg) and in DBP (intervention 82.5-79.1 
mmHg; control 79.0-78.6 mmHg). Mash et al. (47) reported a weighted mean SBP reduction of 
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4.65 mmHg (95% CI -9.18 to -0.12), which was not statistically significant. Further, a weighted 
mean DBP reduction of -3.30 mmHg (95% CI -5.35 to -1.26) was statistically significant.  
Body mass index (BMI) 
Only one RCT, Zhong et al. measured BMI, which was reduced in the peer-led intervention group 
from 24.3 kg/m2 to 23.7 kg/m2 (p<0.001) whilst it increased in the control group from 23.5 kg/m2 
to 24 kg/m2 (p<0.001) between baseline and 12 months. (45) 
Diabetes symptoms 
Only Gargliardino et al. (46) reported changes in classical diabetes symptoms (polydipsia, 
polyuria, polyphagia, pruritus, and asthenia). The symptoms were statistically significantly 
reduced in both control and intervention groups between baseline and 12 months with no 
significant differences between control- and intervention reductions. The authors did not report 
whether these findings were clinically relevant.  
Behavioural health outcomes  
Self-management care outcome     
Only two RCT studies reported on self-management care activities. Zhong et al. and Mash et al., 
(45,47) found no significant differences in self-management practices relating to diet, physical 
activity, glucose monitoring and medication adherence. 
Physical activity 
Two of the three RCTs reported on physical activity. Gargliardino et al. (46) demonstrated a 
significant reduction in the number of participants practicing regular physical activity in control 
(56% to 37%, p=0.0006), but not the COMP-DSMPs intervention group (69% to 60%, p=0.221). 
Notably, there was a significant difference in the reduction (in %) between the two groups (19% 
versus 9%, p=0.035). Zhong et al. (45) reported no improvement in self-reported physical activity. 
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Psychological health outcomes  
Self-efficacy  
Although self-efficacy for diabetes management was measured using different scales, two RCT 
studies reported increased self-efficacy in the intervention group compared to the control group 
when measured at 6 to 12 months. Zhong et al. (45) found significant improvements in self-
efficacy with the intervention in two out of six sites, where a COMP-DSMPs was implemented. 
However, Mash et al., (47) reported the COMP-DSMP-intervention did not improve psychological 
health outcomes including self-efficacy. 
Diabetes knowledge. 
Two RCT studies reported on diabetes knowledge. Zhong et al. (45) found statistically significant 
improvements at twelve months’ follow-up in a knowledge domain made up of twelve items (four 
concerning glucose, three concerning diabetic complications, two concerning diet and three 
concerning insulin). However, the control group’s knowledge diminished from baseline. 
Gargliardino et al. (46) showed that the attendees’ knowledge increased significantly (p<0.01) in 
both groups, but without any significant difference between intervention and control groups. 
Depression, diabetes-related distress and quality of life 
 Gargliardino et al. (46) reported on diabetes-related distress, while Mash et al. (47) reported on 
depression. Neither study reported significant differences in these measurements in the 
intervention and control groups at baseline-to-12 months. Zhong et al. (45) did not report on any 
of these measures, and none of the RCTs reported on quality of life.  
8.6.5.2. Pre-test/post-test and non-RCTs (Table 4)  
Clinical outcomes  
HBA1c 
Four studies, Assah et al., Micikas et al., Baumann et al. and Less et al.  (48, 49,50, 54) reported 
HbA1c as an outcome measure. Assah et al (48) reported a greater reduction in HbA1c in the 
peer-led intervention than the control group (difference = -1.7%, 95%CI: -2.2 to -1.3%, p<0.001). 
The other three studies with significant improvements were quasi-experimental in design. Micikas 
et al. and Baumann et al. (49,50) reported the mean HbA1c decreased from 10.1% and 11.1% at 
 167 
 
baseline to 8.9% and 8.3% at four months (p=0.01 and p=0.005) respectively. Less et al. (54) 
reported a reduction of 0.6% in mean HbA1c in the intervention group between baseline and six-
month values and an increase of 0.6% in the control group, with the difference being statistically 
significant after controlling for potential confounders (p<0.05). (54)  
Fasting blood glucose levels 
 Only Eggermont et al. (52) reported on blood glucose outcomes. The study demonstrated a 
statistically significant reduction in fasting blood glucose (10.0 mmol/l to 7.7 mmol/l, p<0.001) two 
years after baseline,  
Blood pressure:  
 Two studies reported on blood pressure. Eggermont et al. (52) identified significant reductions in 
systolic (134 to 124 mmHg, p<0.001) and diastolic (85 to 77 mmHg, p<0.001) blood pressure. In 
contrast, Baumann et al. (50) reported that diastolic (85-76 mmHg, p<0.001) but not systolic (146-
140 mmHg, p=0.25) blood pressure decreased significantly in the intervention group compared 
to the control group.   
BMI  
There was no difference found between- or within-group changes in BMI in the four studies where 
BMI was assessed. (49,52-53) 
Behavioural health outcomes  
Self-management care outcome  
 Three studies reported on self-management care activities. Assah et al. (48) found a significantly 
increased level of self-care activities in the intervention compared to the control group (p < 0.001). 
Baumann et al. (50) reported that the adherence to the eating plan improved from pre- to post-
intervention (p<0.005), which was measured regarding a ‘healthy eating index’ created by the 
authors. However, there were no significant pre-/post-intervention changes in physical activity, 
missed medication, helpfulness of social support, emotional well-being, confidence, and barriers 
to self-care. Shen et al. (53) reported that overall self-management activities were significantly 
higher in the intervention group compared to the control group. However, self-management of diet 
and medication did not differ significantly between the two groups at four and twelve weeks. These 
analyses were adjusted for baseline variables and multiple comparisons.  
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Only Shen et al. (51) reported a reduction in the number of visits to a doctor (MD -0.73, p=0.03) 
and a community health centre (MD -0.60, p=0.03) in the intervention compared to the control 
group. However, there were no significant differences in the number of visits to the emergency 
room, the frequency of hospitalisation, or the days of hospitalisation between the groups at four 
or twelve weeks. 
 Physical activity  
One study, by Micikas et al., (49) reported on physical activity. The study did not observe 
significant changes in the proportion of patients who exercised for ≥30 minutes per day after four 
months of the intervention (20% to 18%, p=0.811). 
Psychological health outcomes  
Self-efficacy 
 One study reported on self-efficacy. Baumann et al. (50) measured various aspects of self-
efficacy including overall self-efficacy, and self-efficacy relating to diet, exercise, medication use, 
blood glucose testing, foot care, and hyperglycaemia/hypoglycaemia. At four weeks and twelve 
weeks, overall self-efficacy (both p<0.021) and self-efficacy relating to blood glucose testing (both 
p<0.005), foot-care (both p<0.001) and hyper-/hypoglycaemia (both p<0.001) were significantly 
higher in the intervention compared to the control group. 
Diabetes knowledge 
One study reported on diabetes knowledge. Micikas et al. (49) reported that the intervention (over 
four months) significantly improved diabetes knowledge about targets for HbA1C (6% to 42%, 
p=0.001); fasting blood glucose (19% to 87%, p=0.001); and the foods that raise blood glucose 
levels (13% to 31%, p=0.032). However, knowledge about the impact of emotions on blood 
glucose levels did not improve (p=0.687). 
Depression, diabetes distress, quality of life 
Two studies reported on these measures.  Shen et al. (51) measured depressive status 
subdivided into ‘overall depressive status’, ‘unhappy status’, ‘somatic status’, ‘interpersonal 
status’, ‘depressed affect status’. The mean score for ‘unhappy status’ decreased significantly in 
the intervention group between 4 and 12 weeks (p=0.037), while it did not change in the control 
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group (p=0.26). However, there were no significant differences between the intervention and 
control groups regarding ‘overall depressive status’, and ‘somatic’, ‘interpersonal’ and ‘depressed 
affect status’. Rotheram-Borus et al. (53) evaluated diabetes distress in terms of coping skills, 
which was significantly improved between baseline and three months, but not between three and 
six months. Furthermore, spiritual hope decreased between three and six months (p<0.01).  
Social support 
Two studies reported on social support. Shen et al (51) identified that the intervention group had 
significantly higher overall social support (both p<0.001), information and emotional support (both 
p<0.001), positive interaction (both p<0.001), and affectionate support (both p<0.001) compared 
to the control group assessed at four and 12 weeks. However, the peer intervention failed to 
improve tangible support significantly (include assisting with transportation, helping with 
household chores, helping to prepare food, providing physical care, and providing financial help) 
at the same time intervals four and twelve weeks. Rotheram-Borus et al. reported improvements 
in social support (p<0.01) and positive action coping style (p<0.01) after three months. (53) 
8.7.5. Implementation fidelity of all the included studies 
Implementation fidelity refers to the extent to which a proposed intervention is enacted as 
designed. This measure is essential to determine to which extent the intervention in question is 
the primary mechanism underlying any changes observed (42,43). Table 5 summarises the 
adherence, moderators and assessment fidelity of the included studies in this review.  
The moderators of fidelity refer to factors which may influence or moderate the degree of fidelity 
with which an intervention is implemented such as intervention complexity, facilitation strategies, 
quality of delivery, and participant responsiveness. (43, 55) We were able to monitor fidelity in 
three studies, which had published protocols. (45, 47, 51) The most frequently used indicator of 
fidelity was adherence (to the content, frequency and duration of the intervention). (45, 47, 51)  
Three studies (45,47,51) refer to facilitating strategies to increase the implementation quality. In 
one study (47) the quality of the program delivery was used as a moderator. Overall, three studies 
(45, 47,51) used a questionnaire or interviews completed by the participants and providers. Two 
studies (47,51) combined a direct observation, recording of sessions and self-reported measures 
(questionnaire or interviews completed by the participants and providers) to assess the adherence 
to the program content.  
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Measured (+), None (-).   NPCHW: Non-professional community health workers               
 
Table 8–3 Assessment of implementation outcomes of diabetes self-management peer support strategies in LMIC by mode of intervention delivery. 
Mode of 
delivery  
Domain   Study 
design  
Acceptability Adoption Appropriateness Feasibility Implementation 
Cost 
Penetration Sustainability Available measurement/s 
Peer  Zhong 2015 
 (45) 
RCT   (+) (+) (+) (+) (-) (+) (+) focus groups/ 
interviews/report/records 
Gargliardino, 2014 
(46) 
RCT  
 
(-) (-) (-) (+) (-) (-) (-) Structured 
questionnaire/interviews 
Assah, 2015 (48) Non-RCT 
With a 
control arm  
(-) (-) (-) (-) (-) (-) (-) Structured questionnaires 
Baumann 2014 (50) Pre/post  (+) (-) (-) (+) (-) (+) (+) Report/ phone records/ 
questionnaires 
Huixia Shen 2008 
(51) 
Pre/post (+) (-) (-) (+) (-) (-) (-) Focus 
groups/report/records/ 
questionnaire 
Eggermont N 2011 
(52) 
Pre/post (-) (-) (-) (-) (-) (-) (-) Structured questionnaire/ 
in-depth interviews 
Rotheram-Borus 
2012 (53) 
Pre/post  (+) (-) (-) (+) (-) (-) (-) Structured 
questionnaire/interviews 
NCHWS Mash, 2014  
 (47) 
RCT (-) (-) (-) (-) (-) (-) (-) Interviews/report/records/ 
questionnaire 
 Micikas M, 2014 
(49) 
Pre/post  (+) (-) (-) (-) (-) (-) (-) Focus groups/ Structured 
questionnaires 
 Less 2010 (54) Pre/post  (-) (-) (-) (-) (+) (-) (+) Structured questionnaire 
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↔ = no statistically significant differences   ↑= Significant increase ↓= Significant decrease   NR=not reported, HbA1C: glycated 
haemoglobin, FBG/PPG: Fasting glucose and 2-hour postprandial glucose, BP: blood pressure, BMI: Body Mass Index, NR: Not Reported. 
 
 
 
Table 8–4 Summary of intervention effects on clinical, behavioural and psychological outcomes by study design 
Authors year 
 
Zhong 
2015 
(45) 
Gargliardi
no 2014 
(46) 
Mash 
2014 
(47) 
Assah 
2015 
(48) 
 Micikas 2014 
(49) 
Baumann 
2014 
(50) 
Huixia 2008 
(51) 
Eggermont 
2011 
(52) 
Rotheram-
Borus 2012 
(53) 
Less 2010 
(54) 
Design RCT RCT RCT Non-
RCT 
wth 
control 
Pretest-
posttest 
(one-group) 
Pretest-
posttest 
(one-group) 
Pretest-
posttest 
with 
comparison 
group 
Pretest 
posttest 
(one-group) 
Pretest-
posttest 
( one-group) 
Pretest-posttest 
with comparison group 
Sample size n=229 
C:94 
I:135 
n=198 
C:105 
I: 93 
 
n=1570 
C: 860      
I:710 
 
n=200 
C: 96 
I:96 
 
n=100 
 
n=46 
 
n= 181 
C: 89 
I:92 
 
n=3078 
 
n=19 
 
 
n=:318 
C: 159 
I:159 
Duration of diabetes (year) 9.3  6 NR NR  NR 6.7 NR  NR NR 5-21 
Follow-up (months) 12 12 12 6  4 4 3 24 6 6 
HbA1C NR NR ↔ ↓  ↓ ↓ NR NR NR ↓ 
FBG/PPG ↓ NR NR NR  NR NR NR ↓ NR NR 
BP ↓ NR ↓ NR  NR ↓ DBP NR ↓ NR NR 
BMI ↓ ↔ ↔ NR  ↔ NR NR ↔ ↔ ↔ 
Diabetes symptoms NR ↔ NR NR  NR NR NR NR NR NR 
Clinical visits/hospitalisation NR NR NR NR  NR NR ↔ NR NR NR 
Self-management activities ↔ NR ↔ ↑  NR ↔ ↑ NR NR NR 
Physical actvity NR ↔ NR NR  ↔ NR NR NR          NR NR 
Self-efficacy ↑ NR ↔ NR  NR NR ↑ NR NR NR 
Diabetes knowledge ↑ ↑    NR NR ↑ NR NR NR NR NR 
Depression NR ↔ ↔ NR NR NR ↔ NR ↔ NR 
Social support NR NR NR NR NR NR ↑ NR ↑ NR 
Quality of life NR NR ↔ NR NR NR ↔ NR NR NR 
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Table 8–5 Assessment of elements of implementation fidelity (Ref 43) 
Study by 
Mode of 
intervention 
Delivery 
Adherence  
 
Moderators  Assessment 
 Content Coverage Frequency Duratio
n 
Intervent
-ion 
complex-
ity 
Facilit-
ation 
strateg-
ies 
 
Quality 
of 
deliver
y 
Participant 
responsive-
ness 
Direct 
observ-
ation 
Audi
o/vid
eo 
tap 
Provider 
question 
naire or 
checklist 
Provider 
interview 
Participants 
questionnaire 
Participant
s interview 
Peers  
Zhong 2015 
(45)     
✓ NA ✓ ✓ ✓ ✓ NA ✓ NA ✓ NA ✓ NA ✓ 
Gargliardino, 
2014 (46) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Baumann. 
2014 (50) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Huixia Shen 
2008 (51) 
✓ NA ✓ ✓  NA ✓ NA ✓ ✓ ✓ ✓ ✓ ✓ ✓ 
Eggermont N 
2011 (53) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Rotheram-
Borus 2012 
(53) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
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IF = Implementation Fidelity, NA = not assessed in the primary papers  
 
Assah, 2015 
(48) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
NCHWs 
Mash, 2014 
(47) 
✓  NA ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ - ✓ ✓ ✓ 
Micikas M, 
2014 (49) 
NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
Less 2010 (54) NA NA NA NA NA NA NA NA NA NA NA NA NA NA 
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8.7. Discussion   
 
This systematic review found that COMP-DSMPs were inconsistently associated with 
improvements in clinical (45-48, 51) behavioural (45-47,48- 5 ) and psychological (45- 48 ,50 ) 
outcomes in LMIC. There was high variability in reported outcomes. As a consequence, 
meaningful meta-analysis or comparisons were not possible.  The included studies only assessed 
short-term outcomes and no ‘hard-endpoints’ in terms of co-morbidity, microvascular, 
macrovascular events and mortality were reported.  
Most included studies were of low-quality design with significant risks of bias particularly in relation 
to the blinding of outcomes. Furthermore, the majority of the non-RCT studies did not address 
issues surrounding selection bias or gave insufficient information regarding the selection process. 
The strategies employed were often not described in much detail and were poorly or not assessed 
regarding implementation fidelity. Finally, most of the studies reporting on clinical outcomes only 
evaluated the outcomes in terms of statistical significance and not clinical relevance. These 
results are discussed here in terms of implications for health care delivery, as well as implications 
for future design and implementation of studies of COMP-DSMPs in diabetes care delivery in 
LMIC. 
 Current literature, mainly from HIC supports the findings from this review that effects of-of COMP-
DSMPs are equivocal. A systematic review by Webel et al. reported major heterogeneity between 
studies both in outcomes and designs, (56) while Dale et al. reported that peer-support seemed 
to benefit some adults living with diabetes, but suggested that the evidence was inconsistent and 
inadequate to support firm recommendations. (57) Large RCTs in HIC (58, 59) have also reported 
modest benefits for some, but not all outcomes assessed.  
Throughout our analysis of the nature of the implementation strategies, we relied on the 
framework developed by Proctor et al. (40) While most of the studies touched on five of the six 
dimensions included in the taxonomy adapted for this study, none directly followed the Proctor 
framework and thus did not readily lend themselves to being evaluated using this framework. 
Further, none of the studies described temporality. This is at odds with the suggestion of Proctor 
et al. (40) that temporality be considered by researchers planning implementation/intervention 
programs and applied systematically across study populations, unless otherwise stated, to ensure 
that the experimental conditions are the same.  Temporality can be a critical factor contributing to 
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the effectiveness of an implementation strategy, because peers'/CHWs’ skills, knowledge, and 
engagement may decrease over time if not employed.  
Few existing studies have employed Proctor’s framework. Yet studies such as that of  Powel et 
al. (60) illustrate the value of using such a standardised framework when they adopted the 
framework  to report on a diabetes quality improvement intervention in its original commercial 
care setting and in community health care centres, in which actors, action, temporality, and dose 
were adapted to fit the local context. (60) The models of peer/CHW-led program need to be further 
explored, especially given the inevitability of a professional healthcare workforce shortage in 
LMIC. 
Furthermore, COMP-DSMPs have the potential to fulfil the ideals of ‘triple aims of health care’ 
defined by the Institute for Healthcare Improvement, which involves improving a patient’s 
experiences of care, improving the health of populations, and reducing per capita costs of care. 
Thus, COMP-DSMPs for diabetes deserve more attention. (61) Future studies should include an 
assessment of cost-effectiveness due to the limited data on this aspect of COMP-DSMPs. A 
single study in HIC from the UK  revealed no significant differences in the final cost-effectiveness 
endpoints for a group-based peer support intervention for type 2 diabetes in general practice. (62) 
Mash et al. found that a structured group education programme delivered by health promotors. at 
primary care clinics in South Africa for the management of Type 2 diabetes was cost-effective 
(63) Ideally, it would be important to assess cost-effectiveness in terms of traditional hard 
outcomes such as mortality and micro- and macro-vascular complications, but the longer length 
of follow-up and large sample sizes are likely to be costly. (63)  
8.8. Conclusion 
The evidence supporting the use of PSMSPs for people with diabetes in LMICs is equivocal.. We 
recommend well-designed studies using a framework such as the MRC framework for the 
development and evaluation of complex interventions to inform the evidence base on the 
contribution of COMP-DSMP in LMIC. 
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Chapter 9 
SUMMARY AND CONCLUSIONS 
 
IMPLICATIONS FOR POLICY, PRACTICE AND FUTURE RESEARCH 
 
9.1. Chapter outline  
This body of work aimed to inform the development of a self-care management programme for 
older people attending public sector primary healthcare services in Cape Town, South Africa 
based within the PRECEDE planning model. This chapter summarises the main findings of the 
various studies which form part of this thesis. It also presents the implications of the findings for 
policy and practice, recommendations for future research, and strengths and limitations.  
9.2. Principal findings 
The key results framed within the PRECEDE planning model in this study are presented in Figure 
9–1. 
1. Epidemiological assessment 
The systematic review of the prevalence of diabetes mellitus, the first estimate of the burden of type 
2 diabetes among older people (>55yr) in Africa, found that type 2 diabetes is not rare in individuals 
of this age group across the continent (overall prevalence was 13·7 % (95% CI 11·3–16·3). In 
addition, the estimated prevalence of diabetes was twofold higher in studies that used an OGTT than 
in those that used FPG to diagnose diabetes, and that non-STEPs studies showed a prevalence 1.6 
times higher than STEPS studies. The following data were not part of the planned epidemiological 
assessment but do provide important epidemiological insights. In an analysis of SAGE South Africa 
Wave 1 data, a 9.2% prevalence rate of self-reported diabetes was found and individuals with 
diabetes had at least twofold higher rates of coexisting chronic conditions than those without 
diabetes. 
 
 
 
 182 
 
2.Social assessment  
From the analysis of SAGE South Africa Wave 1 data, self-reported diabetes was associated with a 
lower quality of life and greater disability amongst older South Africans. Further, diabetes 
represented not only a risk factor for disability but was associated with a wide range of impairments 
and co-morbidities predisposing to loss of autonomy, as were sociodemographic characteristics (low 
education, being in a low wealth quintile, having a poor employment history, not being in a 
partnership), lifestyle habits (low physical activity, alcohol use) and co-morbid conditions. 
Nevertheless, study participants with and without diabetes who had a high level of physical activity 
were found to have higher quality of life scores. 
3.Educational and ecological assessment 
In the cross-sectional study of 406 adults aged 60 years or more undertaken in the Cape Town 
Metropole primary care clinics, half of the participants had a poor knowledge level in relation to 
symptoms and complications of diabetes, but most participants received family support to follow 
aspects of diabetes self-management. Subsequent regression analyses showed older age was 
negatively associated with knowledge, higher income was associated with self-management 
practice and family support was positively associated with the score for a number of specific self-
management practices as well as with a knowledge score. This may be of an advantage in many 
cultures, such as in South Africa, where strong family relationships and informal care from family 
and friends are essential and highly valued. 
4.Administrative, policy and intervention-alignment assessment 
 Step A: To get an understanding of current policies and programmes that relate to older people 
with diabetes, a review of policies and programmes and qualitative individual interviews with key 
informants (KI) were conducted. There was a consensus among KIs that generally older persons 
wanted to be ‘compliant’, but they faced numerous barriers in managing their condition. There are 
multiple efforts to re-orientate the healthcare system to focus more effectively on NCDs for the 
population, which would benefit older patients with diabetes. 
 Older people were keen to engage on matters relating to their health, thereby making it feasible 
for health care providers to interact with older persons and play a more active role in enhancing 
health literacy, health promotion and self-management. What was not mentioned by the key 
informants – but which may be of equal importance – is that healthcare providers need to gain 
appropriate communication skills and educational resources to effectively educate and counsel 
older persons on lifestyle behaviour change and self-care. The current gaps in knowledge of 
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diabetes in this population group it is critical for establishing evidence-based practice which 
necessitates identifying research priorities, allocating resources, and setting health care policies.   
Step B:  
The second systematic review explored community-based peer and community health worker-led 
diabetes self-management programmes (COMP-DSMP) in low and middle-income countries’ 
(LMIC) primary care settings and evaluated implementation strategies and diabetes-related 
health outcomes. The main review findings were that the effects of COMP-DSMP were equivocal. 
While these findings are in keeping with studies from High-Income Countries, many of the studies 
included in the review were evaluated as being of a low quality.   
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  Figure 9–1 Application of PRECEDE planning model   for development self-management care for older people in Cape Town City, South Africa    
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9.3. Implications for policy and practice 
 
The work underpinning this thesis has a number of implications for policy and practice.  
There is a clear need to invest in surveillance, diabetes prevention, and creation of affordable, 
innovative models of health-care access and systems to halt the growing burden of diabetes in 
Africa. 
For successful monitoring of secular trends in the incidence and prevalence of diabetes in older 
people, associated with the epidemiological transition across all African countries, the use of 
standardised methods is necessary. National and not subnational samples should be studied. 
While using the OGTT would be ideal in epidemiological studies of older people, this is not likely 
to be implementable across the region due to cost and inconvenience. HbA1c would be the 
simplest indicator, as it avoids the need for fasting and measurement of glucose concentrations 
at two hours for an OGTT, but the cost and lack of data regarding the diagnostic cut point in Africa 
are among the potential barriers. There will need to be general acknowledgement that the use of 
FBG alone will underestimate the true prevalence and thus burden. 
 
Thisstudy highlights a need to fill gaps in the knowledge towards improving quality of life and 
meeting care needs in older persons with diabetes. Multimorbidity is common among the older 
persons, the management of which requires integration and coordination of chronic care services.  
Poor health literacy related to low educational attainment and limited access to information among 
older persons is a known contributing factor to suboptimal diabetes outcomes among this group. 
There is a need for educational material to be provided in the form of simple messages, delivered 
in a style that engages the person with diabetes and is personalised to their needs, with the 
emphasis on what he/she needs to know, rather than all there is to know about diabetes. This 
study recommends sustainable policies to promote healthy lifestyle behaviours, increase physical 
activity and manage health conditions, across the life course. This requires identifying research 
priorities, allocating resources, the designing and testing of new integrated care models targeted 
at older people within the roll-out of universal health coverage. 
In this study social support was positively associated with better knowledge and diabetes self-
management practices. Consideration needs to be given to developing and evaluating education 
programmes that focus on the needs of older persons with diabetes and emphasises the role of 
family and friends. For instance, groups held outside of primary care clinics in the community and 
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led by trained CHWs may be a better option, so too may the active participation by family 
members in these groups. It is imperative to introduce such programmes at a younger age so that 
diabetes self-management strategies are embedded as a life course perspective to enhance 
positive outcomes for persons living with diabetes.  
The models of a peer/community health worker-led programme need to be further explored, 
especially given the inevitability of a professional healthcare workforce shortage in LMICs, 
particularly in the public sector primary health care services in South Africa. Furthermore, 
community-based peer and community health worker-led diabetes self-management 
programmes (COMP-DSMPs) have the potential to fulfil the ideals of ‘triple aims of healthcare’ 
which involves improving a patient’s experiences of care, improving the health of populations, and 
reducing per capita costs of care. Thus, COMP-DSMPs for diabetes deserve more attention. As 
clearly documented by the key informants in this study, the establishment of community-based 
services to provide self-management support, promote health and easy access to medicine, as 
well as home visits by district-based CHWs, help to overcome many of the barriers to care 
experienced by older persons. It enables services to be delivered early and close to home, 
decreases waiting times, reduces transport and other associated costs for older persons and 
provides for continuity of care.   
    9. 4. Implications for future research 
First, a dearth of research as evidenced in the systematic reviews in this study on leading health 
issues such as diabetes in older adults in sub-Saharan African countries impacts health policy 
and planning. Evidence-based policy and planning on services for older clients is underdeveloped 
or lacking in the sub-continent, partially due to epidemiological and demographic transitions being 
recent and more rapid than in high-income countries and as well as to competing interests for 
resources. Second, future studies should assess the prevalence of type 2 diabetes according to 
uniform case definition and diagnostic methods and provide standardised prevalence values for 
older people across Africa to enable comparisons within countries and across the continent. 
Third, future research must focus on care models that improve outcomes in this age group while 
preserving (and improving) the quality of life. This should be guided by outcomes relevant to the 
patient group and their families. Future research should focus on developing and evaluating 
family/friends-focused community-based multi-disciplinary education programmes and on 
improving self-care practices among older individuals attending primary care clinics. Fourthly, 
qualitative research is required to address in depth those research questions which relate to the 
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impact of factors such as retirement, low income, living arrangements, age-friendly vs ageist 
attitudes of health professionals towards older clients, and the promotion of health behaviours. 
Fifth, this study recommends well-designed studies using a framework such as the MRC 
framework for the development and evaluation of complex interventions to inform the evidence 
base on the contribution of COMP-DSMP in LMICs, particularly in a limited-resource setting such 
as the public sector primary health care services in South Africa.  
9.5.  Strengths and limitations of this research study     
This study contributes to an understanding and fills a gap in the current knowledge of a number 
of issues relating to diabetes in the older person in South Africa and particularly relating to 
diabetes self-management practices, and perceived social support from family and friends for 
their care. However, the study has some limitations. Ideally, the work would have progressed to 
the PROCEED or implementation phases of the PRECEDE-PROCEED model but due to limited 
resources available for the present body of work, only the (PRECEDE) four phases (phase 1–
phase 4) were conducted.  For pragmatic reasons, the lower age for definition for the older person 
was not consistent across all the studies. For example, the systematic review of the prevalence 
of diabetes in Africa included people of 55 years and older because of lack of consistency in the 
age bands used in many studies from the region. The SAGE survey included people over the age 
of 50 years, but analyses included different age groups above this age.  
The studies based on the SAGE survey and in community health centres in Cape Town were both 
cross sectional and as such could not assess cause and effect. In the latter, the measurements 
were self-reported rather than direct observation of self-care practices and, the use of a 
convenience sample drawn from a population who attend a diabetes clinic excludes those who 
did not attend. Because of the small number of key informants interviewed and its limitation to 
one region only, the study may not be representative of all older South Africans with diabetes, 
thus impacting on the generalisability of the findings.  
The lack of in-depth interviews and focus group discussions with older people with diabetes and 
their support network would have added to a better understanding of enablers and barriers to 
effective self-management. Lastly, rigorous methods were used in the systematic reviews, 
however, for the systematic review on the effectiveness of peer and COMP-DSMP in LMICs, the 
differences in study designs, outcomes, the scale of measurements, and measurement times 
precluded meta-analysis and only provided for a narrative summary of the findings across studies.  
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The study does, however, have a number of strengths. It was undertaken within a well-recognised 
model used in health promotion, it made use of a mixed methods approach, including rigorous 
methods for the systematic reviews and has focused on a group that has received little attention 
to date.  
In conclusion, this research study has described the extent of the proposed need for developing 
and evaluating education programmes that focus on older people with diabetes mellitus and 
emphasises the role of family and friends. Whilst there have been some significant policy 
interventions pertaining to the protection of the health and welfare of older persons in SA, the 
needs of this vulnerable group remain relatively low on the list of priorities in terms of focus and 
resource allocation. In this context, older people, as a distinct group, are also not a strong focus 
in current health policy relating to the provision of NCD care. This thesis alerts policymakers and 
clinicians to some of the specific issues considered to be pertinent and important in the care and 
management of older persons with diabetes. Many of these would also be applicable to older 
individuals with other chronic conditions.
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 Appendix 6:  DATA EXTRACTION FORM 
                    
                                                           
STUDY ID: 
  
Reviewer’s Initials                                                                                         
                                                    Part 1: COVERSHEET 
Study Title:  
Journal: 
 
Language: 
                                                           Citation:        
 
 
 
Part 2: STUDY CHARACTERISTICS. 
Publication Year: Country of study: 
  Study design: 
 
                   cross-sectional 
           
                  case-report 
                     
                  other __________________   
 
Study period: 
  
Data source:                                  Setting  
          
       medical records                        Urban     
          
      special survey                            Rural  
          
      multiple source 
           
      surveillance 
           
       registries 
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Population study:  
 
                   total population 
                   
                 specific group population 
                   
                 other __________________ 
 
Diagnostic Criteria. 
 
❖ WHO Criteria: (Y / N). 
❖ Measured or Defined by: 
• Fasting plasma glucose (FPG)  
• glucose tolerance test (OGT)   
• Self-reported                          
 
Age groups included (describe): 
 
 
 
 
Genders included:          (Total numbers) 
          
Male         
 
Female     
 
Both         
 
 
Dominator (s) (N): 
 
❖ Please use the attached checklist (Tick as appropriate (√) 
 
Inclusion criteria:                             
 
Exclusion Criteria:                          
 
Included         Excluded        pending   
 
Reason(s) for exclusion, uncertainty or to contact 
authors 
 
 
 
 
 
 
 
 
                                          Part 3: RESULTS. 
 
Measure of the prevalence 
         
          Crude Measure 
        
          Adjusted measure 
 
 
If adjusted what factors were adjusted for in this study (list): 
 
 
 
 
 
1.  
2. 
3.  
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Reported measure of the prevalence:  
 
 
 
 
 
 
 
 
 
 
 
 
 
Missing data to be reported from the author: 
(any communication with author Yes       No    
If yes, pleases specify  
 
 
 Other comments:                                                        
                                                
 
 
 
 
 
 
 202 
 
Appendix 7:  Summary of risk of bias of the included studies. 
 
    
Country Author/Year Risk 
of bias 
1 
Risk 
of bias 
2 
Risk 
of bias 
3 
Risk 
of bias 
4 
Risk 
of bias 
5 
Risk 
of bias 
6 
Risk 
of bias 
7 
Risk 
of bias 
8 
Risk 
of bias 
9 
Risk 
of bias 
10 
Overall 
risk of bias 
Algeria Malek  2001 
 
Low Low Low Low Low Low Low Low Low Low Low 
Algeria Zaoui 2007 Low Low Low Low Low Low Low Low Low Low Low 
Algeria 2003 NCS NCS Low Low Low Low Low Low Low NCS Moderate 
Angola Evaristo 2012 Low Low Low Low Low Low Low Low Low Low Low 
Benin 2008 Low Low Low Low Low Low Low Low Low Low Low 
Botswana 2007 Low Low Low Low Low Low Low Low Low Low Low 
Cameroon Nchanchou 
2008 
Low Low Low Low Low Low Low Low Low Low Low 
Canary 
Islands 
Boronat 2005 Low Low Low Low Low Low Low Low Low Low Low 
Congo 2004 Low NCS NCS NCS Low Low Low NCS Low NCS High 
Eternal Validity   Internal Validity 
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DRC Onkin  2008 Low Low Low Low Low Low Low Low Low Low Low 
DRC Katchunga 
2012 
Low Low Low Low Low Low Low Low Low Low Low 
DRC 2006 High Low Low High Low Low Low Low Low High Moderate 
Egypt 2006 Low Low Low Low Low Low Low Low NCS NCS Moderate 
Ethiopia Muluneh 2012 Low Low Low Low Low Low Low Low Low Low Low 
Ethiopia Tran , 2011 Low Low NCS NCS Low Low NCS NCS NCS NCS High 
Gabon 2009 NCS NCS Low Low Low Low Low Low NCS Low Moderate 
Ghana Amoah,,2002 High NCS NCS High Low Low High Low NCS NCS High 
Guinea Balde 2007 Low Low Low Low Low Low Low Low Low Low Low 
Kenya Ayah 2013 Low Low Low Low Low Low Low Low Low Low Low 
La Reunion Favier  2005 Low Low Low Low Low Low Low Low Low Low Low 
Libya Kadiki  2001 Low Low Low Low Low Low Low Low Low Low Low 
Libya 2009 Low Low Low Low Low Low Low Low Low Low Low 
Malawi 2010 Low Low Low NCS Low Low Low Low Low Low Low 
Mayotte Solet  2011 Low Low Low Low Low Low Low Low Low Low Low 
Mauritania 2006 Low Low Low High Low low Low Low NCS NCS Moderate 
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NCS (Not Clearly Stated) 
Mauritius 2006 Low Low Low Low Low Low Low Low Low High Low 
Mozambique Silva-
Matos2011 
Low Low Low Low Low Low Low Low NCS NCS Moderate 
Niger 2006 Low High Low NCS Low Low Low Low Low NCS Moderate 
Nigeria Ekpenyong 
2012 
 
Low Low Low Low Low NCD NCS Low Low Low Moderate 
Seychelles Faeh  2007 Low Low Low Low Low Low NCD Low Low NCS Moderate 
South Africa Motala 2008 Low Low Low Low Low low Low Low Low Low Low 
South Africa Erasmus 2012 Low Low Low Low Low Low Low Low Low Low Low 
South Africa Peer 2012 Low Low Low Low Low Low Low Low Low Low Low 
Sudan 2005 Low NCS Low Low NCS Low Low NCS Low Low Moderate 
Tchad 2008 Low High NCS NCS NCS Low NCS NCS High NCS High 
Togo 2010 Low Low Low Low Low Low Low Low Low Low Low 
Tunisia Bouguerra  
2007 
Low Low Low Low Low Low Low Low Low Low Low 
Tunisia Hammami 
2012 
Low Low Low Low Low Low Low Low Low Low Low 
Uganda Mayega 2013 Low Low Low Low Low Low Low Low Low Low Low 
Zambia 2008 Low High NCS Low NCS Low Low High NCS NCS High 
Zimbabwe 2005 Low Low NCS Low NCS Low Low NCS Low NCS Moderate 
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 Appendix 8: Assessment of risk bias in included studies
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Appendix 9: Forest plots of meta-analysis results, showing men prevalence for type 2 
diabetes among older people in Africa. 
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 Appendix 10 Forest plots of meta-analysis results, showing men prevalence for type 2 
diabetes among older people in Africa. 
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 Appendix 11 Forest plots of meta-analysis results, showing women prevalence for type 2 
diabetes among older people in Africa. 
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Appendix 12: Excluded Research Studies: 
 
 
 Excluded Research Studies: 
The application of the selection criteria resulted in 110 studies excluded from the systematic review. The primary reasons for the 
exclusion of studies were as follows:  
1. The study was not original research (e.g., Narrative reviews, opinion pieces, letters, or any other publications lacking primary 
data and/or explicit methods descriptions.) (n = 26),  
2. The study did not use any of the study designs considered in the review (n = 6)   
3. The study did not report measurable data for the outcomes of interest (prevalence) (n = 21) 
4. The study did not target the populations of interest (n = 15) 
5. The study was not on Type 2 diabetes prevalence (n = 12) 
6. The study did not published with review period 2000-2013 (23)  
7. The study was not retrieved (n = 2) 
8. The study with poor quality rate  (n =5) 
Table 2 lists the excluded studies and the reason for their exclusion from the systematic review. 
Main reason for exclusion:  
 The study was not original research (N = 26 ) 
1. Îufº, À. (2007). Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab Jamahiriya. Eastern Mediterranean health 
journal, 13(1), 169. 
2. Motala, A. A., Omar, M. A., & Pirie, F. J. (2003). Epidemiology of type 1 and type 2 diabetes in Africa. European Journal of Cardiovascular 
Risk, 10(2), 77-83. 
3. Whiting, D. R., Hayes, L., & Unwin, N. C. (2003). Challenges to health care for diabetes in Africa. European Journal of Cardiovascular Risk, 
10(2), 103-110. 
4. Motala, A. A. (2002). Diabetes trends in Africa. Diabetes/metabolism research and reviews, 18(S3), S14-S20. 
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7. The study was not retrieved (n = 2) 
8. The study with poor quality rate  (n =5) 
Table 2 lists the excluded studies and the reason for their exclusion from the systematic review. 
  Main reason for exclusion:  
 The study was not original research (N = 26 ) 
1. Îufº, À. (2007). Profile of diabetes health care at Benghazi Diabetes Centre, Libyan Arab Jamahiriya. Eastern Mediterranean health 
journal, 13(1), 169. 
2. Motala, A. A., Omar, M. A., & Pirie, F. J. (2003). Epidemiology of type 1 and type 2 diabetes in Africa. European Journal of Cardiovascular 
Risk, 10(2), 77-83. 
3. Whiting, D. R., Hayes, L., & Unwin, N. C. (2003). Challenges to health care for diabetes in Africa. European Journal of Cardiovascular Risk, 
10(2), 103-110. 
4. Motala, A. A. (2002). Diabetes trends in Africa. Diabetes/metabolism research and reviews, 18(S3), S14-S20. 
5. Mohamed Ahmed, A., & Hassan Ahmed, N. (2001). Diabetes mellitus in Sudan: the size of the problem and the possibilities of efficient 
care. Practical Diabetes International, 18(9), 324-327. 
6. Gill, G. V., Mbanya, J. C., Ramaiya, K. L., & Tesfaye, S. (2009). A sub-Saharan African perspective of diabetes. Diabetologia, 52(1), 8-16. 
 
7. Sobngwi, E., Mauvais-Jarvis, F., Vexiau, P., Mbanya, J. C., & Gautier, J. F. (2001). Diabetes in Africans. Diabetes Metab, 27, 628-634. 
8. Hall, V., Thomsen, R. W., Henriksen, O., & Lohse, N. (2011). Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health 
implications. A systematic review. BMC public health, 11(1), 564. 
9. Bos, M., & Agyemang, C. (2013). Prevalence and complications of diabetes mellitus in Northern Africa, a systematic review. BMC public 
health, 13(1), 387. 
10. Bakoush, O., & Elgzyri, T. (2006). Do we have a diabetes epidemic in Libya? Libyan Journal of Medicine, 1(2), 123-125. 
11. Abubakari, A. R., & Bhopal, R. S. (2008). Systematic review on the prevalence of diabetes, overweight/obesity and physical inactivity 
in Ghanaians and Nigerians. Public health, 122(2), 173-182 
12. Levitt, N. S. (2008). Diabetes in Africa: epidemiology, management and healthcare challenges. Heart, 94, 1376-1382. 
13. Badran, M., & Laher, I. (2012). Type II diabetes mellitus in Arabic-speaking countries. International journal of endocrinology, 2012. 
14.  Oputa, R. N., & Chinenye, S. (2012). Diabetes mellitus: a global epidemic with potential solutions. African Journal of Diabetes Medicine 
Vol, 20(2). 
15. BeLue, R., Okoror, T. A., Iwelunmor, J., Taylor, K. D., Degboe, A. N., Agyemang, C., & Ogedegbe, G. (2009). An overview of cardiovascular 
risk factor burden in sub-Saharan African countries: a socio-cultural perspective. Globalization and health, 5(1), 10. 
16. Levitt, N. S. (2008). Diabetes in Africa: epidemiology, management and healthcare challenges. Heart, 94(11), 1376-1382. 
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17. Alhyas, L., McKay, A., Balasanthiran, A., & Majeed, A. (2011). Quality of type 2 diabetes management in the states of the Co-operation 
Council for the Arab States of the Gulf: a systematic review. PloS one, 6(8), e22186. 
18. Dalal, S., Beunza, J. J., Volmink, J., Adebamowo, C., Bajunirwe, F., Njelekela, M., & Holmes, M. D. (2011). Non-communicable diseases in 
sub-Saharan Africa: what we know now. International journal of epidemiology, 40(4), 885-901. 
19. Boutayeb, A., Lamlili, M. E., Boutayeb, W., Maamri, A., Ziyyat, A., & Ramdani, N. (2012). The rise of diabetes prevalence in the Arab 
region. Open Journal of Epidemiology, 2, 55. 
20. Sierra, G. N. (2009). The global pandemic of diabetes. African Journal of Diabetes Medicine, 17(11), 4-8. 
21. Ogle, G. D. (2001). Type 2 diabetes mellitus in Papua New Guinea-an historical perspective. Papua New Guinea Medical Journal, 44(3/4), 
81-87. 
22. Vlad, I., & Popa, A. R. (2012). Epidemiology of Diabetes Mellitus: A Current Review. Romanian Journal of Diabetes Nutrition and 
Metabolic Diseases, 19(4), 433-440. 
23. Azevedo, M., & Alla, S. (2008). Diabetes in Sub-Saharan Africa: Kenya, Mali, Mozambique, Nigeria, South Africa and Zambia. Int J Diab 
Dev Ctries, 28(4) 
24. Eschwege, E. (2000). [Epidemiology of type II diabetes, diagnosis, prevalence, risk factors, complications]. Archives des maladies du 
coeur et des vaisseaux, 93, 13-17. 
25. Kengne, A. P., Amoah, A. G., & Mbanya, J. C. (2005). Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation, 
112(23), 3592-3601. 
26. Elnasri, H. A., & Ahmed, A. M. (2008). Patterns of lipid changes among type 2 diabetes patients in Sudan. Eastern Mediterranean Health 
Journal, 14(2). 
 
 
   Main reason for exclusion:   
  The study did not use any of the study designs considered in the review (N=6) 
1. Bradshaw, D., Norman, R., Pieterse, D., & Levitt, N. S. (2007). Estimating the burden of disease attributable to diabetes in 
South Africa in 2000. S Afr Med J, 97, 700-706. 
2. Levitt, N. S., & Bradshaw, D. (2006). The impact of HIV/AIDS on type 2 diabetes prevalence and diabetes healthcare needs 
in South Africa: projections for 2010. Diabetic medicine, 23(1), 103-104. 
3. Joubert, J., Norman, R., Bradshaw, D., Goedecke, J. H., Steyn, N. P., Puoane, T., & Collaboration, S. A. C. R. A. (2007). Estimating 
the burden of disease attributable to excess body weight in South Africa in 2000. South African Medical Journal, 97(8), 683-
690. 
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4. Joubert, J., Norman, R., Lambert, E. V., Groenewald, P., Schneider, M., Bull, F., & Collaboration, S. A. C. R. A. (2007). Estimating 
the burden of disease attributable to physical inactivity in South Africa in 2000. South African Medical Journal, 97(8), 725-
731. 
5. FRANK, L. K., HERACLIDES, A., DANQUAH, I., BEDU-ADDO, G., MOCKENHAUPT, F. P., & SCHULZE, M. B. (2013). Measures of 
general and central obesity and risk of type 2 diabetes in a Ghanaian population. TM & IH. Tropical medicine & international 
health, 18(2), 141-151. 
6. Belmokhtar F, Belmokhtar R, Charef M (2011) Risk Factors Associated With Type 2 Diabetes Mellitus in West Region of 
Algeria, Maghnia. J Diabetes Metab 2:148. doi:10.4172/2155-6156.1000148 
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   Main reason for exclusion: 
The study did not report measurable data for the outcomes of interest (prevalence of type 2 DM) 
(N=21) 
 
1. Motala, A. A., Pirie, F. J., Gouws, E., Amod, A., & Omar, M. A. K. (2003). High incidence of Type 2 diabetes mellitus in South African 
Indians: a 10‐year follow‐up study. Diabetic medicine, 20(1), 23-30. 
2. Levitt, N. S., Steyn, K., Lambert, E. V., Reagon, G., Lombard, C. J., Fourie, J. M., ... & Hoffman, M. (1999). Modifiable risk factors for Type 
2 diabetes mellitus in a peri‐urban community in South Africa. Diabetic Medicine, 16(11), 946-950. 
3. Alberts, M., Urdal, P., Steyn, K., Stensvold, I., Tverdal, A., Nel, J. H., & Steyn, N. P. (2005). Prevalence of cardiovascular diseases and 
associated risk factors in a rural black population of South Africa. European Journal of Cardiovascular Prevention & Rehabilitation, 
12(4), 347-354. 
4. Roaeid, R. B., & Kablan, A. A. (2010). Diabetes mortality and causes of death in Benghazi: a 5-year retrospective analysis of death 
certificates. Eastern Mediterranean Health Journal, 16(1). 
5. Okafor, C. I., Fasanmade, O. A., & Oke, D. A. (2008). Pattern of dyslipidaemia among Nigerians with type 2 diabetes mellitus. Nigerian 
journal of clinical practice, 11(1), 25-31. 
6. Ejim, E. C., Okafor, C. I., Emehel, A., Mbah, A. U., Onyia, U., Egwuonwu, T., ... & Onwubere, B. J. (2011). Prevalence of cardiovascular 
risk factors in the middle-aged and elderly population of a Nigerian rural community. Journal of tropical medicine, 2011. 
7. Unachukwu, C., Babatunde, S., & Ihekwaba, A. E. (2007). Diabetes, hand and/or foot ulcers: a cross-sectional hospital-based study in 
Port Harcourt, Nigeria. Diabetes research and clinical practice, 75(2), 148-152. 
8. Ben, A. A., Thabet, H., Soltane, I., Gaha, K., Gaha, R., Tlili, H., & Ghannem, H. (2006). [Knowledge of patients with type 2 diabetes about 
their condition in Sousse, Tunisia]. Eastern Mediterranean health journal= La revue de sante de la Mediterranee orientale= al-Majallah 
al-sihhiyah li-sharq al-mutawassit, 13(3), 505-514. 
9. Mengesha, A. Y. (2008). Hypertension and related risk factors in type 2 diabetes mellitus (DM) patients in Gaborone City Council 
(GCC) clinics, Gaborone, Botswana. African health sciences, 7(4). 
10. Kasiam, L. O., Longo-Mbenza, B., Nge, O. A., Kangola, K. N., Mbungu, F. S., & Milongo, D. G. (2008). Classification and dramatic epidemic 
of diabetes mellitus in Kinshasa Hinterland: the prominent role of type 2 diabetes and lifestyle changes among Africans. Nigerian 
journal of medicine: journal of the National Association of Resident Doctors of Nigeria, 18(3), 311-320. 
11. Longo-Mbenza, B., On'kin, J. K. L., Okwe, A. N., Kabangu, N. K., & Fuele, S. M. (2010). Metabolic syndrome, aging, physical inactivity, 
and incidence of type 2 diabetes in general African population. Diabetes and Vascular Disease Research, 7(1), 28-39. 
12. Elhwuegi, A. S., Darez, A. A., Langa, A. M., & Bashaga, N. A. (2012). Cross-sectional pilot study about the health status of diabetic 
patients in city of Misurata, Libya. African health sciences, 12(1), 81-86. 
13. Danquah, I., Bedu-Addo, G., Terpe, K. J., Micah, F., Amoako, Y. A., Awuku, Y. A., ... & Mockenhaupt, F. P. (2012). Diabetes mellitus type 
2 in urban Ghana: characteristics and associated factors. BMC public health, 12(1), 210. 
14. Katchunga, P., Masumbuko, B., Belma, M., Kashongwe, M. Z., Hermans, M. P., & M'buyamba-Kabangu, J. R. (2012). Age and living in 
an urban environment are major determinants of diabetes among South Kivu Congolese adults. Diabetes & metabolism, 38(4), 324-
331. 
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Main reason for exclusion: The study did  not target the populations of interest (N = 15)          
 
1- Williams, J. W., Zimmet, P. Z., Shaw, J. E., De Courten, M. P., Cameron, A. J., Chitson, P., ... & Alberti, K. G. M. M. (2003). Gender 
differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabetic 
medicine, 20(11), 915-920. 
2- Gharbi, M., Akrout, M., & Zouari, B. (2002). Prevalence and risk factors of non-insulin-dependent diabetes mellitus in the rural and 
urban population of Tunisia. Revue d'épidémiologie et de santé publique, 50(4), 349. 
3- Aspray TJ, Mugusi F, Rashid S, Whiting D, Edwards R, Alberti KG. (2000).Rural and urban differences in diabetes prevalence in 
Tanzania: the role of obesity, physical inactivity and urban living. Trans R Soc Trop Med Hyg. Dec;94(6):637–44. 
4-  Cameroon Burden of Diabetes Project (Cambod) (2004): Baseline Survey Report. Ministry of Health, Cameroon; 2004. 
5- Djrolo, F., Houinato, D., Gbary, A., Akoha, R., Djigbénoudé, O., & Sègnon, J. (2012). Prevalence of diabetes mellitus in the adult 
population at cotonou benin. [Prévalence du diabète sucré dans la population adulte à Cotonou, Bénin] Medecine Des Maladies 
Metaboliques, 6(2), 167-169. Retrieved from 
15. Meiloud, G., Arfa, I., Kefi, R., Abdelhamid, I., Veten, F., Lasram, K., ... & Houmeida, A. O. (2013). Type 2 diabetes in Mauritania: 
Prevalence of the undiagnosed diabetes, influence of family history and maternal effect. Primary care diabetes, 7(1), 19-24. 
 
16. obngwi, E., Mbanya, J. C., Unwin, N. C., Porcher, R., Kengne, A. P., Fezeu, L., ... & Alberti, K. G. M. M. (2004). Exposure over the life 
course to an urban environment and its relation with obesity, diabetes, and hypertension in rural and urban Cameroon. International 
journal of epidemiology, 33(4), 769-776. 
17. Tran, A., Gelaye, B., Girma, B., Lemma, S., Berhane, Y., Bekele, T., & Williams, M. A. (2011). Prevalence of metabolic syndrome among 
working adults in Ethiopia. International journal of hypertension, 2011. 
18. Darkwa, S. (2011). Prevalence of diabetes mellitus and resources available for its management in the Cape Coast Metropolis. Journal 
of Health and Environmental Sciences Vol, 1(1), 1-7. 
19. Pastakia, S. D., Ali, S. M., Kamano, J. H., Akwanalo, C. O., Ndege, S. K., Buckwalter, V. L., ... & Bloomfield, G. S. (2013). Screening for 
diabetes and hypertension in a rural low income setting in western Kenya utilizing home-based and community-based strategies. 
Globalization and health, 9(1), 21. 
20. Aspray, T. J., Mugusi, F., Rashid, S., Whiting, D., Edwards, R., Alberti, K. G., & Unwin, N. C. (2000). Rural and urban differences in 
diabetes prevalence in Tanzania: the role of obesity, physical inactivity and urban living. Transactions of the Royal Society of Tropical 
Medicine and Hygiene, 94(6), 637-644. 
21. Lasky, D., Becerra, E., Boto, W., Otim, M., & Ntambi, J. (2002). Obesity and gender differences in the risk of type 2 diabetes mellitus 
in Uganda. Nutrition, 18(5), 417-421. 
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6- Nyenwe, E. A., Odia, O. J., Ihekwaba, A. E., Ojule, A., & Babatunde, S. (2003). Type 2 diabetes in adult Nigerians: a study of its 
prevalence and risk factors in Port Harcourt, Nigeria. Diabetes Research and Clinical Practice, 62(3), 177-185. 
7- Abubakari, A. R., Lauder, W., Jones, M. C., Kirk, A., Agyemang, C., & Bhopal, R. S. (2009). Prevalence and time trends in diabetes and 
physical inactivity among adult West African populations: The epidemic has arrived. PUBLIC HEALTH, 123(9), 602-614.Levitt, N. 
S., & Bradshaw, D. (2006). The impact of HIV/AIDS on type 2 diabetes prevalence and diabetes healthcare needs in South Africa: 
projections for 2010. Diabetic medicine, 23(1), 103-104. 
8- Rguibi, M., & Belahsen, R. (2006). Prevalence and associated risk factors of undiagnosed diabetes among adult Moroccan Sahraoui 
women. Public health nutrition, 9(6), 722-727. 
9- Duboz, P., Chapuis-Lucciani, N., Boëtsch, G., & Gueye, L. (2012). Prevalence of diabetes and associated risk factors in a Senegalese 
urban (Dakar) 
10- Muyer, M. T., Muls, E., Mapatano, M. A., Makulo, R., Mvitu, M., Kimenyembo, W., & Buntinx, F. (2011). Estimating prevalence of 
diabetes in a Congolese town was feasible. Journal of clinical epidemiology, 64(2), 172-181. 
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glucose level or diabetes and its correlates in Lusaka urban district, Zambia: a population based survey. Int Arch Med, 4(1), 2. 
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14- Eghan, B. A., Frempong, M. T., & Adjei-Poku, M. (2007). Prevalence and predictors of microalbuminuria in patients with diabetes 
mellitus: a cross-sectional observational study in Kumasi, Ghana. Ethnicity and Disease, 17(4), 726.Chicago. 
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Main reason for exclusion:  The study was not on type 2 diabetes. (N=12) 
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and thyroid autoantibodies in patients with autoimmune endocrine disease from Cameroon. Clinical Immunology, 118(2), 229-
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Appendix A: Summary statistics for WHOQoL 
Table A1. Summary statistics (mean and standard deviation) for WHOQOL (0-100) by covariates and diabetes 
status 
 
 
 
  
  
WHOQoL mean (std deviation) 
Factor Category All subjects Diabetics Non-
diabetics 
All subjects   47.4 (12.8) 46.9 (11.3) 47.4 (13.0) 
Diabetes No  47.4 (13.0)     47.4 (13.0)  
  Yes  46.9 (11.3)   46.9 (11.3)    
Sex Female  46.4 (13.0)   46.5 (11.3)   46.4 (13.2)  
  Male  48.6 (12.5)   47.9 (11.3)   48.7 (12.6)  
Age 50-59 years  47.7 (12.8)   46.5 (11.6)   47.8 (12.9)  
  60-69 years  47.2 (12.8)   45.7 (10.9)   47.4 (13.0)  
  70+ years  46.7 (12.9)   49.2 (11.3)   46.3 (13.1)  
Marital status Single  44.1 (12.9)   42.7 (11.1)   44.3 (13.1)  
  Married/cohabiting  49.5 (12.3)   49.2 (10.9)   49.5 (12.5)  
  Separated/divorced  44.2 (14.0)   44.9 (9.6)   44.2 (14.2)  
  Widowed  45.2 (12.7)   45.7 (11.4)   45.1 (12.9)  
Years of education 0-5 years  44.0 (11.6)   42.6 (9.5)   44.1 (11.8)  
  6-12 years  48.4 (12.6)   48.3 (11.4)   48.4 (12.8)  
  13+ years  55.7 (11.3)   56.0 (7.7)   55.6 (11.5)  
Ethnicity African/black  44.9 (11.9)   44.5 (11.2)   44.9 (11.9)  
  White  58.6 (10.5)   55.7 (6.7)   59.0 (10.9)  
  Coloured  50.8 (12.2)   50.8 (11.2)   50.8 (12.3)  
  Indian/Asian  49.5 (12.4)   48.7 (10.0)   49.7 (13.1)  
Same location Yes  46.8 (12.0)   47.7 (10.7)   46.8 (12.2)  
  No  47.8 (13.5)   45.9 (12.5)   47.9 (13.6)  
Past work Yes  48.2 (12.5)   48.0 (11.4)   48.2 (12.7)  
  No  42.3 (13.3)   41.6 (9.1)   42.4 (13.7)  
Wealth quintile poorest  40.2 (11.7)   37.9 (9.4)   40.3 (11.8)  
  second  44.1 (11.7)   41.0 (12.3)   44.4 (11.6)  
  middle  46.8 (12.3)   48.7 (10.4)   46.7 (12.4)  
  fourth  49.5 (11.5)   46.7 (10.5)   49.8 (11.5)  
  richest  55.5 (11.5)   52.6 (8.9)   55.9 (11.8)  
Tobacco No  47.4 (12.7)   47.0 (11.4)   47.5 (12.9)  
  Yes  47.2 (13.1)   46.9 (10.9)   47.2 (13.2)  
Alcohol No  47.7 (12.5)   47.7 (11.2)   47.7 (12.6)  
  Yes  46.3 (13.8)   41.9 (10.8)   46.6 (13.9)  
Physical activity Low  46.0 (12.8)   44.8 (11.2)   46.1 (13.0)  
  Moderate  49.8 (12.5)   47.3 (8.9)   50.0 (12.8)  
  High  49.8 (12.3)   55.0 (10.6)   49.4 (12.3)  
Arthritis No  48.5 (12.6)   47.3 (11.2)   48.5 (12.7)  
  Yes  44.0 (12.8)   46.5 (11.4)   43.5 (13.0)  
Stroke No  47.6 (12.7)   47.3 (11.4)   47.6 (12.9)  
  Yes  41.9 (13.8)   42.2 (8.9)   41.8 (14.6)  
Angina No  47.5 (12.8)   47.1 (11.3)   47.6 (12.9)  
  Yes  44.2 (13.2)   45.9 (11.3)   43.7 (13.7)  
Lung disease No  47.5 (12.7)   47.5 (11.2)   47.5 (12.9)  
  Yes  42.9 (15.2)   41.0 (10.4)   43.6 (16.6)  
Asthma No  47.7 (12.7)   47.6 (11.3)   47.7 (12.9)  
  Yes  41.5 (13.1)   40.5 (9.2)   41.7 (13.8)  
Depression No  47.5 (12.8)   47.2 (11.4)   47.6 (12.9)  
  Yes  41.4 (12.6)   42.2 (8.7)   41.3 (13.3)  
Hypertension No  47.7 (13.0)   47.3 (10.6)   47.8 (13.1)  
  Yes  46.5 (12.5)   46.8 (11.6)   46.4 (12.7)  
Cataracts No  47.3 (12.9)   46.6 (11.2)   47.4 (13.0)  
  Yes  49.1 (11.5)   51.3 (9.9)   48.2 (12.0)  
# chronic conditions 0  49.4 (12.4)   47.4 (9.4)   49.5 (12.5)  
  1  45.6 (12.9)   47.0 (12.6)   45.4 (13.0)  
  2  45.6 (13.2)   47.6 (11.3)   45.0 (13.6)  
  3+  44.0 (12.5)   47.1 (9.3)   42.9 (13.3)  
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Appendix B: Summary statistics for WHODAS 
Table A2. Summary statistics (mean and standard deviation) for WHODAS (0-36) by covariates and diabetes 
status 
              
  
  
WHODASi-r mean (std deviation) 
Factor Category All subjects Diabetics Non-
diabetics 
All subjects   20.5 (20.3) 25.6 (19.1) 20.2 (20.3) 
Diabetes No  20.2 (20.3)     20.2 (20.3)  
  Yes  25.6 (19.1)   25.6 (19.1)    
Sex Female  22.7 (20.6)   27.2 (18.7)   22.2 (20.7)  
  Male  17.8 (19.6)   22.4 (19.5)   17.6 (19.6)  
Age 50-59 years  15.8 (16.9)   19.4 (15.8)   15.8 (17.0)  
  60-69 years  22.0 (21.2)   29.2 (20.6)   21.3 (21.1)  
  70+ years  30.3 (22.8)   29.7 (19.1)   30.3 (23.1)  
Marital status Single  21.1 (18.9)   27.1 (15.7)   20.8 (19.2)  
  Married/cohabiting  17.8 (19.1)   23.1 (18.4)   17.4 (19.2)  
  Separated/divorced  22.6 (22.8)   12.8 (10.0)   23.4 (23.3)  
  Widowed  26.2 (21.8)   29.2 (20.8)   26.0 (21.7)  
Years of education 0-5 years  24.3 (21.4)   30.0 (20.9)   24.1 (21.4)  
  6-12 years  18.7 (19.0)   22.9 (17.8)   18.3 (19.1)  
  13+ years  11.6 (14.2)   27.8 (15.3)   10.5 (13.5)  
Ethnicity African/black  21.8 (20.4)   26.5 (18.5)   21.6 (20.6)  
  White  12.6 (15.9)   27.6 (16.3)   10.6 (14.8)  
  Coloured  18.9 (19.7)   13.9 (18.5)   19.5 (19.7)  
  Indian/Asian  26.7 (22.2)   32.6 (20.9)   25.2 (22.1)  
Same location Yes  20.1 (19.8)   23.5 (17.8)   20.0 (19.9)  
  No  21.8 (20.9)   29.2 (21.2)   21.1 (20.7)  
Past work Yes  19.4 (19.4)   23.0 (17.3)   19.0 (19.5)  
  No  27.5 (23.8)   39.1 (22.0)   26.9 (23.7)  
Wealth quintile poorest  23.9 (21.5)   35.2 (22.1)   23.8 (21.4)  
  second  21.6 (21.5)   29.5 (16.3)   21.0 (21.6)  
  middle  21.4 (20.1)   22.3 (18.5)   21.3 (20.3)  
  fourth  20.0 (18.8)   24.1 (19.2)   19.5 (18.7)  
  richest  16.2 (18.7)   23.2 (18.3)   15.3 (18.6)  
Tobacco No  20.9 (20.4)   27.5 (18.1)   20.1 (20.5)  
  Yes  20.2 (20.1)   18.4 (21.0)   20.3 (20.0)  
Alcohol No  20.7 (20.4)   25.2 (18.9)   20.2 (20.5)  
  Yes  20.6 (20.1)   28.3 (20.1)   20.2 (20.0)  
Physical activity Low  24.7 (22.2)   26.2 (20.1)   24.5 (22.4)  
  Moderate  16.6 (16.7)   27.5 (13.7)   15.5 (16.6)  
  High  13.4 (14.3)   17.5 (14.0)   13.1 (14.3)  
Arthritis No  17.4 (18.9)   21.4 (17.7)   17.2 (19.0)  
  Yes  30.5 (21.1)   30.7 (19.4)   30.4 (21.4)  
Stroke No  20.0 (19.8)   24.5 (18.4)   19.5 (19.9)  
  Yes  37.5 (23.6)   39.6 (22.8)   37.0 (23.8)  
Angina No  20.2 (20.1)   25.0 (18.5)   19.8 (20.2)  
  Yes  28.9 (21.1)   30.1 (22.3)   28.5 (20.8)  
Lung disease No  20.5 (20.2)   24.6 (18.8)   20.1 (20.3)  
  Yes  27.9 (20.7)   36.5 (18.7)   24.8 (20.7)  
Asthma No  20.2 (20.2)   25.5 (19.0)   19.7 (20.3)  
  Yes  29.4 (19.5)   26.4 (20.3)   30.1 (19.4)  
Depression No  20.4 (20.3)   24.8 (18.9)   20.0 (20.4)  
  Yes  29.9 (18.0)   39.6 (17.2)   27.8 (17.6)  
Hypertension No  18.3 (19.6)   21.4 (18.7)   18.2 (19.6)  
  Yes  26.0 (20.9)   27.4 (19.0)   25.6 (21.3)  
Cataracts No  20.4 (20.3)   25.3 (18.9)   19.9 (20.4)  
  Yes  25.4 (18.5)   23.2 (18.3)   26.2 (18.6)  
# chronic conditions 0  14.9 (18.0)   20.8 (16.1)   14.7 (18.0)  
  1  23.9 (20.2)   23.5 (19.0)   23.9 (20.3)  
  2  28.6 (21.3)   25.3 (19.2)   29.6 (21.8)  
  3+  33.5 (20.3)   30.8 (18.7)   34.4 (20.8)  
 223 
 
Appendix C: Distribution of WHOQoL (0-100 scale) 
 
Figure C1. Histogram of WHOQoL scores, with superimposed fitted normal distribution 
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Figure C2. Box-and whisker plots of WHOQoL scores (0-100 scale), stratified by diabetes status, 
sociodemographic factors, health risk behaviours, and number of chronic conditions
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Appendix D: Distribution of WHODAS (0-36 scale) 
 
Figure D1. Histogram of WHODAS scores, with superimposed fitted negative binomial distribution and zero-
inflated negative binomial distribution
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Figure D2. Box-and whisker plots of WHODAS scores (0-36 scale), stratified by diabetes status, 
sociodemographic factors, health risk behaviours, and number of chronic conditions 
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Appendix E: Methodology 
 
Data were analysed using R (version 3.1.3) and Stata (Stata/MP 13.1). The sampling design and probability weights 
were taken into account using R’s ‘survey’ package and Stata’s suite of  ‘svy’ commands .  
We assessed the association of diabetes and other factors with WHOQOL and WHODAS, as well as the moderation 
effects of diabetes, using generalised linear models.  WHOQoL and WHODAS were considered in turn. 
For WHOQOL, a standard multiple linear regression model was used. Estimated effect sizes captured the absolute 
change in the mean WHOQOL score as a factor changed from the reference category to the indicated category, holding 
all else equal – termed additive effects in the text. These impacts were allowed to differ by diabetes status. Initially 
diabetes was allowed to moderate all effects (see Appendix F for the full model), but in the main text a trimmed model 
is presented, where the moderation effects included are those where the initial model suggested evidence of moderation 
(p-values <0.1). 
For WHODAS, a zero-inflated negative binomial regression model was used to describe disability on a 0-36 count scale, 
with higher values indicating greater disability level. Within this framework, disability scores are split into two distinct 
groups. Firstly, there are the excess of 0 scores, corresponding to no disability, that result in a peak of scores at 0. This 
clustering of 0 values needs to be explicitly accounted for in the statistical model. Secondly, there are the remaining 
scores which range from 0 upwards and follow a standard statistical distribution (a negative-binomial distribution in this 
case). Two sets of effect sizes are thus reported:  Odds ratios (ORs) for the excess 0 scores, and multiplicative effects, 
a term used here to indicate the ratio change in the mean of the remaining scores. In the initial model, each factor was 
allowed to (independently) impact the OR, and the multiplicative effect allowed to differ by diabetes status (see 
Appendix G for the full model). In the main text, a trimmed model is presented: the moderation effects included are 
those where the initial model suggested evidence of moderation (p-values <0.1); an OR was included for a factor only 
where the initial model suggested evidence for this (p-values <0.1). Changes in factors that are associated with a decrease 
in disability can be identified by an OR greater than 1 (i.e. more scores are clustered at 0) and a multiplicative effect 
less than 1 (i.e. after accounting for and removing the excess of 0 scores, the average of the remaining scores is also 
smaller). Conversely, when the OR is less than 1 and multiplicative effect greater than 1, there are fewer excess 0 scores 
and the remaining scores are centered around a larger value, and there is greater disability.  
Model fit was assessed using residual plots (not shown here) and comparisons of observed and model-fitted means 
(see Appendix H for some outputs).  
Confidence intervals (CIs) for estimated model parameters are based on Wald-type intervals. The significance of 
terms was assessed using Wald tests, where small p-values suggest evidence of relationships (or rather evidence 
against the hypotheses of no relationships). 
List-wise deletion of observations with missing values resulted in 2848 observations for WHOQOL and 2866 
observations for WHODAS. The most common sources of missing values were: 570 for education, 492 for place of 
residence and 123 for physical activity.  
Estimated effect sizes and CIs are reported in the results, as well as two key p-values for each factor: (1) The p-value 
for ‘factor’ relates to testing whether that factor is related to well-being (WHOQOL or WHODAS) in any way. (2) The 
p-value for the ‘moderation effect’ relates to testing whether diabetes moderates the relationship between that factor and 
the well-being score – i.e. whether the relationship is different between individuals with diabetes and those without.  
Because testing for moderation is of interest, the dataset was not stratified into individuals with diabetes and those 
without, but rather all data used in the model. 
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Appendix F: Untrimmed regression model for WHOQoL 
Table F1: Association of diabetes, sociodemographic characteristics, self-reported health behaviours and 
comorbidities with WHOQOL (0-100) – original model before removing terms 
  
Additive effect / regression 
coefficient (95% CI) 
P-value1 
Factor Category Non-diabetic 
group 
Diabetic 
group 
Factor Moderation 
effect 
Diabetes 
  
No (ref)   4.6 (-1.4;10.7) <0.001  N/A 
Yes -4.6 (-10.7;1.4)   
Sex 
  
Female (ref) 
 
  0.086 0.373 
  Male -1.6 (-3.0;-0.2) -0.2 (-3.0;2.7) 
Age 
  
  
50-59 years (ref)     0.177 0.975 
  
  
60-69 years 1.7 (0.3;3.2) 1.3 (-2.4;5.0) 
70+ years 1.4 (-0.4;3.3) 1.1 (-2.9;5.1) 
Marital status 
  
  
  
Single -2.6 (-4.9;-0.3) -2.4 (-6.2;1.4) 0.052 0.978 
  
  
  
Married/cohabiting (ref) 
 
  
Separated/divorced -1.2 (-4.3;1.9) -1.1 (-6.8;4.5) 
Widowed -2.6 (-4.3;-0.9) -1.7 (-5.2;1.7) 
Years of education 
  
  
0-5 years (ref)     0.001 0.102 
  
  
6-12 years 2.1 (0.4;3.8) 2.7 (-0.7;6.1) 
13+ years 4.4 (1.2;7.6) 12.5 (5.4;19.7) 
Same location 
  
Yes (ref)     0.704 0.411 
  No 0.4 (-1.2;2.0) -1.1 (-4.3;2.1) 
Past work 
  
Yes (ref) 
 
  0.003 0.086 
  No -4.3 (-6.7;-1.9) -0.5 (-4.3;3.3) 
Wealth quintile 
  
  
  
  
poorest -6.8 (-9.2;-4.5) -9.3 (-14.3;-4.3) <0.001 0.075 
  
  
  
  
second -2.8 (-5.2;-0.3) -5.8 (-12.0;0.5) 
middle (ref) 
 
  
fourth 0.6 (-1.5;2.6) -3.4 (-8.0;1.2) 
richest 7.0 (4.3;9.7) 0.4 (-3.4;4.2) 
Tobacco 
  
No (ref) 
 
  0.228 0.138 
  Yes 0.2 (-1.6;2.0) 3.4 (-0.5;7.3) 
Alcohol 
  
No (ref)     0.14 0.924 
  Yes -1.6 (-3.6;0.3) -1.8 (-4.8;1.2) 
Physical activity 
  
  
Low -3.3 (-5.3;-1.3) -1.2 (-4.6;2.3) <0.001 0.023 
  
  
Moderate (ref) 
 
  
High -0.1 (-2.2;2.0) 8.0 (2.7;13.4) 
# chronic 
conditions 
  
  
  
0 (ref)     <0.001 0.001 
  
  
  
1 -4.7 (-6.2;-3.1) -2.2 (-5.7;1.4) 
2 -6.6 (-8.5;-4.8) -0.4 (-4.4;3.6) 
3+ -6.9 (-10.0;-3.8) 1.6 (-2.3;5.5) 
1 The p-value for ‘factor’ relates to testing whether that factor is related to well-being in any way. The p-value for the ‘moderation 
effect’ relates to testing whether diabetes moderates the relationship between that factor and the well-being score – i.e. whether 
the relationship is different between individuals with diabetes and those without.  
 
 
  
 231 
 
Appendix G: Untrimmed regression model for WHODAS 
Table G1: Association of diabetes, sociodemographic characteristics, self-reported health behaviours and 
comorbidities with WHODAS (0-36) – original model before removing terms 
 
  
Effect sizes (95% CI) 
P-value1 
 
Factor Category 
Odds Ratio  
(OR) 
 Multiplicative effect / 
exponentiated  regression 
coefficient  
Factor Moderation 
effect 
Non-diabetic 
group 
Diabetic 
group 
Diabetes 
  
No (ref) 1.9 (0.6,5.5)   0.6 (0.4,0.8)  <0.001 
  
N/A 
Yes 0.5 (0.2,1.6) 1.7 (1.2,2.5)   
Sex 
  
Female (ref)      0.119 
  
0.031 
  Male 1.1 (0.8,1.6) 1.0 (0.9,1.2) 0.7 (0.5,1.0) 
Age 
  
  
50-59 years (ref)       <0.001 
  
  
0.846 
  
  
60-69 years 0.8 (0.5,1.1) 1.1 (0.9,1.2) 1.1 (0.8,1.5) 
70+ years 0.6 (0.3,0.9) 1.4 (1.2,1.5) 1.5 (1.1,2.0) 
Marital 
status 
  
  
  
Single 0.5 (0.3,0.9) 1.1 (0.9,1.3) 1.0 (0.8,1.4) 0.015 
  
  
  
0.047 
  
  
  
Married/cohabiting (ref)      
Separated/divorced 0.5 (0.2,1.2) 1.0 (0.9,1.2) 0.6 (0.3,0.9) 
Widowed 0.5 (0.3,0.9) 1.1 (0.9,1.2) 0.9 (0.7,1.2) 
Years of 
education 
  
  
0-5 years (ref)       <0.001 
  
  
0.000 
  
  
6-12 years 2.0 (1.4,2.9) 0.9 (0.8,1.0) 0.9 (0.7,1.1) 
13+ years 3.2 (1.8,5.9) 0.6 (0.5,0.8) 1.5 (1.0,2.3) 
Same 
location 
  
Yes (ref)      0.005 
  
0.121 
  No 1.3 (0.9,1.8) 1.1 (1.0,1.3) 1.4 (1.1,1.8) 
Past work 
  
Yes (ref)      0.004 
  
0.183 
  No 1.0 (0.5,1.9) 1.3 (1.0,1.5) 1.5 (1.2,2.1) 
Wealth 
quintile 
  
  
  
  
poorest 1.3 (0.7,2.2) 1.2 (1.0,1.4) 1.3 (0.9,2.0) 0.087 
  
  
  
  
0.870 
  
  
  
  
second 1.1 (0.7,1.9) 1.1 (1.0,1.2) 1.3 (0.9,1.9) 
middle (ref)      
fourth 0.6 (0.3,1.0) 1.0 (0.8,1.1) 1.0 (0.7,1.4) 
richest 0.9 (0.5,1.5) 0.9 (0.8,1.1) 1.0 (0.7,1.4) 
Tobacco 
  
No (ref)      0.361 
  
0.077 
  Yes 1.0 (0.7,1.5) 1.0 (0.9,1.2) 0.7 (0.5,1.0) 
Alcohol 
  
No (ref)       0.033 
  
0.537 
  Yes 1.0 (0.6,1.5) 1.2 (1.0,1.4) 1.4 (0.9,2.0) 
Physical 
activity 
  
  
Low 1.0 (0.6,1.7) 1.4 (1.2,1.6) 0.9 (0.7,1.1) <0.001 
  
  
0.002 
  
  
Moderate (ref)      
High 0.7 (0.4,1.3) 0.8 (0.7,1.0) 0.7 (0.5,1.0) 
# chronic 
conditions 
  
  
  
0 (ref)       <0.001 
  
  
  
0.003 
  
  
  
1 0.4 (0.2,0.5) 1.3 (1.2,1.5) 0.9 (0.6,1.1) 
2 0.2 (0.1,0.3) 1.7 (1.5,1.9) 1.0 (0.8,1.4) 
3+ 0.1 (0.0,0.3) 1.7 (1.4,2.0) 1.0 (0.7,1.4) 
1 The p-value for ‘factor’ relates to testing whether that factor is related to well-being in any way. The p-value for the ‘moderation 
effect’ relates to testing whether diabetes moderates the relationship between that factor and the well-being score – i.e. whether 
the relationship is different between individuals with diabetes and those without.  
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Appendix H: Observed versus model fitted average scores 
 
Table H1: Observed versus model-fitted (trimmed model) mean WHOQoL (0-100 scale) scores 
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Table H2: Observed versus model-fitted (trimmed model) mean WHODAS (0-36 scale) scores 
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Study 3: Supplementary Materials 
This appendix formed part of the original submission and has 
been peer reviewed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        
 
 
 235 
 
 
            Appendix A Questionnaire Survey  ( Translated Version from English to Afrikaans ) 
 
 
 
 
 
                       
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Chronic Disease Initiative in Africa (CDIA) /UCT 
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A. Can you please give me information about yourself ( Choose the answers that describes you best) Kan 
u/ju asseblief vir my informasie gee oor uself/jouself. (Kies die antwoorde wat u/jou die beste beskryf) 
 
Q1. In what year were you born? 
Y Y Y Y M M D D 
        
 
 
In watter jaar is u/jy gebore? 
 
J J J J M M D D 
        
 
Q2. Gender 
 Male         Female 
Geslag 
  Manlik    Vroulik  
 
Q3. What is your current marital status? 
 single  married  divorced       widow/widower          
Wat is u/jou huwelikstatus op die oomblik? 
 
 Enkel   Getroud   Geskei  Weduwee  Geskei 
 
Q4. What is the highest level of education that you completed 
 none         lower than grade6(Standard 4)          grade 6(Std4)        grade9(Std7)        
grade 10(Std8)    grade 11(Std9)         grade 12(Std10)        college        university 
 
Wat is die hoogste vlak van opvoeding wat u/jy voltooi het? 
 
 Nie opvoeding voltooi nie  opvoeding tot by graad 6  graad 6   graad 9   graad 10
  graad11Universiteit ollege  k 12 adgra   
 
Q5. Are you currently employed with an income 
 yes             no 
Het u/jy huidiglik ń werk met ń inkomste? 
 Ja       Nee 
 
Q6a.If yes, are you working  
 full time          part time 
Indien ja, werk u/jy 
 Voltyds   Deeltyds  
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Q6b. If no, are you 
 unemployed( but physically able to work) 
 
  not able to work because of e.g health problems   receiving a state grant (e. g pension) 
Indien nee, is u /jy? 
 Werkloos (maar liggaamlik instaat om te werk) 
 
 Nie instaat om te werk as gevolg van (a.g.v) gesondheids-probleme  ontvang a toelaag 
van die staat (b.v. pension) 
Q7. With who are you sharing a house 
 spouse               family member             friend                living alone               
more than one person in the house 
Wie deel ń huis met u/jou? 
 Eggenoot  Familie lid   Vriend/Vriendin  Bly alleen   Meer as een person in huis  
 
Q8. What is your monthly income 
 <R 500  R 500 - R1499  R1500 - R2999  >R 3000 
 
Wat is u/jou inkomste per maand? 
 <R 500  R 500 - R1499  R1500 - R2999  >R 3000 
 
B. I  am now going to ask you questions about your diabetes/ sugar illness 
B. Ek gaan u/jou nou vrae vra oor u suikersiekte/diabetes 
Q1. How long have you had diabetes/ sugar illness 
 less than 5 years                    5-10 years         11-16 years          17 years 
Hoeveel jaar het u/jy nou suikersiekte/diabetes? 
 Minder as 5 jaar   5-10 jaar   11-16 jaar  17 jaar 
 
Q2. Are you taking any medication for the sugar illness/diabetes that has been prescribed by a doctor or 
nursing sister 
 yes          no 
Neem u/jy medisyne vir die suikersiekte/diabetes wat deur ń dokter of verpleegster voorgeskryf is?  
   Ja              Nee 
 
Q3.if yes, please indicate the type of treatment 
   insulin injections                     tablets                  both           no medication                 
  I don’t know 
 Indien ja, kies die tipe behandeling? 
 Insulien inspuitings   Pille   Beide  Geen medikasie   ek weet nie 
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Q4.are you taking any other medication for other chronic illnesses  
high blood pressure      heart disease traditional medicine    other       (………………………) 
 I don’t know 
Ontvang u/jy medisyne vir enige ander kroniese siektes  
 
 Hoë Bloeddruk   Hartsiekte   Tradisionele medikasie   ander (………………………) 
 Ek weet nie  
 
Q5a.did you ever receive any advise from a doctor, dietician or nurse on how to live with diabetes/ sugar 
illness 
 yes  no 
 
 (a) Het u/jy al ooit enige raad/advies ontvang vanaf ń dokter, dietkundige of verpleegster, oor hoe om te 
lewe met suikersiekte/diabetes? 
 Ja     Nee 
 
Q5b. or from a health promoter or community health care worker 
   yes    no 
Of vanaf ń gesondheids promotor of ń gemeenskaps gesondheids werker? 
 Ja                  Nee 
Did you ever experience any of the following problems that is associated with diabetes/ sugar illness (name 
the following and tick the appropriate boxes) 
Q6 
 low blood sugar (<4mmol/L)  High blood sugar(>10 mmolL) 
 Heart problems                sexual problems/dysfunction    damage to the back of the eye 
 damage to the nerves (e.g numbness, pins and needles in the hands and feet or sores on the feet) 
 Kidney problems               none of the above 
 I don’t know 
 
Het u al enige van die volgende probleme, wat met suikersiekte/diabetes geassosieer word eervaar? 
(Noem die volgende en merk die wat pas) 
 
 Lae bloedsuiker  (< 4 mmol/L)  Hoë bloedsuiker  (>10 mmol/L) 
 
 Hart problem/siekte              Seksuele probleme        Beskadiging in die agterkant van die oog 
  
 Beskadiging van die senuwees (b.v gevoelloosheid, prikkel gevoel in die hande en voete, of  sere op die 
voete) 
 Nier problem                Niks van bogenoemde  
 
 Ek weet nie  
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Q7.have you been admitted to  hospital for diabetes/ sugar illness in the last 12 months 
 Yes   No  
 
Was u/jy in die laaste 12 maande opgeneem in die hospital vir u/jou suikersiekte/diabetes  
 Ja             Nee 
 
Q8.what is your current status in terms of smoking 
  
 currently smoking  previous smoker  never smoked  
 
Wat is u/jou huidige posisie ten opsigte van die rook van sigarette? 
 Rook tans                 het voorheen gerook     nog nooit gerook  
 
Q9. If you are smoking, how long have you been smoking 
 Less than 2 years  2–3 years  3–4 years  4–5 years  5 or more years 
Indien u/jy well rook, hoelank rook u? 
 Minder as 2 jaar    2–3 jaar     3–4 jaar   4–5 jaar     5 jaar of meer  
 
Q10. Did your doctor, nurse or health care worker ever gave you counselling to stop smoking 
 Yes   No   Not applicable  
Het u/jou dokter, verpleegster, of gesondheids werker u/jou al ooit berading gegee om op te hou rook ?  
 Ja   Nee   Nie van toepassing  
I am now going to ask you questions regarding your lifestyle and how you manage your 
sugar illness/ diabetes 
 Ek gaan u/jou nou vrae vra met betrekking tot u/jou leefwyse en hoe u/jy die 
suikersiekte/diabetes beheer? 
Q1. In the last 7 days how often did you go for a walk out of the house or in the yard?  Example doing 
exercise just for fun, walked to work, took the dog for a walk, walked to the shop ect  
 Never (0 days)  Seldom (1 or 2 days)  Sometimes (3 or 4 days)  Often (5–7 days) 
 
In die afgelope 7 dae hoe gereeld het u/jy  ń end gestap buite die huis of in die agterplaas ?  Byvoorbeeld  
Oefening gedoen net vir pret, werk toe geloop, die hond vir ń stappie geneem, na die winkiel toe geloop ens) 
 Nooit (0 dae)  Weinig  (1 of 2 dae)  Somtyds  (3 of 4 )  Gereeld (5–7 dae) 
Q2 in the last 7 days how often did you participate in a sitting activity like reading, watching television or 
doing needle work 
 Never (0 days)  Seldom (1 or 2 days)  Sometimes (3 or 4 days)  Often (5–7 days)  
 
In die afgelope 7 dae hoe gereeld het u/jy  deelgeneem in ń sittende aktiwiteit soos lees, televisie kyk, of 
handwerk doen? 
 Nooit (0 dae)  Weinig  (1 of 2 dae)  Somtyds  (3 of 4 dae)  Gereeld (5–7 dae) 
 
Q3a.in the past did you ever receive any information from a doctor or nurse regarding physical activity and 
sugar illness/diabetes 
 Yes  No 
(a) Het u/jy al enige advies/informasie in die verlede ontvang, vanaf ń dokter of verpleegster met 
betrekking tot, fisiese aktiwiteite/oefeninge en suikersiekte/diabetes  
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 Ja   Nee 
 
Q3b. or from a health promoter or community health care worker 
 Yes  No 
(b) Of vanaf ń gesondheids promotor of gemeenskaps gesondheids werker ? 
 Ja   Nee 
 
 
 
Q4. Do you sometimes forget to take your medication 
 Yes  No       
Het u/jy al somtyds vergeet om u/jou medikasie te neem vir suikersiekte/diabetes? 
 Ja   Nee 
Q5a. do you need help with giving/ injecting/  administering your insulin 
 Yes  No 
Benodig u/jy hulp met die toediening van u/jou insulien inspuitings?  
 Ja   Nee 
 
Q5b. if yes, what do you need help with 
 Drawing up  Injecting  others (specify ……………………….)  none needed 
 
Indien Ja, watter tipe hulp benodig u/jy? 
 Optrek van die oplossing   Toediening van die inspuiting Ander (Verduidelik…………………) 
 Geen hulp word benodig 
 
Q6.did you ever stopped taking your medication without your doctors permission because it made you feel 
unwell 
 Regularly  Sometimes   Rarely    No 
 
Het u/jy al ooit sonder die dokter se toestemming opgehou om u/jou medikasie te neem, , omdat dit u/jou laat 
sleg voel?  
 Gereeld      Somtye   Weinig     Nee 
 
Q if you travel or leave the house do you ever forget to take your medication for diabetes/ sugar illness with 
you 
 Yes  No   some times 
 
Indien u/jy op reis gaan of die huis verlaat, vergeet u/jy om u/jou medikasie vir suikersiekte/diabetes te neem?  
 Ja   Nee 
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Q8. When you feel your sugar illness / diabetes is under control, do you stop your medication 
 Yes  No   sometimes 
Wanneer u/jy voel dat die suikersiekte/diabetes onder beheer is, stop u/jy die medikasie ? 
 Ja   Nee   Somtye 
 
Q9. A lot of people think to drink medication every day is very difficult. Do you find it difficult to stick to 
your sugar illness/ diabetes treatment plan 
 Yes  No   not sure  
Baie mense voel om hulle medikasie elke dag te drink is baie moeilik. Vind u/jy dit ooit moeilik om te hou by 
u/jou suikersiekte/diabetes behandelings plan? 
 Ja      Nee  Nie Seker nie   
 
Q10. How often do you find it difficult to remember to take all your medication 
 Never/rarely  occasionally  All the time  
Hoe gereeld vind u/jy dit moeilik om te othou om al u/jou medisyne te neem?  
 Nooit/Weinig   Somtye   Altyd 
 Do you follow a diabetes/ sugar illness eating plan 
Q11.   
 Yes  No 
Volg u/jy ń suikersiekte/diabetes eetplan  
 Ja      Nee 
 
Q12.did you ever receive any advice/information from a doctor, dietician or nurse regarding what you must 
eat for your diabetes/ sugar illness 
 Yes  No 
Het u/jy al ooit advies/informasie ontvang vanaf ń dokter, dietkundige of ń verpleegster, oor wat u/jy moet 
eet, as gevolg van (a.g.v.) die suikersiekte/diabetes? 
 Ja      Nee 
 
Q13a.  Do you ever test your blood sugar 
 Yes  No 
Toets u/jy ooit u/jy bloed suiker? 
 Ja      Nee 
 
Q13b if yes, how often 
 Once a day  3 or 4 times a day  1 or 2 times a week  occasionally as needed 
Indien ja, hoe gereeld?  
 Eenkeer per Dag   3 of 4 keer per dag     1 of 2 keer per week    Somtye soos benodig  
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Q13c. Who test your blood sugar  
 Myself  Family  health care Workers  other  
Wie doen dit?  
 Self     Familie     Gesondheids werker   Ander  
 
Q14. When last did you test your urine 
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Wanneer laas was u/jou urine  getoets?  
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
 
 
Q15 when last was your blood pressure tested 
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Wanneer laas was u/jou bloeddruk /geneem? 
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
  
Q16. When last was your cholesterol( fat in the blood) tested 
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Was laas was u/jou bloedvet(cholesterol) getoets?  
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
 
Q17 when did a doctor or nurse looked at the back of your eye or took a photo of the back of your eye 
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Wanneer het ń dokter/verpleegster gekyk na die agterkant van u/jou oë of ń foto geneem van die agterkant 
van u/jou oë? 
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
Q18. When last was your feet examined 
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Wanneer laas was u/jou voete ondersoek?  
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
 
Q19 when last dis you have a doctor’s visit or attended a doctor’s appointment   
 One month ago  Six months ago  One year ago  Two years ago  Not done at all 
Wanneer laas het u/jy ń dokter’s besoek gehad?  
 Een maand gelede   Ses maande gelede   Een jaar gelede   Twee jaar gelede   Nog nie gedoen 
nie  
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D. I am now going to ask you questions about diabetes/ sugar illness ( choose the most appropriate 
answer(s) for the following stat 
Ek gaan u/jou nou vrae vra oor suikersiekte/diabetes  
(Kies die mees gepaste antwoord(e) vir die volgende verklarings) 
 
Q1. Sugar illness/ diabetes is a condition whereby the body: 
 has a higher sugar level in the blood as normal 
has a lower sugar level in the blood as normal 
 I don’t know 
Suikersiekte/diabetes is ń toestand waarby die liggaam:  
 ń Hoër suikervlak in die bloedstroom het as normal  
 ń Laer suikervlak in die bloedstroom het as normal 
 Ek weet nie  
 
Q2. The biggest cause of sugar illness /diabetes is: 
 too much insulin in the body 
 too little insulin in the body 
 I don’t know 
Die grootste oorsaak van suikersiekte/diabetes is:  
 Te veel insulin in die liggaam  
 Te min insulin in die liggaam  
 Ek weet nie  
 
Q3. The signs and symptoms of sugar illness/ diabetes is : 
 Going to the toilet to pass urine more frequently 
  Excessive hunger and thirst 
 Excessive tiredness 
 wounds/ sores takes longer to heel 
 I don’t know 
Die tekens van suikersiekte/diabetes is:  
 Gaan meer tye toilet toe om te urineer  
 Voel meer honger en dors  
 Voel meer moeg  
 Wonde/sere vat langer om gesond te raak  
 Ek weet nie  
Q4. Sugar illness/ diabetes that is not treated : 
 Can cause eye problems 
 Can cause kidney problems 
 Can cause foot sores 
 Can cause heart problems 
 I don’t know 
Suikersiekte/diabetes wat nie behandel word nie:  
 Kan oog probleme veroorsaak  
 Kan nier probleme veroorsaak  
 Kan voetsere veroorsaak  
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 Kan hart probleme veroorsaak  
 Ek weet nie  
Q5. The best way to monitor your sugar illness/ diabetes is to:  
 tset your blood sugar levels           test the sugar in your urine              HbA1c              I don’t 
know 
Die beste manier om suikersiekte/diabetes te monitor is deur die:  
 Toest van die bloed suiker vlakke   Toets van suiker in die urine   HbA1c  Ek weet nie  
 
Q6. In patients with diabetes high blood pressure can increase the risk of 
 heart attack                          strokes                            eye problems 
   kidney problems                         I don’t know  
Hoë bloeddruk kan vir pasiente met suikersiekte/diabetes die risiko’s vererger vir:  
 Hartaanval   Beroerte   Oog probleme  
 Nierprobleme   Ek weet nie 
 
 
 
 
Q7. A person that suffers from sugar illness/ diabetes must have his/her blood pressure checked: 
 Once a year  once every six months  once every two months  once every month 
 Need not check at all  I don’t know 
ń Pasient wat lei aan suikersiekte/diabetes moet sy/haar bloeddruk laat neem: 
 Eenkeer per jaar   Eenkeer elke ses maande   Eenkeer elke twee maande   Eenkeer elke maand  
 Benodig nie om dit te neem nie   Ek weet nie  
 
Q8.in order to live healthy when you are suffering from sugar illness/diabetes , you need to do the following 
changes in your lifestyle 
 loose weight  stop smoking   stop using alcohol   healthy diet  
  Regular physical activity(Exercise)   I don’t know 
Om gesond te leef wanneer u/jy lei aan suikersiekte/diabetes, benodig u/jy om die volgende veranderings 
aan u/jou leefstyl te doen 
 Verloor gewig     Hou op rook         Hou op met die gebruik van alcohol       Gesonde diët 
 Gereelde fisiese oefening   Ek weet nie  
Q9.a person that suffers from sugar illness/diabetes must have his eyes tested: 
 Once a year   Once every six months  Need not check at all 
ń Pasient wat lei aan suikersiekte/diabetes moet sy/haar oë laat toets: 
 Eenkeer per jaar  Eenkeer elke ses maande   Benodig nie om dit te toets nie  
 
Q10 a balanced diet includes: 
 green leafy vegetables  high fibre foods  foods low in sugar, oil and fat    all of the above          
 I don’t know 
  ń Gebalanseerde diet sluit in: 
 Groen blaar groente   Velselryke kosse   Lae suiker, olie en vet   Alles wat genoem is  
 Ek weet nie  
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Q11for proper foot care, a person with sugar illness/ diabetes must 
  wash and inspect the feet daily    choose the most appropriate/ comfortable shoes  
  walk bare foot in and outside of the house    must not walk barefoot in and outside of the house  
Vir ń behoorlike  voetversorging, moet ń pasient wat lei aan suikersiekte/diabetes: 
 Die voete daagliks was en ondersoek   Kies die mees gepaste/gemaklikste skoene   
 Loop kaalvoet binne en buite die huis   Moet nie kaalvoet loop binne en buite die huis nie  
 
Q12.  The treatment of sugar illness/ diabetes include: 
 treatment with antibiotics   blood transfusion   taking of insulin injections   tablets  I don’t know  
Die behandeling van suikersiekte/diabetes sluit in:  
 Behandeling met antibiotika   Bloed oortappings   Neem van insulien inspuitings   Pille             
 Ek weet nie  
 
 
 
 
Q13 sugar illness/ diabetes cannot be treated  with: 
 Insulin   metformin    antibiotics   I don’t know 
Suikersiekte/diabetes kan NIE behandel word met:  
 Insulien  Metformin  Antibiotika   Ek weet nie  
 
Q14. As soon as the diabetes is under control your medication can be 
 stopped immediately    stopped after a month  must be taken for life 
 I don’t know 
Sodra die suikersiekte/diabetes onder beheer is kan u/jy die medikasie: 
 Onmiddelik stop   Stop na ń maand   Moet lewenslank geneem word  
 Ek weet nie  
 
Q15 do you have any religious or cultural practices or beliefs that would influence how you would care for 
your diabetes 
 Yes  No 
: If yes, please explain  
 
…………………………………………………………………………………………………………………………………………………………………………  
…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………………………………… 
Het u/jy enige godsdienstige of kulturele praktyke of oortuigings wat beïnvloed hoe u/jy na u/jou  
suikersiekte/diabetes kyk 
 Ja     Nee 
Indien ja, verduidelik 
…………………………………………………………………………………………………………………………………………………………………………  
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…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………………………………………………………………
………………………………………………………………………………………………………………………………………………………………………… 
    
 
 
Q16.? To help us understand the health needs of the different communities we would like to know in which 
one of the following race groups you would classify yourself.  
 
 black south African  white  coloured indian(Asian) Other(specify)                                                                                                              
Dit help ons om te verstaan die gesondheids behoeftes van die verskillende gemeenskappe en vir dié rede wil 
ons graag weet in watter van die volgende groupe u/jy uself/jouself sal klassifiseer  
 Swart Suid Afrikaans     Wit   Kleurling    Indian (Asian)  Ander (Spesifiseer) 
 
 
 
 
 
 
E. ( 
 
 
 
 
 
 
 
 
 
Item Date Visit I  Visit II Visit III 
Fasting blood 
glucose 
level/mg/dl 
    
 
HbA1c % 
    
Blood pressure     
Item  Datum  Besoek  I  Besoek  II Besoek III 
Vastende 
bloedglukose vlak 
/ mg / dlblem 
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(Hierdie gedeelte moet deur die Personeel (field-workers) voltooi word) 
Glukose + BP data vir die laaste drie besoeke (Soos in pasient leër) 
 
 
 
HbA1c % 
    
Bloed druk      
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F. Social Support Scale  
You might think that some of these questions has already been asked, but in this  section we ask you questions regarding your 
family and friends 
Q1. My family and friends supports me a lot to: ( circle one answer per line)  
 Strongly 
Disagree 
 
Somewhat 
Disagree 
 
Neutral 
 
Somewhat Agree Strongly Agree 
 
Does Not 
Apply 
 
a) Follow my diet/ healthy 
eating plan 
1 2 3 4 5 N/A 
b)   take my medication 1 2 3 4 5 N/A 
c) Care  for my feet 1 2 3 4 5 N/A 
d) Getting enough exercise/ 
physical activity 
1 2 3 4 5 N/A 
e) Testing  my blood 
sugar levels 
1 2 3 4 5 N/A 
f) Handle my feelings 
about diabetes 
1 2 3 4 5 N/A 
 
 
F. Sosiale ondersteunings skaal  
U/jy mag dink dat somige van die volgende vrae alreeds gevra was, maar in die deel vra ons oor u/jou familie en vriende  
 
Q1.My familie en vriende help en ondersteun my baie  om : (Omkring een antwoord per lyn) 
 
 249 
 
 Stem nie 
heeltemal 
saam nie  
 
 Stem  nie ietwat 
saam nie  
 
Neutraal 
 
Stem ietwat saam  Stem heeltemal 
saam  
 
Is nie 
gepas nie  
 
a) Volg my eetplan  1 2 3 4 5 N/A 
b. Neem my medikasie  1 2 3 4 5 N/A 
c. Sorg vir my voete  1 2 3 4 5 N/A 
d. Kry genoeg fisiese 
aktiwiteite/oefening. 
1 2 3 4 5 N/A 
e. Toets my bloedsuiker vlakke . 1 2 3 4 5 N/A 
f. Hanteer my gevoelens oor 
suikersiekte/diabetes  
1 2 3 4 5 N/A 
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Q2. My family and friends(circle one answer per line) 
 
 Strongly 
Disagree 
 
Somewhat 
Disagree 
 
Neutral 
 
Somewhat Agree Strongly Agree 
 
Does Not 
Apply 
 
a. Accepts me and my 
diabetes 
1 2 3 4 5 N/A 
b. Feels uncomfortable 
around me due to my 
diabetes 
1 2 3 4 5 N/A 
c. Encourages me and 
reassures me about 
by diabetes 
1 2 3 4 5 N/A 
d. Discourages and 
upsets me because of 
my diabetes 
1 2 3 4 5 N/A 
e. Listens to me if I 
want to talk about 
my diabetes 
1 2 3 4 5 N/A 
f. Complains about my 
diabetes 
1 2 3 4 5 N/A 
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Q2.My familie of vriende : : (Omkring een antwoord per lyn) 
 
 
 
 
 
 
 
 
 Stem nie 
heeltemal 
saam nie  
 
 Stem  nie ietwat 
saam nie  
 
Neutraal 
 
Stem ietwat saam  Stem heeltemal 
saam  
 
Is nie gepas nie  
 
a. Aanvaar my en my 
suikersiekte/diabetes . 
1 2 3 4 5 N/A 
b. Voel ongemaklik rondom 
my as gevolg van my 
suikersiekte/diabetes  
1 2 3 4 5 N/A 
c. Moedig my aan en stel my 
gerus oor my 
suikersiekte/diabetes  
1 2 3 4 5 N/A 
d. Ontmoedig en onstel my 
oor my suikersiekte/diabetes  
1 2 3 4 5 N/A 
e. Luister na my as ek wil 
gesels oor my 
suikersiekte/diabetes 
1 2 3 4 5 N/A 
f. Kerm/kla oor my 
suikersiekte/diabetes 
1 2 3 4 5 N/A 
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Title of study: Development of self-management programme for older people 
with type 2 diabetes attending community health centres in Cape Town 
metropole. 
Appendix (B) Informed Consent Form 
(For the participants in the questionnaire survey) 
                                                                                                                                                                                                                 
 
 
Name of Principle investigator:                                                                                                                      
Professor Dinky Naomi Levitt.                                                                      
 Name of Co-investigator:                                                                       
Dr Sebastiana Kalula                                                                
Name of Student:                                                            
Dr Mahmoud Werfalli                                                                                      
 
Dear Sir/Mam 
 
You are invited to participate in a research project conducted by the Chronic Diseases Initiative in 
Africa (CDIA) based in the Department of Medicine at the University of Cape Town. We would like 
to ask you to take apart in this study. By taking part in this study, you will help us to understand 
what people with diabetes attending community health centers know about diabetes and how 
they take care of themselves. 
 
This information sheet provides some information to help you decide whether to do so.  If there 
is anything that you do not understand, or if you would like more information, please ask us. Please 
take time to consider whether you wish to take part. 
 
1. Why is this study being done?  
 I am a PhD student in medicine at the University of Cape Town and this study is part of my degree.The 
main reason we are doing this study is to know more about diabetes in the older person. We specifically 
want to better understand how people with diabetes mellitus take care of themselves. This will help us to 
develop a program to improve the care for the 
 older person with diabetes in Cape Town. I believe the study is also important in helping health care staff 
gain a better understanding of how you manage your diabetes. 
 
2. Do I have to take part?   
 
All adults (60 years and over and have diabetes) who attend this community health center clinic 
are eligible to take part. It is up to you to decide if you want to take part in this study. We will 
describe the study and go through this information sheet with you to answer any questions you 
may have.  If you agree to take part, we will ask you to sign a consent form and give you a copy for 
you to keep. However, you would still be free to withdraw from the study at any time, without 
needing to give a reason. 
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3. What will happen to me if I decide to take part? 
 
 
3.1. Written consent. 
 
If you decide you would like to take part in the study the field work assistant will ask you to sign a 
consent form.  You will be given a copy of this form to keep. 
 
3.2. Study questionnaire  
 
The field work assistants will ask you to complete a questionnaire, which is designed to find out 
what you know about your diabetes and how you manage it. You may write down your responses 
or the field worker will write down your responses. This will roughly take 30-35 minutes to 
complete. 
 
4. What are the risks and discomforts of taking part in this study? 
 
There are no foreseeable risks to you associated with participating in this study. 
 
5. Are there any benefits from taking parts in this study? 
 
There are no direct benefits of you participating in the study. It is hoped that the knowledge gained 
from the study will help identify areas where older people with diabetes will benefit from 
improved education and support. Snacks will be provided after the interview as appreciation for 
your participation in this study.        
  
6. What will happen if I start answering the questionnaire but then decide I don’t want to carry on? 
 
If you decide you do not want to carry on with the study. You can withdraw from the study at any 
time and you do not have to give a reason.  If you decide to withdraw it will not affect your care 
or treatment at the clinic. 
 
7. What will happen to the results of the research? 
 
The research will be published in medical journals. We will inform the Department of Health of the 
findings. 
 
8. Will I receive any reward for taking part in this study? 
 
No you will not receive any reward. 
 
 
 
9. Who will see the information which is collected during the study? 
 254 
 
 
Only the research team of this study will see the information collected during this study. Any 
information collected about you during this would be kept strictly confidential.  Your consent form 
will be kept in a locked cabinet in a secure building, and will only be accessed by the research 
team. All other information (your age, gender, date of birth) will be anonymised. A code and not 
your name will be used so that the results could not be linked back to you. Any personal 
information about you will be destroyed at the end of the study. 
 
10. What if something goes wrong? 
 
The University has arrangements in place to provide for harm arising from participation in the 
study for which the university is the Research Sponsor. If you have any concerns about any aspect 
of this study, please contact one of the study Investigators who will do their best to answer your 
questions, (Professor Naomi Levitt, who can be telephoned at 0214066474.) ,(Dr Sebastiana Kalula) 
0214066211) and (Mahmoud Werfalli 0214066582) . 
 
If you remain unhappy, and wish to make a complaint, you may contact the University of Cape 
Town Human Research Ethics Committee office on 021 406 6492 or the head of Human research 
Ethics Committee, Professor Marc Blockman on   0214066338     
 
 
 
 
11. Who has reviewed this study? 
 
All research studies are checked by an ethics committee to ensure the research is conducted safely 
and to the best standards.  This research has been reviewed by and received ethics clearance 
through the University of Cape Town Human Research Ethics Committee. 
 
12. Who is organizing and funding the research? 
 
The research is organized in the Department of Medicine at Groote Schuur Hospital and the 
University of Cape Town. It is funded by the Department of academic scholarships, Ministry of 
higher education. Libya  
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      Thank you for taken the time read this information sheet 
 
 
 
Declaration by the study participant 
I have read, or had read to me, this consent form. I have had the 
opportunity to ask questions and all my questions have been answered to 
my satisfaction. I freely and voluntarily agree to be part of this research 
study. I have received a copy of this agreement. 
I understand I may withdraw without question from the study at any time 
and my withdrawal will not affect my future care. 
PARTICIPANT'S NAME: -------------------------------------------------------------------------------------- 
CONTACT DETAILS:      --------------------------------------------------------------------------------------- 
PARTICIPANT'S SIGNATURE: ------------------------------------------------------- 
Date: --------------------------------------------------------- 
Statement of researcher's responsibility 
I have explained the nature and purpose of this research study and the 
procedures to be undertaken. I have offered to answer any questions and 
fully answered such questions. I believe that the participant understands 
my explanation and has freely given informed consent. 
INVESTIGATOR’S SIGNATURE: ------------------------------------------------------------------- 
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Table. S1. Mean Diabetes Knowledge, self-management practice and social support scores of the 
participants by socio-demographic characteristics. 
Variables N Total knowledge score 
 
Total self-management 
practice score 
Total social support 
score 
   Mean  (SD) Mean  (SD) Mean  (SD) 
Sex  Male  126 45.0 
12.7 54.2 19.9 79.7 20.7 
 Female   280 47.7 
13.1 53.6 17.3 75.3 20.8 
 * P value    0.053  0.76  0.048  
Age group 60-69 
257 47.8 11.9 53.3 18.7 76.7 19.9 
 70-79 
121 45.6 15.2 54.3 16.9 76.4 22.7 
 80 or above 
28 42.6 11.3 55.2 18.5 79.3 20.8 
 + P value  0.21  0.10  0.54  
Level of 
Education 
        
 None / some primary school 
233 45.7 12.4 51.5 18.2 77.7 20.4 
 
Some high school 150 47.6 13.5 54.9 17.5 75.1 21.0 
 Matric / Tertiary 
12 50.1 10.1 58.4 17.7 77.8 20.3 
 # P value  0.008  0.180  0.817  
Marital status Single 
44 41.2 12.9 54.5 17.4 78.7 22.7 
 Married 
209 46.7 12.5 54.4 18.5 77.4 20.1 
 Divorced/ Separated 
65 45.5 15.1 50.1 18.00 74.5 20.3 
 Others  
88 49.4 12.7 54.2 17.3 75.2 21.8 
 + P value  0.008  0.68  0.83  
Race 
 
        
 
Coloured (mixed race) 312 47.0 12.7 53.2 18.3 76.5 20.7 
 
Other (White, Black, Indian and 
other 
94 47.2 13.3 55.9 17.6 77.0 21.7 
 * P value  0.21  0.20  0.84  
Who are Living 
with 
        
 Spouse 
52 49.6 12.1 55.4 18.3 67.7 21.0 
 Family member 
246 46.8 13.1 54.3 17.8 77.3 20.6 
 Friend/ More than one 
83 45.7 14.7 55.5 19.5 82.3 18.0 
 Alone 
25 45.0 12.3 50.6 18.5 75.0 21.5 
 + P value  0.24  0.35  0.001  
Monthly family 
income 
  
  
    
 Less than R 1 500 350 
46.6 12.9 54.1 18.4 77.0 21.0 
 R 1 500 or more 46 
47.6 14.3 53.1 14.0 74.8 20.1 
  * P value  0.63  0.69  0.48  
* t-test for Equality of Means (Sig. (2-tailed), + ONE-WAY ANOVA test,  
+ 
Others: have a joint household, live together. cohabit  
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Table S2.. Mean Diabetes Knowledge, self-management practice and social support scores by 
clinical characteristics of the Participants. 
 
Variables  N Total knowledge 
score 
 
Total self-management 
practice score 
Total social support 
score 
   Mean  (SD) Mean  (SD) Mean  (SD) 
Duration of 
Diabetes         
 
Less than 5 
years 
125 45.3 14.03 55. 16.8 77.0 19.8 
 
5-10 years 158 47.3 13.07 52.0 19.5 75.2 22.3 
 
11-16 years 84 48.2 11.8 53.7 19.0 79.0 18.9  
>17 years 36 46.9 12.1 56.0 13.8 76.3 22.5 
 +P value 
 0.42  0.34  0.59  
Type of medication 
used 
 
       
 
Insulin 
injections 
28 43.3 13.9 52.9 17.1 77.9 26.0 
 
Pills 250 47.6 13.1 52.5 17.9 76.7 20.1 
 
Both 125 46.1 12.6 56.2 18.7 76.8 21.2 
 
+ P value  0.19  0.18  0.95  
Have you 
experienced low 
blood sugar 
No 333 45.9 13.2 53.2 18.4 77.02 21.5 
 
Yes 73 51.2 11.2 56.7 16.5 75.2 18.0 
 * P value 
 .001  0.12  .45  
Have you 
experienced high 
blood sugar 
No 211 45.1 13.5 55.0 16.6 78.5 19.8 
 
Yes 195 48.7 12.2 52.2 19.6 74.7 21.8 
 * P value  .005  .092  .064  
Receiving 
medication for 
chronic 
hypertension 
        
 
No 100 45.2 13.0 54.18 17.8 75.8 21.27 
 
Yes 306 47.4 13.0 53.7 18.3 76.9 20.8 
 * P value  0.15  0.83  .63  
  Receiving 
medication for 
heart disease 
        
 No 
345 46.4 13.0 54.7 17.9 76.6 20.4 
 Yes 
61 49.4 13.0 48.7 18.8 77.0 23.7 
 * P value 
 .097  .017  0.88  
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Receiving 
medication for 
other chronic 
disease(s) 
No  
268 45.9 13.4 53.7 18.6 76.2 21.0 
 Yes  
138 48.7 11.9 53.9 17.1 77.7 20.7  
* P value  0.038  0.93  0.48 
 
Hospitalised in past 
12 months 
No  
20 48.8 13.1 43.6 22.1 70.8 23.0 
 Yes  
382 46.7 13.0 54.5 17.7 76.3. 20.8 
 * P value  0.48  .042  0.20  
‡ Blood glucose 
control achieved Not 
achieved 
(<5.0 or >7.2 
mmol/l) 
331 46.9 13.3 54.1 18.5 77. 20.0 
 
Achieved 
(5.0 -7.2 
mmol/l) 
71 46.3 11.9 52.2 16.6 72.7 24.1 
 P value  0.70  0.43  o.12  
 
‡ For blood glucose control according to Krikman criteria, 2012, the range (Not achieved (<90 or >130), 
Achieved (90-130) 
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Table S3. Association of socio-demographic variables, HbA1c and social support with knowledge score 
Variable  95% CI P value 
Female 0.660 -0.285; 1.604 0.160 
Age group, years  
(ref = 55-69 years) 
70-79 years -0.461 -1.495; 0.572 0.380 
>80 years -1.893 -3.754; -0.031 0.046 
Education level 
(ref = None / some primary school) 
Some or completed High school/Tertiary education 0.639 -0.273; 1.550 0.169 
Income >R1500 
(ref = <R1500) 
0.324 -1.013; 1.661 0.634 
Living alone 
(ref = Living with Family/friends/spouse) 
0.111 -1.668; 1.889 0.903 
HbA1c >8% 
(ref = HbA1c <8%) 
-0.272 -1.183; 0.638 0.557 
Social support -0.018 -0.093; 0.058 0.649 
 Multivariable linear regression was used to evaluate the associations between knowledge (dependant variable) and 
sociodemographic variables (gender, age group, education level, income, living environment, glycaemic control and social 
support (independent variables). 
Adjusted R-squared – 1.0%, Prob  > F  =  0.206  
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Table S4. Association of socio-demographic variables, HbA1c and social support with self-management practice score 
Variable  95% CI P value 
Female 1.230 -0.372; 2.831 0.131 
Age group, years  
(ref = 55-69 years) 
70-79 years 0.510 -1.178; 2.199 0.551 
>80 years 0.443 -2.505; 3.392 0.767 
Education level 
(ref = None / some primary school) 
Some or completed High school/Tertiary education -0.038 -1.592; 1.516 0.961 
Income >R1500 
(ref = <R1500) 
3.434 0.797;  6.070 0.011 
Living alone 
(ref = Living with Family/friends/spouse) 
-0.725 -3.496; 2.047 0.606 
HbA1c >8% 
(ref = HbA1c <8%) 
  0.117 -1.427; 1.660 0.881 
Social support -0.061 -0.065; 0.188 0.340 
 Multivariable linear regression was used to evaluate the associations between self-management practice score 
(dependant variable) and sociodemographic variables (gender, age group, education level, income, living environment, 
glycaemic control and social support (independent variables). 
Adjusted R-squared – 1.3%, Prob  > F  =  0.275 
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Study 4: Supplementary Materials 
This appendix formed part of the original submission and 
has been peer reviewed. 
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Title  Author and date of 
publication 
Sourced 
White Paper for Social Welfare Ministry of Social 
Development 1994 
 
www.gov.za/sites/default/files/White_Paper_on_Social_Welfare_0.pdf.  
Older Person’s Act (Act 13 of 2006) 
 
SA Parliament  www.westerncape.gov.za/legislation/older-persons-act-13-2006.  
SA National Plan of Action on Ageing 
 
Ministry of Social 
Development 2002 
www.tafta.org.za/images/SAPlanofActiononAgeing.pdf.  
South Africa’s Progress on the Implementation of the Madrid Plan of 
Action on Ageing  
 
Ministry of Social 
Development 2007 
http://libguides.lib.uct.ac.za/c.php?g=214526&p=1579027.  
Policy implications and challenges of populations ageing in South 
Africa 
 
Goodrick WF, 2013 scholar.google.com/scholar.  
Vulnerable Groups Series II: The Social Profile of Older Persons, 
2011–2015 
 
Statistics South Africa 
2017 
http://www.statssa.gov.za/publications/Report%2003-19-03/Report%2003-19-
032015.pdf.  
Society for Endocrinology, Metabolism and Diabetes of South Africa 
(SEMDSA) issued the first edition of the Consensus Guidelines for 
the management of type 2 diabetes 
 
JEMDSA, 2017, Vol 22, 
no 1, Supp 1, pages 
S1-S196 
www.semdsa.org.za/images/647-4385-1-pb.pdf.  
Master’s Thesis in Sociology, University of Free State, 2013: Policy 
implications and challenges of population ageing in South Africa 
 
Wade Francis Goodrick http://scholar.ufs.ac.za:8080/xmlui/handle/11660/1879.  
The Samson Institute for Ageing Research (SIFAR) 
 
  
http://www.sifar.org.za.  
SA Strategic Plan for the Prevention and Control of NCDs 
 
 http://www.hsrc.ac.za/uploads/pageContent/%20proof.pdf.  
SA Health Review 20th edition, 2017 
 
2017 http://www.hst.org.za/publications/South%2%20Version.pdf.  
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Supplementary Table 2: Barriers to self-management experienced by older 
diabetic patients 
Side effects of 
medication 
“Many patients experience side effects with Metformin. We get tons of 
returned meds in the pharmacy bins. Patients want to be seen as ‘good 
patients’ and just accept medication, even if they don’t intend using 
them.”  (K1) 
 
Loss of function  “With poor vision and motor control it is difficult for them to give 
themselves injections and examine their own feet.” (K1) 
 
“Many patients have cognitive decline that isn’t diagnosed or 
acknowledged, so they don’t understand clearly or get confused.” K1) 
 
“They get forgetful and can’t remember which pills for what are and if 
they have even taken them.” 
K1) 
Constrained 
dietary choices 
“The elderly have fewer choices because they are often living with their 
children and have no say in the shopping or cooking. They just eat what 
there is to avoid feeling like a burden.” (K5) 
 
“They think they need to eat special foods labelled “Diabetic” and these 
are expensive. Fruit and vegetables are also expensive if you don’t have 
transport to Wholesalers like Fruit&Veg.” (K5) 
 
High carb foods are relatively cheap for the satiety they give. For 
example, if one is hungry a loaf of bread and polony is cheap and filling.” 
(K5) 
 
Prevalent social 
norms around food 
“Rejecting food that is offered is seen as rude, especially at a social 
function like a wedding or birthday. People do not usually cater for 
diabetics: big life events are celebrated with calorie dense, sugary food.” 
(K5) 
 
Poverty “Many of my older patients wear cheap shoes that squeeze their toes 
and give poor support because they cannot afford sports shoes with 
thick soles and a wide toe box.” (K3) 
 
“It is hard to prioritise good diabetic control, when the emphasis is on just 
living day to day.” (K3) 
 
Lack of education  
 
“Self-management can be a problem for many older patients because 
they are not well educated.” (KI 4) 
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Lack of family 
support 
 
“Often, they have no support from their families.” (K3) 
Constrained 
opportunity for 
physical activity 
 
“It is not safe for older patients to walk or exercise outside in areas of 
high crime.” (K2) 
 
Difficulty 
accessing 
healthcare 
“Many patients have difficulty with transport to the community health 
centre or to Orthotics in Pinelands, either because it is not available or 
too expensive.” (K2) 
 
“Some of them are not so mobile and cannot get to the healthcare 
facility, so they need special care to accommodate them.” (KI 5) 
 
Severely limited 
consultation time 
“Older patients need longer consultations but when you are seeing 35 
patients a day, there is no time.” (KI 3) 
 
“It is very hard to explain a complex condition with complex therapy in 
the time allotted and doctors often don’t communicate well.” (KI 3) 
 
Poor 
communication 
with healthcare 
providers 
“Generally, communication between providers and patients is very poor. 
Staff are sometimes impatient and disrespectful, because they are burnt 
out.” (K2) 
 
“Providers tend to use medical terms which patients are not acquainted 
with. Patients would prefer simple explanations.” 
 
“The staff should come down to the patient’s level so that they can feel 
they are part of the discussion about their health.” (KI 5)  
 
“Doctors tend to speak to the family members instead of directly to the 
older patient. So, the patient is disempowered.” (K3) 
 
Lack of status “Patients with chronic disease are undervalued by the health system.” 
(K2) 
 
“Most of the people managing diabetics have more interest in the 
younger people. They say they are the future generation. But that leaves 
old people with a feeling of being ignored.” (KI 5) 
 
“I am interested in managing diabetes in older people as I think they 
have real problems in managing themselves. Proper education should be 
provided to them to avoid them feeling rejected due to old age.” (KI 5) 
 
Depression “Patients are often depressed, and this affects their motivation to live 
healthily.” (K3) 
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Multi-morbidity “It is particularly difficult for the older patient with multi-morbidity: there 
are too many pills with side effects and drug interactions.” (K3) 
 
“Older patients are likely to be taking more than one chronic medication, 
which means they need closer monitoring as there may be drug 
interactions.” (KI 5) 
 
“Each co-morbidity affects the other. For example, a patient with Osteo 
arthritis or Chronic Obstructive Pulmonary Disease finds it difficult to 
exercise.” (K3) 
 
“Food that might be good for one condition, may not be good for 
another. For example, diabetic patients should eat more greens, but a 
patient on warfarin should avoid spinach because it has vitamin K, which 
thickens the blood.” (KI 5) 
 
“Once you have checked on all the different conditions, there is little time 
to focus on diabetes. Patients with co-morbidities especially need longer 
consultation times.” (KI1) 
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Study 5: Supplementary Materials 
This appendix formed part of the original submission 
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Additional File 1. Search Strategy 
 
A. Search strategy structure ( A AND B AND C OR D AND E) 
(A) "diabetes mellitus"[MeSH Terms] OR ("diabetes"[All Fields] AND "mellitus"[All Fields]) OR "diabetes mellitus"[All Fields] 
OR "diabetes"[All Fields] OR "diabetes insipidus"[MeSH Terms] OR ("diabetes"[All Fields] AND "insipidus"[All Fields]) OR 
"diabetes insipidus"[All Fields])) AND (Clinical Trial[ptyp] AND "aged"[MeSH Terms]))) AND (peer support diabetes AND 
Clinical Trial[ptyp] 
(B)  AND ((((((((((((((((peer[All Fields] AND based[All Fields] AND interventions[All Fields]) OR (peer-led[All Fields] AND 
interventions[All Fields])) OR (peer[All Fields] AND ("education"[Subheading] OR "education"[All Fields] OR "educational 
status"[MeSH Terms] OR ("educational"[All Fields] AND "status"[All Fields]) OR "educational status"[All Fields] OR 
"education"[All Fields] OR "education"[MeSH Terms]))) OR "Social Support"[Mesh]) OR peers[All Fields]) OR (peer[All 
Fields] AND support[All Fields])) OR (peer[All Fields] AND ("counselling"[All Fields] OR "counseling"[MeSH Terms] OR 
"counseling"[All Fields]))) OR "Self-Help Groups"[Mesh]) OR (("population groups"[MeSH Terms] OR ("population"[All 
Fields] AND "groups"[All Fields]) OR "population groups"[All Fields] OR "group"[All Fields]) AND support[All Fields])) OR 
(("population groups"[MeSH Terms] OR ("population"[All Fields] AND "groups"[All Fields]) OR "population groups"[All Fields] 
OR "group"[All Fields]) AND ("education"[Subheading] OR "education"[All Fields] OR "educational status"[MeSH Terms] 
OR ("educational"[All Fields] AND "status"[All Fields]) OR "educational status"[All Fields] OR "education"[All Fields] OR 
"education"[MeSH Terms]))) OR (peer[All Fields] AND leader[All Fields])) OR (lay[All Fields] AND ("health educators"[MeSH 
Terms] OR ("health"[All Fields] AND "educators"[All Fields]) OR "health educators"[All Fields]))) OR (lay[All Fields] AND 
("manpower"[Subheading] OR "manpower"[All Fields] OR "workers"[All Fields]))) OR (lay[All Fields] AND ("health"[MeSH 
Terms] OR "health"[All Fields]) AND advisor[All Fields])) OR "Community Health Workers"[Mesh]) OR ("community health 
workers"[MeSH Terms] OR ("community"[All Fields] AND "health"[All Fields] AND "workers"[All Fields]) OR "community 
health workers"[All Fields] OR ("community"[All Fields] AND "health"[All Fields] AND "worker"[All Fields]) OR "community 
health worker"[All Fields]))) AND 
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(C) AND  (Africa or "Latin America" or Caribbean or "West Indies" or "Eastern Europe" or Soviet or "South America" or 
"Middle East" or "Latin America" or "Central America") or(Afghanistan or Albania or Algeria or Angola or Antigua or Barbuda 
or Argentina or Armenia or Armenian or Aruba or Azerbaijan or Bahrain or Bangladesh or Barbados or Benin or Byelarus 
or Byelorussian or Belarus or Belorussian or Belorussia or Belize or Bhutan or Bolivia or Bosnia or Herzegovina or 
Hercegovina or Botswana or Brasil or Brazil or Bulgaria or Burkina Faso or Burkina Fasso or Upper Volta or Burundi or 
Urundi or Cambodia or Khmer Republic or Kampuchea or Cameroon or Cameroons or Cameron or Camerons or Cape 
Verde or Central African Republic or Chad or Chile or China or Colombia or Comoros or Comoro Islands or Comores or 
Mayotte or Congo or Zaire or Costa Rica or Cote d'Ivoire or Ivory Coast or Croatia or Cuba or Cyprus or Czechoslovakia or 
Czech Republic or Slovakia or Slovak Republic or Djibouti or French Somaliland or Dominica or Dominican Republic or 
East Timor or East Timur or Timor Leste or Ecuador or Egypt or United Arab Republic or El Salvador or Eritrea or Estonia 
or Ethiopia or Fiji or Gabon or Gabonese Republic or Gambia or Gaza or Georgia Republic or Georgian Republic or Ghana 
or Gold Coast or Greece or Grenada or Guatemala or Guinea or Guam or Guiana or Guyana or Haiti or Honduras or 
Hungary or India or Maldives or Indonesia or Iran or Iraq or Isle of Man or Jamaica or Jordan or Kazakhstan or Kazakh or 
Kenya or Kiribati or Korea or Kosovo or Kyrgyzstan or Kirghizia or Kyrgyz Republic or Kirghiz or Kirgizstan or Lao PDR or 
Laos or Latvia or Lebanon or Lesotho or Basutoland or Liberia or Libya or Lithuania or Macedonia or Madagascar or 
Malagasy Republic or Malaysia or Malaya or Malay or Sabah or Sarawak or Malawi or Nyasaland or Mali or Malta or 
Marshall Islands or Mauritania or Mauritius or Agalega Islands or Mexico or Micronesia or Middle East or Moldova or 
Moldovia or Moldovian or Mongolia or Montenegro or Morocco or Ifni or Mozambique or Myanmar or Myanma or Burma or 
Namibia or Nepal or Netherlands Antilles or New Caledonia or Nicaragua or Niger or Nigeria or Northern Mariana Islands 
or Oman or Muscat or Pakistan or Palau or Palestine or Panama or Paraguay or Peru or Philippines or Philipines or 
Phillipines or Phillippines or Poland or Portugal or Puerto Rico or Romania or Rumania or Roumania or Russia or Russian 
or Rwanda or Ruanda or Saint Kitts or St Kitts or Nevis or Saint Lucia or St Lucia or Saint Vincent or St Vincent or Grenadines 
or Samoa or Samoan Islands or Navigator Island or Navigator Islands or Sao Tome or Saudi Arabia or Senegal or Serbia 
or Montenegro or Seychelles or Sierra Leone or Slovenia or Sri Lanka or Ceylon or Solomon Islands or Somalia or South 
Africa or Sudan or Suriname or Surinam or Swaziland or Syria or Tajikistan or Tadzhikistan or Tadjikistan or Tadzhik or 
Tanzania or Thailand or Togo or Togolese Republic or Tonga or Trinidad or Tobago or Tunisia or Turkey or Turkmenistan 
or Turkmen or Uganda or Ukraine or Uruguay or USSR or Soviet Union or Union of Soviet Socialist Republics or Uzbekistan 
or Uzbek or Vanuatu or New Hebrides or Venezuela or Vietnam or Viet Nam or West Bank or Yemen or Yugoslavia or 
Zambia or Zimbabwe or Rhodesia). 
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(D)OR (((("poverty"[MeSH Terms] OR "poverty"[All Fields] OR ("low"[All Fields] AND "income"[All Fields]) OR "low 
income"[All Fields]) AND countries[All Fields]) OR (middle[All Fields] AND ("income"[MeSH Terms] OR "income"[All Fields]) 
AND countries[All Fields])) OR (low-middle[All Fields] AND ("income"[MeSH Terms] OR "income"[All Fields]) AND 
countries[All Fields])))  
(E) AND (((((interventions [All Fields] OR "Randomized Controlled Trial"[Publication Type]) OR RCT[All Fields]) OR 
"Controlled Clinical Trial"[Publication Type]) OR CCT[All Fields]) OR experiment[All Fields]) AND (("2000/01/01"[PDAT] : 
"2017/12/31"[PDAT]) AND "adult"[MeSH Terms]) 
 
 
 270 
 
Additional file 2 
Cochrane Risk of Bias Tool 
Domain Description High Risk of Bias Low Risk of Bias Unclear Risk of bias  Reviewers assessment  Reviewers comments   
 
Selection bias 
Random 
sequence 
generation 
 
Described the method 
used to generate the 
allocation sequence in 
sufficient detail to allow 
an assessment of 
whether it should 
produce comparable 
groups 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate generation 
of a randomized 
sequence 
Random sequence 
generation method 
should produce 
comparable groups 
Not described in 
sufficient detail 
High 
Low 
Unclear 
 
Selection bias 
Allocation 
concealment 
Described the method 
used to conceal the 
allocation sequence in 
sufficient detail to 
determine whether 
intervention allocations 
could have been 
foreseen before or 
during enrollment 
Selection bias (biased 
allocation to 
interventions) due to 
inadequate 
concealment of 
allocations prior to 
assignment 
Intervention allocations 
likely could not have 
been foreseen in 
before or during 
enrollment 
Not described in sufficient 
detail 
High 
Low 
Unclear 
 
Reporting bias 
Selective reporting 
Stated how the 
possibility of selective 
outcome reporting was 
examined by the 
authors and what was 
found 
 
 
Reporting bias due to 
selective outcome 
reporting 
Selective outcome 
reporting bias not 
detected 
Insufficient information to 
permit judgment† 
High 
Low 
Unclear 
 
Performance bias 
Blinding (participants 
and personnel) 
Described all measures 
used, if any, to blind 
study participants and 
personnel from 
knowledge of which 
intervention a 
participant received. 
Provided any 
information relating to 
whether the intended 
blinding was effective. 
Performance bias due 
to knowledge of the 
allocated interventions 
by participants and 
personnel during the 
study. 
Blinding was likely 
effective. 
Not described in sufficient 
detail 
High 
Low 
Unclear 
 
Detection bias 
Blinding (outcome 
assessment 
Described all measures 
used, if any, to blind 
outcome assessors 
from knowledge of 
which intervention a 
participant received. 
Detection bias due to 
knowledge of the 
allocated interventions 
by outcome 
assessors. 
Blinding was likely 
effective. 
Not described in sufficient 
detail 
High 
Low 
Unclear 
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Provided any 
information relating to 
whether the intended 
blinding was effective 
Attrition bias 
Incomplete outcome 
data 
Described the 
completeness of 
outcome data for each 
main outcome, 
including attrition and 
exclusions from the 
analysis. Stated 
whether attrition and 
exclusions were 
reported, the numbers 
in each intervention 
group (compared with 
total randomized 
participants), reasons 
for attrition/exclusions 
where reported. 
Attrition bias due to 
amount, nature or 
handling of incomplete 
outcome data. 
Handling of incomplete 
outcome data was 
complete and unlikely 
to have 
Insufficient reporting of 
attrition/exclusions to permit 
judgment (e.g., number 
randomized not stated, no 
reasons for missing data 
provided) 
High 
Low 
Unclear 
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Additional file 3 
 
 Risk of bias of included studies 
  
Author:  (Zhong  2015)                                                   Study design: RCT                                              Country: China 
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
Unclear risk Insufficient information. 
Selection bias 
 Allocation concealment 
Unclear risk Insufficient information. 
Detection bias 
 Blinding (outcome assessment 
High Risk Community nurses collecting outcome data could not be 
blinded to allocation due to nature of 
intervention/control 
Attrition bias  
Incomplete outcome data 
High risk Acknowledge loss to follow up.  However, ITT analysis 
wasn’t attempted. 
Reporting bias  
Selective reporting 
Low risk The main primary and secondary outcomes were stated. 
Performance bias Blinding 
(participants and personnel) 
Unclear risk Authors acknowledge that patients receiving the 
intervention were seen at the same clinic as the control 
group.  It is thus possible that the presence of peer 
leaders influenced the usual care group. 
Author:   (Gargliardino  2014)                                      Study design:  RCT                                      Country: Argentina  
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
Unclear risk Insufficient information. 
Selection bias 
 Allocation concealment 
Unclear risk Insufficient information. 
Detection bias 
 Blinding (outcome assessment 
High Risk It was not possible  to blind outcome assessors due to 
nature of intervention/control. 
Attrition bias  
Incomplete outcome data 
Unclear risk Insufficient information. 
Reporting bias  
Selective reporting 
Low risk The main outcomes were stated. 
Performance bias Blinding 
(participants and personnel) 
High risk  It was not possible to blind the peer , patients o  due to 
nature of intervention/control 
Author: (Mash  2014)                                          Study design: RCT                                               Country: South Africa   
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
Low risk Computer-generated random numbers were used 
Selection bias 
 Allocation concealment 
Unclear risk Insufficient information. 
Detection bias 
 Blinding (outcome assessment 
High Risk It was not possible to blind the data collection teams as 
to whether the health centre was a control or 
intervention site. 
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Attrition bias  
Incomplete outcome data 
Low risk  Missing data were imputed using appropriate methods, 
including logistic regression and inverse probability 
weighting. 
Reporting bias  
Selective reporting 
Low risk The  study was conducted according to a protocol 
containing pre-specified outcomes  
Performance bias Blinding 
(participants and personnel) 
High  It was not possible to blind the peers, patients to whether 
the health centre was a control or intervention site 
 Author: (Liu et al. 2012)                             Study design: RCT                                                          Country: China 
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
 
Low risk Participants in the same community were randomized 
into "intervention group" and "control group", according 
to a random-number table with a randomization ratio 
designed to yield no fewer than 20 and no more than 25 
participants in a group.” 
Selection bias 
 Allocation concealment 
Low risk Investigators and assessors (those collecting and 
analysing data) were blinded to group assignments. 
Detection bias 
 Blinding (outcome assessment 
Low risk  Data collection was completed by university students 
who did not know the patients or their intervention 
status.  
Attrition bias  
Incomplete outcome data 
High  The study report fails to include results for a key outcome 
that would be expected to have been reported for such a 
study. No data on HbA1c levels nearly 15% of participants 
did not complete the study, which may cause bias 
results.” 
Reporting bias  
Selective reporting 
Low risk The study protocol is available and all of the study’s pre-
specified (primary and secondary) outcomes that are of 
interest in the review have been reported in the pre-
specified way 
Performance bias Blinding 
(participants and personnel) 
High risk  Participants were aware of their treatment assignments.” 
The blind wasn’t effective  
Author:  (Wu et al. 2011)                               Study design: RCT                                                 Country: Taiwan   
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
Low risk Participants  were randomly assigned to either the 
control group or the intervention group by using a 
random number table. 
Selection bias 
 Allocation concealment 
Unclear risk Insufficient information. 
Detection bias 
 Blinding (outcome assessment 
High Risk It was not possible to blind outcome assessors due to 
nature of intervention/control. 
Attrition bias  
Incomplete outcome data 
Low risk The characteristics of those who dropped out were 
similar to those who participated in the study “Other 
significant outcomes (HbA1c, Body Mass Index, blood 
pressure, and body weight) were not measured in this 
study. 
Reporting bias  
Selective reporting 
High Risk  other significant outcomes (HbA1c, Body Mass Index, 
blood pressure, and body weight) were not measured in 
this study. 
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Performance bias Blinding 
(participants and personnel) 
High Risk 1. It was not possible to blind the peer , patients  
due to nature of intervention/control.  
2. The effects of the SEEIP in this study might have 
been influenced by a Hawthorne effect due to 
the increased amount of attention that was paid 
to the participants in the intervention group by 
the group facilitator. 
Author: (Assah et al., 2015)               Study design:  Non-randomized Control Trial                  Country: Cameroon  
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  non-randomized controlled trial 200 adults with poorly 
controlled Type 2 diabetes (HbA1c > 7%) were initially 
recruited from the National Obesity Centre, at the 
Yaoundé Central Hospital. One hundred subjects were 
recruited into the intervention arm; Thereafter, 96 age 
and sex-matched controls were recruited into the control 
arm. 
Selection bias 
 Allocation concealment 
High risk  No  
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible  to blind outcome assessors due to 
nature of intervention/control 
Attrition bias  
Incomplete outcome data 
Unclear risk Insufficient information. 
Reporting bias  
Selective reporting 
High risk  One or more outcomes of interest in the review are 
reported incompletely so that they cannot be entered in 
a meta-analysis. In the control group, the only data 
collected was HbA1c; in the intervention group BP, 
cholesterol, BMI, etc. Was also obtained. 
 
Performance bias Blinding 
(participants and personnel) 
High risk It was not possible to blind the peer, patients o due to 
nature of intervention/control 
Author :( Micikas M  .2014)          Study design: a pre-post quasi experimental                  Country: Guatemala 
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  no information. 
Selection bias 
 Allocation concealment 
High risk  no information.  
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible to blind the  data collection teams  
due to nature of intervention/control 
Attrition bias  
Incomplete outcome data 
Unclear risk Insufficient information. Provided. 
Reporting bias  
Selective reporting 
High risk  The survey instrument used in the study was designed 
for Latino populations in Atlanta and includes measures 
that seek to quantify levels of physical activity, food 
intake, depression, and social support scales which did 
not translate well to the cultural context of this 
community 
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Performance bias Blinding 
(participants and personnel) 
High risk  It was not possible to blind the peer , patients   due to 
nature of intervention/control. 
 (Baumann 2014)             Study design: a pre-post quasi experimental               Country: Uganda 
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  The method didn't specify 
Selection bias 
 Allocation concealment 
High risk  The method didn't specify 
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible  to blind outcome assessors due to 
nature of intervention/control 
Attrition bias  
Incomplete outcome data 
Low risk   information on reasons for missing data provided 
Reporting bias  
Selective reporting 
Low risk  All stated outcome measures reported 
Performance bias Blinding 
(participants and personnel) 
High risk It was not possible to blind the peer , patients   due to 
nature of intervention/control. 
(Huixia Shen  2008)                    Study design: pre-post quasi experimental              Country:  China   ( Thesis) 
 
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk No 
Selection bias 
 Allocation concealment 
High risk  A quasi-experimental, nonequivalent control group 
design was used and. Subjects are not randomly 
assigned.’ 
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible  to blind outcome assessors due to 
nature of intervention/control. 
Attrition bias  
Incomplete outcome data 
Unclear risk Insufficient information. 
Reporting bias  
Selective reporting 
Low risk  The study protocol is available and all about outcomes 
that are of interest have been reported in the pre-
specified way. 
Performance bias Blinding 
(participants and personnel) 
High  risk It was not possible to blind the peer , patients  due to 
nature of intervention/control 
(Eggermont N 2011)               Study design: before-after study design                  Country: Cambodia (thesis) 
   
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  No  
Selection bias 
 Allocation concealment 
High risk  No  
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible to blind outcome   due to nature of 
intervention/control. 
Attrition bias  
Incomplete outcome data 
Unclear risk Insufficient information. 
Reporting bias  
Selective reporting 
Low risk All stated outcome measures reported 
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Performance bias Blinding 
(participants and personnel) 
High  risk It was not possible to blind peer and patients   due to 
nature of intervention/control. 
(Rotheram-Borus et al 2012)                   Study design: before-after study                           Country:  South Africa  
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  No  
Selection bias 
 Allocation concealment 
High risk  No  
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible to blind the outcome assessors due to 
nature of intervention/control 
Attrition bias  
Incomplete outcome data 
Low risk   reasons for missing data provided. 
Reporting bias  
Selective reporting 
Low risk  The main outcomes were stated. 
Performance bias Blinding 
(participants and personnel) 
High  risk It was not possible to blind the peer and  patients  due to 
nature of intervention/control 
(Less  2010)                                                    Study design:  Before and after  study                           Country:  Jamaica  
ITEM AUTHORS’ JUDGMENT SUPPORT FOR JUDGMENT 
Selection bias  
Random sequence generation 
High risk  No  
Selection bias 
 Allocation concealment 
High risk  No  
Detection bias 
 Blinding (outcome assessment 
High risk It was not possible to blind the outcome  assessors due to 
nature of intervention/control. 
Attrition bias  
Incomplete outcome data 
Low risk   reasons for missing data provided. 
Reporting bias  
Selective reporting 
Low risk  The main outcomes were stated. 
Performance bias Blinding 
(participants and personnel) 
High risk It was not possible to blind the peer and patients  due to 
nature of intervention/control. 
 
 
 
 
 
 
 
